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Introduction: Nightmares are a common problem recognised in Post-traumatic stress 
disorder (PTSD; Neylan et al., 1998) and Borderline personality disorder (Semiz, Basoglu, 
Ebrinc and Cetin (2008).  In a healthy student sample, nightmare distress was positively 
correlated with paranoia and psychoticism (Levin & Fireman, 2002).  However, nightmares 
have never been investigated in people with psychosis.  Imagery Rehearsal (IR) has been 
effective in reducing the frequency of nightmares, improving sleep and symptoms of PTSD 
(Casement & Swanson, 2012), but again, has never been trialled in psychosis.  Aims: Study 
A examined the prevalence of nightmares in those with psychosis, their link with sleep 
quality, psychotic, affective and cognitive symptoms.  Study B investigated whether an IR 
protocol (IR; Nappi, Drummond, Thorp & McQuaid, 2010) might be suitably adapted for 
people with psychosis.  Methods:  Forty participants with psychotic symptoms completed 
a semi-structured interview to assess nightmares, sleep quality, severity of delusions, 
hallucinations, depression, anxiety, stress, global distress, PTSD, daily activities and working 
memory.  Five participants completed 4-6 sessions of IR for nightmares (study B).  Results: 
55% of patients reported weekly distressing nightmares.  Nightmare frequency was related 
to sleep quality, sleep efficiency and depression.  More distressing nightmares were 
associated with worse delusions, depression, anxiety, stress and working memory.  The 
case series demonstrated the feasibility of IR for the treatment of nightmares in those with 
psychosis; reductions in nightmare distress, vividness, intensity, affective and psychotic 
symptomatology were observed post-intervention.  Conclusion: Nightmares are common 
in those with psychosis and impact on day and night time experiences.  They may present a 
target for intervention.  The cross sectional nature of study A and small, uncontrolled 
sample of study B present limitations to conclusions.  Future research should aim to 
uncover the direction of causality between nightmares and daytime symptoms and further 
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“A ruffled mind makes a restless pillow” 
       Charlotte Brontë  
 
 




 The role of sleep and nightmares in mental health has received remarkably little attention 
in the scientific literature.  Only in the last twenty years have empirical investigations taken 
place to look at the relationship between nightmares, sleep quality and clinical diagnoses, 
such as post-traumatic stress disorder (Neyla et al., 1998; Leskin, Woodward, Young & 
Sheikh, 2002; Krakow et al., 2000; Davis & Wright, 2007; Davis et al., 2011; Nappi, 
Drummon, Thorp & McQuaid, 2010) and borderline personality disorder (Semiz, Basoglu, 
Ebrinc & Cetin, 2008).  The past five years has drawn attention to major sleep disruption in 
those with psychosis (Wilson & Argyropoulos, 2012; Afonso, Figuera & Paiva, 2013; Wulff, 
Dijk, Middleton, Foster & Joyce, 2012; Freeman, Pugh, Vorontsova & Southgate, 2009; 
Bromundt et al., 2011).  However, the role of nightmares in those with a diagnosis of 
psychosis has not been considered. This study contributes to this new research area. The 
phenomenology of nightmares within the context of psychosis is described and a 
psychological intervention for the treatment of nightmares was adapted and piloted for 
those with psychotic symptoms in a small case series. 
 
The literature review that follows is divided into three parts.  The first section considers the 
classification, epidemiology and economic impact of psychotic disorders.  The middle 
section of the review will justify the relevance of investigating nightmares in those with 
psychosis by considering the impact of sleep and nightmares on daytime functioning 
outside of psychosis literature.  It will consider what is known already about sleep 
disturbance in those with psychosis and lastly, evaluate evidence indicating increased 
prevalence of nightmares in people with experience of psychosis.  The third section of the 
literature review will evaluate evidence of the effectiveness of Imagery Rehearsal (IR) as a 
psychological intervention for nightmares and reviews what adaptations might be needed 
in order to evaluate the efficacy of this approach in those with psychosis.  
 





1.1.2 Clarification of terms; schizophrenia, psychosis and positive symptoms 
Schizophrenia is a diagnostic term used to characterise a condition where individuals can 
experience altered perception, thoughts, affect and behaviour (NCCMH, 2010).  There is no 
single cause of schizophrenia but instead a range of biological, psychological and social 
factors can interact, to varying degrees, to trigger onset (NCCMH, 2010; The Schizophrenia 
Commission, 2012).  Schizophrenia is most commonly diagnosed between the ages of 15 
and 35 (NHS Choices, 2012).  The course of the disorder is marked by three phases: the 
prodromal phase, the acute phase and the post-acute phase.  The prodromal phase is 
characterised by anomalies of experience, deterioration in cognitive and social functioning.  
The acute phase is characterised by positive symptoms, such as hallucinations, delusions 
and interference in the flow of thoughts (Cowen, Harrison & Burns, 2012) and in the post- 
acute phase, positive symptoms might diminish or disappear but leave the person with 
residual symptoms similar to the prodromal period (NCCMH, 2010).  Around 45% of people 
who receive a diagnosis of schizophrenia recover after one or more episodes, around 20% 
show unremitting symptoms and 35% show a mixed pattern of remission and relapse 
(Schizophrenia Commission, 2012). 
 
Whilst schizophrenia is a diagnostic term widely used in healthcare settings, the clinical and 
research value of ‘schizophrenia’ as a discreet diagnostic entity has been bought under 
much scrutiny (Bentall, 2003).  There is evidence to suggest that those with a diagnosis of 
schizophrenia do not share the same aetiology, symptomatology or response to treatment 
(Bentall, 2004).  Instead a factor analytic study has found that those with schizophrenia 
hold three separate symptom clusters: positive symptoms (hallucinations and delusions), 
negative symptoms (including for example avolition and affective flattening) and 
disorganised thinking (Andreasen, Arndt, Alliger, Miller & Flaum, 1995).  Rather than 
referring to specific diagnostic criteria, the term ‘psychosis’ follows a more specific and 
straightforward definition: ‘the inability to distinguish between subjective experience and 
external reality, as shown by the presence of delusions or hallucinations’ (Cowen et al., 
2012, p.27).  The term psychosis therefore refers to an experience that is found in 
diagnoses such as schizophrenia, organic and affective disorders.  It is this more specific 
experience, found across a range of disorders that is the subject of this investigation.   
 





1.1.3 Psychosis; epidemiology and impact 
With regards to incidence of psychosis, a recent systematic review reported that the 
pooled incidence of psychosis in England was 32 per 100,000 person years (Kirkbride et al., 
2012).  This incidence is split relatively evenly between schizophrenia and affective 
psychoses (Kirkbride et al., 2011).  Whilst incidence has not changed over time (1950-
2009), incidence rates vary substantially across age, sex, place and migration status / 
ethnicity (Kirkbride et al., 2012), as well as by urbanicity (McGrath et al 2004).   
 
Experience of psychosis is associated with a range of poor functional outcomes including 
small social networks (Sundermann, Onwumere, Bebbington & Kuipers, 2012), increased 
risk of suicide (Palmer, Pankratz & Bostwick, 2005) and low employment rates (Marwaha & 
Johnson, 2004; Thornicroft et al., 2004; Bebbington et al., 2005).  Those with psychosis 
experience a range of poor physical health outcomes such that life expectancy is reduced 
by 15-20 years when compared with other citizens and 87% report experience of stigma or 
discrimination (Henderson et al., 2012).  In addition, caring for a person with psychosis is 
related to increased risk of clinically significant anxiety and depression (Kuipers, Onwumere 
& Bebbington, 2010; Dyck, Short & Vitaliano, 1999; Boydell et al., 2013).  Schizophrenia and 
affective psychosis combined cost the UK economy £13.8 billion per year, largely 
attributable to lost employment and health service costs (Kirkbride et al., 2011).  
 
An improved understanding of the sleep experiences of those with psychosis, their links 
with daytime symptomatology and functioning, together with the possibility of new 
interventions for these difficulties, has the potential for clinical, social and economic 
impact.   
 
1.2 Study A: the phenomenology of nightmares in the context of 
psychosis 
 
1.2.1 What is sleep and why is it relevant to mental health? 
Sleep and wakefulness are behavioural and neurobiological states experienced by all 
human beings and mammals (Lockley & Foster, 2012).  Adult humans currently sleep for an 
average duration of seven hours per night although some historical accounts suggest that 
in pre-industrial times people slept for up to ten hours per day, dependent on the season 
(Lockley & Foster, 2012).  Industrialisation has caused more rigid working schedules and the 





introduction of electric lighting in the nineteenth century reduced the need for sleep to be 
so closely tied to the 24 hour light dark cycle (Lockley & Foster, 2012).   These changes, in 
addition to slow progress in elucidating the purpose of sleep, have left it as an undervalued 
phenomenon and our treatment of it has been considered “brutish” (Lockley & Foster, 
2012, p.2).  This chapter proceeds to assert the importance of sleep processes in general 
and in particular demonstrate the relevance of studying nightmares in those with 
psychosis. 
 
The structure of sleep is made up of two separable states; rapid eye movement (REM) 
sleep and non-rapid eye movement (NREM) sleep (see figure 1).  Polysomnography 
(recordings of brain activity, eye movements and muscle tone) data suggest that the NREM 
sleep state is further divided into four stages of increasing depth: stage 1 (light sleep), stage 
2 (consolidated sleep) and stages 3 and 4 (deep or slow wave sleep) (Lavie, Pillar & 
Malhotra, 2002).  Polysomnography has revealed a consistent pattern of sleep across the 
night.  First, humans enter sleep through NREM stage 1, quickly followed by NREM stage 2, 
followed by stages 3 and 4 (deep, slow wave sleep).  After entering deep sleep, sleep 
decreases in depth back through stages 2 and 1 and then enters a brief period of REM sleep 
(5-10 minutes).  The duration of this first cycle lasts approximately one and half hours 
(Bosch & van den Noort, 2008).  This cycle is repeated throughout the night, however the 
REM sleep periods become longer and the depth of sleep decreases (Bosch & van den 





























Figure 1.  A hypnogram illustrating normal sleep cycles for adult humans (from 
Suwanprathes, 2006, p.671)   
 
REM sleep occupies approximately 25% of total sleep time (Lockley & Foster, 2012), is 
characterised by quick movement of the eyeballs under the eye lids, an inhibition of 
skeletal muscles and is the period in which most realistic dreams occur (Bosch & van den 
Noort, 2008).  Although dreaming can occur in both NREM and REM sleep, dreams in REM 
sleep tend to be longer, more vivid, complex and bizarre (Lockley & Foster, 2012).  The 
state of dreaming spans the majority of REM sleep and as much as 40% of NREM sleep 
(Lockley & Foster, 2012).  Recent hypotheses for the role of dreaming include that it serves 
as an emotion regulator (Desseilles, Dang-Vu, Sterpenich & Schwartz, 2010; Gujar, 
McDonald, Nishida & Walker, 2011; Nielson & Levin, 2007) and helps to consolidate 
emotional memories (Desseiles et al., 2010; Nishida, Pearsall, Buckner & Walker, 2009).   
 
The past two decades have offered insights into the relevance of REM sleep and dreaming 
to a range of clinical diagnoses.  The main focus has been that of depression in which 
research has shown a shortening of REM sleep latency, a lengthening of the first REM 
period and heightened density of REM sleep (Berger & Riemann, 1993).  Further to this, it 
has been demonstrated that shortening the duration of the REM period by awakening the 
patient for a period of three weeks has an anti-depressant effect akin to pharmacological 
treatments (e.g. Imipramine treatment; Berger & Riemann, 1993).  This finding suggests a 
direct impact of REM sleep length on mood. 
 





Those with Borderline Personality Disorder (BPD) have an increase in REM density and 
reduced REM latency (Semiz, Basoglu, Ebrinc & Cetin, 2008).  However, in addition, BPD 
patients show increased sleep fragmentation, negatively toned dreams and nightmares 
when compared to healthy controls, irrespective of posttraumatic stress disorder (PTSD) 
diagnosis (Semiz et al., 2008).  For people diagnosed with PTSD (who often complain of 
nightmares), despite subjective complaints of nightmares and insomnia, objective 
measures via polysomnography demonstrate only small changes in NREM sleep (Van 
Liempt et al., 2013). These results highlight the importance of REM sleep and dreaming to 
the presentation of a range of mental health disorders.  
 
1.2.2 Nightmares; evidence from the general population  
Nightmares are the most common form of parasomnia (Levin & Fireman, 2002), 
characterised by awakening from rapid eye movement sleep with recollection of disturbing 
mental activity (Nielson & Levin, 2007).  The Diagnostic and Statistical Manual for Mental 
Disorders, fourth edition (DSM-IV, American Psychiatric Association (APA), 2000) outlines 
the criteria for Nightmare Disorder: repeated awakenings from either major sleep or naps, 
with detailed recall of frightening dreams that usually involve threats to survival, self 
esteem or security.  The DSM-IV suggests that the nightmares ordinarily occur in the 
second half of sleep, in line with their predominant formation in REM sleep.  Nightmares 
are distinguished from night terrors on the basis that the person is rapidly oriented and 
alert.  The person with Nightmare Disorder (according to DSM-IV) should experience 
clinically significant distress or impairment in functioning.  Lastly, the DSM-IV rules out that 
nightmares are explained by the physiological effects of a substance, nor diagnoses such as 
delirium or PTSD (APA, 2000).  Despite this definition, much of the research to date 
investigates nightmares as an individual entity rather than considering diagnostic criteria 
for Nightmare Disorder.   
 
Krakow (2006) carried out a retrospective case review of patients entering two American 
community sleep facilities.  He revealed that 26% of the sample (n=718) who were asking 
for help with sleep problems,  ranked nightmares as a relevant sleep problem and 16% of 
the total sample were deemed to have a clinically significant nightmare condition (Krakow, 
2006).  Krakow (2006) reports that all participants complained of at least one other sleep 
problem, in fact 91% ranked two or more other sleep conditions in addition to nightmares 
and 64.64% agreed or strongly agreed that their nightmares disrupted their sleep.  It is 





clear that nightmares are both a relevant and common problem.  Indeed Krakow (2006) 
argued that nightmares should be considered co-morbid with other disorders rather than 
subsumed as a symptom of other disorders and called for focussed nightmare treatments 
as adjunctive therapy. 
 
The majority of studies that have reported prevalence of nightmares come from outside of 
the United Kingdom (UK).  Li, Zhang, Martin and Wing (2010) report that 5.1% of a large 
community based cohort of middle-aged Hong Kong Chinese (n=8,558) experienced at least 
weekly nightmares.  Female sex, low monthly income, measures of sleep disturbance and 
sleep related daytime consequences were all positively associated with nightmare 
frequency.  Nielson and Levin (2007) reviewed large epidemiological surveys to report that 
between 2-6% of people experience weekly nightmares, consistent with results from Li et 
al., (2010).  Janson et al. (1995) report the prevalence of nightmares in young adults in four 
European cities across Iceland, Sweden and Belgium.  Participants were selected at random 
(n=2,202) from the European Community Respiratory Survey.  Weekly nightmares were 
reported in 0.9-6.8% of participants across the four locations, broadly in line with figures 
reported by Nielson & Levin (2007) and Li et al. (2010).  Summarising the results of non-UK 
based studies, the prevalence of weekly nightmares lies between 0.9-6.8% in the general 
population. 
 
The only UK based study has been conducted by Blagrove, Farmer and Williams (2004), in 
Swansea, Wales.  Participants (n=147) were recruited from members and associates of a 
university, 42% of whom reported experiencing at least one nightmare over a two week 
period via prospective nightmare logs.  It is difficult to ascertain how the results reported 
by Blagrove et al. (2004) compare with those of the former studies given that they use a 
two week reference period, as opposed to a week’s duration.  In addition, it is possible that 
the sample might have been biased by inclusion criteria specifying that participants had to 
have recalled at least one dream per month.  Never the less the results gain importance 
due to the fact that it is the only UK study. 
 
1.2.3 The impact of nightmares on functioning 
Krakow (2006) reports that of those entering a sleep facility, people suffering with a 
clinically significant nightmare condition showed a consistent pattern of worse mental and 
physical health outcomes compared with sleep disordered controls.  These outcomes 





included for example, a mood disorder, indigestion or rheumatic conditions (Krakow, 
2006).  The severe impact of nightmares on daytime functioning is most highlighted by a 
recent meta-analysis of the association between nightmares and suicide by Pigeon, 
Pinquart and Connor (2012).  Pigeon et al. (2012) report that sleep disturbance in general, 
as well as nightmares and insomnia specifically, represent a risk factor for suicidal thoughts 
and behaviour.  Interestingly, these associations were not moderated by mood (Pigeon et 
al. 2012).  With regards to possible mechanisms for the link between nightmares and 
suicidality, two hypotheses can be posited; a role of increased hopelessness that has been 
found in those with frequent nightmares (Agargun et al., 1998) and / or a role of decreased 
emotion regulation and emotional problem solving following disruption of usual dreaming 
processes (Nielson & Levin, 2007; Desseilles et al., 2010).   
 
Nightmares have recently been demonstrated to impact more widely on sleep architecture.  
Simor, Bodizs, Horvath and Ferri (2013) report that nightmares disrupt NREM sleep 
architecture, even on nights when the person does not experience a nightmare.  This result 
remained significant after controlling for depression and anxiety symptoms.  Simor et al., 
(2013) hypothesise that this might result from a more global (and nightmare independent) 
imbalance in arousal mechanisms during sleep.  This suggests that nightmares disrupt sleep 
processes even on nights when the sufferer is in fact asymptomatic of nightmares. 
 
Levin and Fireman (2002) carried out a prospective study of nightmare prevalence and 
distress in a cohort of students and explored their respective links with daytime 
functioning.  Of interest to the current investigation is that nightmare frequency was 
significantly related to paranoia, whilst nightmare distress was significantly related to both 
paranoia and psychoticism, measured using the Symptom Checklist-90-Revised.  Nightmare 
frequency and nightmare distress were not significantly correlated and it was nightmare 
distress (rather than frequency) that accounted for much of the unique explanatory 
variance in predicting interpersonal sensitivity, paranoia and affective states (depression 
and anxiety).  These results would lead one to speculate nightmares to be more prevalent 
in a clinical population with psychosis and furthermore suggest that it would be distress 
rather than prevalence of nightmares that best accounts for the link between night and 
daytime pathology.  The importance of distress is consistent with other phenomena, such 
as voice hearing. 
 





1.2.4 Nightmares in other clinical populations; Insomnia, PTSD and Borderline Personality 
Disorder  
This section will outline research to date that has investigated nightmares, within the 
context of other psychiatric disorders; Primary Insomnia, PTSD and BPD.   Ohayon, Morselli 
and Guilleminault (1997) investigated nightmares within a sub-sample of 1,049 people with 
Primary Insomnia who responded to a general population survey.   Results indicated that 
18.3% of participants suffered with DSM-IV diagnosed nightmares.  Nightmares were 
associated with increased nocturnal awakenings, increased sleep onset, daytime memory 
impairment following poor nocturnal sleep, daytime anxiety and female gender (Ohayon et 
al., 1997).  Within the psychosis literature there are well documented findings of memory 
impairment (Aleman, Hijman, de Haan & Kahn, 1999) increased sleep latency and nocturnal 
awakenings (Afonso, Figueira and Paiva, 2013) and a high prevalence of insomnia in those 
with persecutory delusions (Freeman, Pugh, Vorontsova & Southgate, 2009).  Given the 
parallel findings between research investigating nightmares in those with insomnia (but 
without psychosis) and the cognitive and sleep attributes of those with psychosis, it would 
seem important to investigate the experience of nightmares within a psychosis population.  
 
Nightmares are well recognised within the clinical presentation of PTSD such that they are 
included in diagnostic criteria (DSM-IV, APA, 2000; ICD-10, WHO, 2010).  With regards to 
prevalence of nightmares in those with PTSD, data from the National Vietnam Veterans 
Study (Neylan et al., 1998) found that 52% of participants reported nightmares ‘sometimes, 
or more frequently’.   Leskin, Woodward, Young and Sheikh (2002) reported 71% of 
participants with PTSD complained of nightmares (though it is unclear how frequently), 
whilst the prevalence of those with PTSD and co-morbid Panic Disorder who complained of 
nightmares was significantly higher (96%).  This suggests that nightmares might be closely 
tied to difficulties in processing traumatic events. 
 
Nightmares have recently been investigated in a sample with Borderline Personality 
Disorder (BPD).  Semiz et al. (2008) compared 88 people with BPD to age and sex matched 
controls.  Results indicated that 49% of those with BPD suffered from DSM-IV diagnosable 
nightmare disorder in comparison to 7% of the healthy control group.  The BPD group also 
indicated significantly higher dream anxiety and disturbed sleep quality.  Dream anxiety in 
particular was related to early traumatic experiences, dissociative symptoms and sleep 
quality.  Furthermore, those in the BPD group diagnosed with nightmare disorder displayed 
more severe clinical characteristics than those with BPD without nightmare disorder.  





These included substance abuse, suicide attempts, other self harm methods and duration 
of self harm (Semiz et al., 2008).  It is clear from the results of Semiz et al. (2008), in 
addition to studies investigating nightmares in the context of PTSD and insomnia that 
nightmares occur more frequently in these clinical populations than in the general 
population and furthermore, have implications for severity of daytime symptoms. 
1.2.5 What is already known about sleep and psychosis? 
Investigation of sleep disturbance in psychosis has been a rapidly growing research area 
over the past five years.  Sleep disturbance is now considered a common feature in the 
presentation of the disorder and a risk factor for developing psychosis in those at high risk 
(Ruhrmann et al., 2010).  The following review will outline disruptions in circadian rhythm 
and sleep architecture, found in those with a diagnosis of schizophrenia.   
 
Afonso, et al. (2013) characterised sleep patterns in 34 participants with schizophrenia in 
comparison to 34 healthy controls, using wrist actigraphy and sleep diaries.  Results 
indicated that despite patients with a diagnosis of schizophrenia going to bed earlier and 
waking later than healthy controls, their overall sleep quality was poorer and was 
characterised by higher sleep latency and more night time awakenings.  Wulff, Dijk, 
Middleton, Foster and Joyce (2012) found similar sleep disruption in all of their twenty 
participants with schizophrenia.  They found more variability in the timing of sleep onset 
and offset and the sleep midpoint in those with schizophrenia.  Crucially, the comparison 
group in the study by Wulff et al., (2012) were all unemployed in order that lack of daytime 
structure was kept relatively constant across groups.  This suggests that sleep disruptions in 
the schizophrenia group are not accounted for by lack of structured daytime activity.  In 
addition, these differences were not explained by anti-psychotic medication dose.  
 
Wulff et al. (2012) found two distinct sleep profiles in those with schizophrenia.  In group 
one, participants’ sleep patterns were not aligned to the day/night cycle, they exhibited 
lower melatonin sulphate levels (a hormone secreted by the pineal gland which 
synchronizes circadian rhythms), slept for longer hours than controls and were less active 
when awake.  Those in the second group exhibited a usual sleep onset time and regular 
melatonin sulphate levels, yet sleep was prolonged, irregular or fragmented (Wulff et al., 
2012).  It is plausible that distressing nightmares, might account (at least in part) for the 





irregular and fragmented pattern, particularly in group two, yet no research to date has 
reported on nightmares in those with schizophrenia. 
 
1.2.6 Sleep structure and psychosis; link with daytime symptomatology 
Although sleep disturbance is a clinically important phenomenon in and of itself, the 
relevance of researching sleep disturbance in those with psychosis is also important 
because of its links with daytime symptoms.    The following section will report on three 
studies linking insomnia with paranoid thinking (Freeman et al., 2012a; Freeman et al., 
2009 & Myers, Startup & Freeman, 2011).  Following this, the link between sleep 
disturbance and frontal executive functioning will be described. 
 
Freeman et al. (2012a) report longitudinal analysis from the British National Psychiatric 
Morbidity Survey including 2,382 participants.  These participants completed a baseline 
assessment and were selected for a follow up assessment based on presence (or high risk) 
of a mental health disorder.  Critically, insomnia was a predictor of both new inceptions 
and persistence of paranoia at 18 month follow up (Freeman et al., 2012a).  An earlier 
study by Freeman et al. (2009) indicated that higher levels of insomnia were associated 
with higher levels of paranoia in the general population and additionally, that moderate to 
severe insomnia was present in over half of those with persecutory delusions attending 
psychiatric services.  Myers et al. (2011) piloted a CBT intervention for insomnia with 15 
participants with persistent persecutory delusions.  Provision of this four session 
intervention resulted in large significant reductions in levels of insomnia and persecutory 
delusions that were maintained at one month follow up.  This data provides experimental 
data demonstrating how an intervention which resulted in improved sleep also impacted 
upon psychotic symptoms. 
 
1.2.7 Sleep structure and their link with cognitive deficits  
Cognitive deficits are now considered a central feature of schizophrenia (Bowie & Harvey, 
2006) appearing in 75-85% of patients to a varying degree (Kayman & Goldstein, 2012).  
The largest cognitive changes often occur prior to first episode of psychosis; however non-
significant cognitive changes have been reported to be observed as far back as primary 
school (Kayman & Goldstein, 2012).   Cognitive deficits have recently been summarised into 
six domains: speed of processing, attention/vigilance, working memory, verbal learning and 
memory, visual learning and memory, and reasoning and problem solving (Nuechterlein et 





al., 2004).  Studies have shown that cognition is the best predictor of functional status in 
psychosis across a range of outcome domains and patient characteristics (Bowie & Harvey, 
2006) and an important attribute of clinical presentation. 
 
Bromundt et al. (2011) measured sleep wake cycles and cognitive functioning in 14 
participants with schizophrenia.  They report much variability in sleep wake patterns, 
similar to that reported by Wulff et al. (2012).  In addition, they found that participants 
with a normal rest-activity cycle (determined by amplitude of day to night time activity) 
performed significantly better on frontal executive neuropsychological tasks (Bromundt et 
al. 2011).  Indeed, age and rest-activity cycle of the participant proved to be the best 
predictors of frontal executive task performance.  Positive and negative symptoms of 
schizophrenia in comparison did not correlate with either cognitive performance nor sleep-
wake cycles.  This study highlights the importance of circadian rhythm in cognitive 
functioning over and above the contribution of other symptoms. 
 
Disruptions in sleep architecture and in particular the sleep spindles (bursts of brain activity 
measurable through electroencephalography; EEG) which exist in stage 2 sleep, have been 
linked to particular domains of cognitive functioning in schizophrenia.  Ferrarelli et al. 
(2010) report that sleep spindles are reduced in amplitude and duration in participants 
with schizophrenia when compared to both matched controls and non-schizophrenia 
patients taking anti-psychotic medication.  Keshavan et al. (2011) report reduced spindle 
density to correlate with impaired attention and reasoning, but not intelligence quotient in 
anti-psychotic naive newly diagnosed patients with psychosis.  Wamsley et al. (2012) report 
that patients with schizophrenia showed reduced spindle number and density, which 
predicted less overnight improvement in a procedural memory (finger tapping) task.  
Furthermore, attributes of the spindle waves correlated with greater severity of positive 
symptoms of psychosis.  The above three studies combined suggest that neurological 
attributes of stage two sleep might account for at least some of the cognitive deficits 
evident in those with schizophrenia, as well as link with positive symptoms. 
 
1.2.8 Why might nightmares be more prevalent in those with psychosis?  The role of 
unusual perceptions and the overlap between day and night. 
One account for the link between psychosis and nightmares is that they share similar 
aetiological pathways.  In a review of the literature, Koffel and Watson (2009) draw on 





several lines of research linking nightmares to unusual perceptual experiences during the 
day.  Firstly, they note a high incidence of schizophrenia spectrum diagnoses and 
schizotypal personality disorder in people reporting frequent nightmares.  Secondly, Koffel 
and Watson (2009) report nightmares to be related specifically to measures of dissociation 
and schizotypy, rather than depression and anxiety more generally.  Lastly, by 
dichotomising participants into high and low frequency nightmare groups they report that 
those with high frequency nightmares score significantly higher on measures of schizotypy.  
This evidence, drawn from both clinical and non-clinical groups is used to add weight to 
Koffel and Watson’s argument that unusual cognitions and perceptions overlap between 
daytime and night time functioning and therefore represent a common domain with shared 
aetiology. 
 
1.2.9 Does the experience of trauma increase risk for nightmares in those with psychosis? 
A second line of research links nightmares with psychosis via trauma.  Psychological trauma 
has been defined as the experience of an uncontrollable event which is perceived to 
threaten a person’s sense of integrity (Horrowitz, 1986).  A growing body of research has 
emphasised the very high prevalence rates of trauma in people with psychosis, in both 
childhood (between 50-78%; Holowka, King, Saheb, Pukall & Brunet, 2003; Read, 
Goodman, Morrison, Ross & Aderhold, 2004; Greenfield, Stratowski, Tohen, Batson, 
Kolbrener, 1994) and adulthood (68-100%; Shaw, McFarlane, Bookless & Air, 2002).  Neria 
et al. (2002) for example report the prevalence of trauma exposure to be 68.5% in a cohort 
experiencing their first hospital admissions for psychosis.  A sub-group of 26.5% of this 
trauma exposed group met criteria for PTSD.  A more recent study followed children who 
were exposed to the South Australian bush fires of 1983 and measured outcomes 20 years 
post-trauma (Galletly, Hooff & McFarlane, 2011).  Although exposure to this one trauma 
was not found to be associated with psychosis, overall lifetime exposure to trauma, high 
rates of childhood adversity and dysfunctional parenting were associated with sub-clinical 
psychotic experiences in this sample.   
 
Childhood sexual abuse has been implicated as a trauma particularly associated with the 
onset of later psychosis.  In a survey, Morrison, Frame and Larkin (2003) report that 34-53% 
of patients with severe mental illness report childhood sexual or physical abuse.  A more 
recent study by Bebbington et al. (2011) utilised a large representative general population 
sample of 7353 English adults to highlight a strong association between sexual abuse prior 





to age 16 and later psychosis.   It must of course be considered that childhood sexual abuse 
is a particularly extreme childhood trauma; not only is the trauma itself severe but often if 
abuse occurs within the family, one would expect family processes to be severely 
disrupted.  It is clear that there is an association between trauma and psychosis, but that it 
is often severe or repeated trauma, in the context of poor parenting that provides the 
clearest link. 
 
Coentre and Power (2011) suggest a high incidence of co-morbidity between psychosis and 
post traumatic stress disorder (PTSD), reporting the prevalence of PTSD in patients with 
severe mental illness to be at least three times higher than the general population.  A 
recent study by Freeman et al., (2013) revealed that almost all the same cognitive factors 
during and after an assault predicted both paranoia and PTSD in a non-clinical population 
who presented at accident and emergency departments.  This study revealed that despite 
paranoia and PTSD being correlated, they were distinct experiences.  Morrison Frame and 
Larkin (2003) conceptualise trauma within psychosis by suggesting that the differential 
experience of PTSD versus psychosis lies within the interpretation assigned to the intrusive 
reactions to the trauma.  Given the clear links between psychosis, trauma and PTSD, and 
the prevalence of nightmares in those with post-traumatic reactions, it would be 
reasonable to assume a higher prevalence of nightmares in those with psychosis.  The 
frequency of nightmares in psychosis has however not been investigated. 
 
1.2.10 Sleep and pharmacological treatment 
Anti-psychotic medication is recommended as the fist line treatment for those with a 
diagnosis of schizophrenia in the UK (NICE 2009, NCCMH, 2010).  Examination of the impact 
of anti-psychotics on dreaming and nightmares is in its infancy, however two studies report 
that particular anti-psychotics might impact on dreaming.  Bretang-Norris and Alexander 
(2012) report two case reports, the first implicates the anti-psychotic Risperidone on 
increased nightmare frequency via an A-B-A design.  The second report utilises the same 
design to comment on the increased frequency of nightmares when medication 
management was altered from Risperidone and Sodium Valproate to Quetiapine and a 
further cessation of nightmares when medication was switched to a further anti-psychotic: 
Ziprasidone.  These two case studies should be interpreted with caution.  Risperidone for 
example has been indicated to decrease post-traumatic nightmares in other studies 





(Escamilla, LaVoy, Moore & Krakow, 2012).  Even so, from the available literature, the 
possible effects of anti-psychotic medications on nightmares should be held in mind. 
 
1.2.11 Summary, aims and hypotheses:  
Psychosis is a severe mental health condition that is commonly associated with high levels 
of morbidity.  Nightmares are a common problem for a range of other diagnoses including 
PTSD, BPD and insomnia, associated with poor sleep and worse daytime symptoms.  This 
study aims to explore the frequency and impact of nightmares in the context of psychosis. 
 
Evidence from existing community samples from outside of the UK have indicated the 
prevalence of weekly nightmares to lie between 0.9-6.8%.  The only UK based study 
indicated 42% of participants experienced one nightmare over a two week reference 
period.  Evidence suggests that the prevalence of nightmares in those with psychosis will be 
significantly higher than rates in community samples for a number of reasons: 
 
1. Nightmare frequency is related to measures of paranoia (Levin & Fireman, 2002) 
and schizotypy (Koffel & Watson, 2009) in non-clinical samples. 
2. Those with schizophrenia have been shown to have irregular / fragmented sleep 
(Wulff et al., 2012) and more night time awakenings (Afonso et al., 2013).  As 
such, moderate to severe insomnia has been found in over half of those with 
persecutory delusions (Freeman et al., 2009).  Nightmares are more prevalent in 
samples with insomnia than the general population (Ohayon et al., 1997), leading 
one to speculate that nightmares may account for at least some insomnia 
symptoms. 
3. Trauma histories are prevalent in those with psychosis (Neria et al., 2002) and 
particularly severe trauma such as childhood sexual abuse (Bebbington et al., 
2011).  Nightmares are prevalent in populations with trauma histories such as 
those with PTSD (Leskin et al., 2002) and BPD (Semiz et al., 2008). 
 
Hypothesis one:  










Evidence suggests that nightmares result in increased time to fall asleep and increased 
nocturnal awakenings (Ohayon et al., 1997; Semiz et al., 2008).  Hypothesis two therefore 
states: Nightmare frequency will be correlated with measures of sleep.  A positive 
correlation is expected between overall sleep quality (measured by the Pittsburgh Sleep 
Quality Index; PSQI) and nightmare frequency (higher scores on PSQI indicate worse sleep 




Koffel and Watson (2009) maintain that daytime and night time functioning represent a 
common domain, with shared aetiology.  On this basis, the third hypothesis states: 
nightmare frequency will be correlated with measures of daytime symptomatology 
including severity of delusions, auditory hallucinations and severity of affective 
symptomatology (PTSD, depression, anxiety, stress and global distress). 
 
Hypothesis four: 
It has been shown in a student sample that it is nightmare distress rather than nightmare 
frequency that best accounts for variance in daytime paranoia and affective 
symptomatology (Levin & Fireman, 2002).  This evidence forms the basis of hypothesis four: 
Nightmare related distress better accounts for the disturbance in daytime psychological 
functioning and daytime activity than nightmare frequency.   
 
Hypothesis five: 
Following the results of Levin and Fireman (2002) hypothesis five states that: Nightmare 
frequency and nightmare distress will exert independent effects on measures of sleep and 
daytime psychiatric symptomatology. 
 
Hypothesis six: 
Sleep quality has been shown to impact on daytime cognitive functioning (Bromundt et al., 
2011; Keshavan et al., 2011; Wamsley et al., 2012).  Hypothesis six states that overall sleep 
quality will be negatively correlated with working memory.  Furthermore it is expected that 
nightmare frequency will be negatively correlated with working memory.  
 





1.3 Study B: Development of a psychological intervention for 
nightmares in the context of psychosis 
 
1.3.1 Psychological interventions for psychosis 
In comparison to other psychiatric disorders such as depression and anxiety, psychological 
interventions for psychosis have developed relatively recently.  This is largely because of 
earlier thinking that schizophrenia is biologically determined and therefore not amenable 
to traditional psychological therapy (Tarrier, 2005).  There is now much supportive 
evidence for the central role of emotional, cognitive and social environmental processes in 
psychological models of psychosis (Kuipers et al. 2006).  As such the past twenty years has 
seen the development of Cognitive Behaviour Therapy for psychosis (CBTp) and the 
publication of several treatment manuals (Chadwick, Birchwood & Trower, 1996; Fowler, 
Garety & Kuipers, 1995; Laroi & Aleman, 2010). A recent meta-analytic review has 
suggested CBTp has a modest effect on positive symptoms of psychosis (0.37), negative 
symptoms (0.44), functioning (0.38) and mood (0.36) (Wykes , Steel, Everitt & Tarrier, 
2008) and is therefore recommended as an adjunct to medication in the UK National 
Institute of Clinical Excellence Guidelines for Schizophrenia (NICE, 2009).  For the purpose 
of the current investigation it is helpful to consider the elements of CBT therapy that are 
more unique to psychosis, in order to consider techniques required for the successful 
implementation of a psychological treatment for nightmares. 
 
Tarrier (2005) lists a range of psychosocial factors which impact on the nature and delivery 
of a CBT type of intervention for those with psychosis.  These include for example restricted 
attention, elevated arousal, co-morbidity, high risk of suicide, risk of victimisation and 
restricted social networks (Tarrier, 2005).  As a means of accounting for variability in these 
factors, Fowler et al. (1995) recommend a highly individualised therapeutic approach, 
incorporating a degree of flexibility in for example the number and length of sessions.  In 
delivering CBTp it is recommended that the therapist be sensitive to the difficulties in 
building and establishing a working relationship that may be caused by, for example, voices 
commanding the patient to kill the therapist, or beliefs that the therapist might be part of a 
conspiracy (Fowler et al., 1995).  It is clear that an intervention for nightmares in the 
context of psychosis should include evidence based components, (as defined by NICE 
2009), but deliver them through flexible means in order to meet the individual needs of 
those with psychosis. 





1.3.2 Imagery techniques for the treatment of daytime intrusive images: 
The use of imagery and the technique of manipulating imagery for positive effect can be 





 century that imagery rescripting  has gained empirical support as a 
transdiagnostic tool for the treatment of distressing imagery in clinical populations 
(Holmes, Arntz & Smucker, 2007).  Imagery rescripting is a technique that utilises the 
imagination in order to re-experience sensory detail from an emotional memory or image 
as if it is occurring in the present moment.  This image is evoked in much sensory detail 
following which the person changes the image or memory in order that it follows a more 
emotionally positive or neutral ending.   
 
Imagery rescripting has a strong evidence base as a trans-diagnostic therapeutic technique 
(Arntz, 2012) and as such forms part of treatment packages of Cognitive Therapy for PTSD 
(Ehlers & Clark, 2000; Ehlers, Clark, Hackman, McManus & Fennel, 2005; Arntz, 2012), 
Social Phobia (Clark et al., 2006; Arntz, 2012) and Schema Therapy for personality Disorders 
(Young, Klosko & Weishaar, 2003; Arntz & Van Genderen, 2009; Arntz, 2012).  Preliminary 
studies suggest that it can also be adapted for use in treatment of specific phobia, 
obsessive compulsive disorder, depression, bullimia nervosa and in health psychology 
populations (Arntz, 2012).  The evidence base for imagery rescripting as applied to the 
treatment of nightmares will be discussed in detail later.  Despite impressive outcomes in 
clinical populations, an evidence base for the underlying mechanisms is currently lagging 
behind that of effectiveness trials and as such it has recently been deemed “a technique in 
need of a theory” (Arntz, 2012, p. 200). 
 
1.3.3 Why are imagery techniques well suited to the treatment of nightmares? 
The use of imagery within psychological therapy might be of particular benefit to the 
treatment of nightmares.  Holmes and Matthews (2010) assert that mental imagery is 
relevant to psychopathology due to its special relationship with emotion.  In particular they 
suggest that mental imagery evokes a greater emotional response than verbal 
representations.  Given that nightmares in particular are associated with much sensory 
detail, it makes sense therapeutically to address such a phenomenon via imagery.  Brewin, 
Gregory, Lipton & Burgess (2010) propose a model of intrusive imagery set within the 
context of cognitive neuroscience.  Brewin et al. (2010) theorise that intrusive images 
represent low level sensory and affectively charged memory representations as opposed to 





more abstract declarative representations that are more easily accessed verbally.  It is 
therefore intuitive to consider imagery techniques for the treatment of nightmares as 
opposed to relying solely on the verbal system. 
 
The model of intrusive imagery set out by Brewin et al. (2010) sits well with recent brain 
imaging studies of REM sleep which suggests that dreaming states are supported by low 
level sensory neural processing.  Imaging studies have evidenced increased activation of 
sensory areas of the brain including the visual and motor cortices during REM sleep whilst 
conversely indicating a decrease in activation in areas supporting attention and frontal 
executive abilities (Desseilles, Dang-Vu, Sterpenich & Schwartz (2011). Desseilles et al., 
(2011) link these data with reports from dream data that suggest much sensory detail but 
with disruption in more frontally mediated cognitive processes such as the lack of control 
over dream events and the unquestioning acceptance of bizarre events during dreams.  It is 
intuitive to use a sensory approach to work therapeutically with a sensory problem, rather 
than relying solely on higher level cognitive processes.   
 
1.3.4 Imagery Rehearsal (IR) as a nightmare specific intervention: 
Nightmares have previously been subsumed as a symptom of PTSD, rather than a co-
morbid disorder in and of itself.  In fact, whilst posttraumatic nightmares are a key feature 
of PTSD, they are frequently resistant to standard PTSD treatments (Gehrmann & Harb, 
2010).  Imagery Rehearsal (IR) techniques are the only nightmare specific treatment 
demonstrated as efficacious in randomised controlled trials by separate research teams.  
Whilst different protocols exist, the basic elements of IR include a psychoeducation phase, 
rescripting a change of ending to the nightmare and daily imaginal rehearsal of the new 
dream narrative (Casement & Swanson, 2012).  IR therefore utilises imagery rescripting 
techniques, but imbedded within psychoeducation and rehearsal of the new script.  It 
should be noted that the terms imagery rehearsal and Imagery Rehearsal Training (IRT) are 
used interchangeably within the literature to refer to the same basic method. 
 
Krakow et al. (2000) were the first to publish a randomised control trial of IR for the 
treatment of post-traumatic nightmares in sexual assault survivors with PTSD.  The protocol 
used was a three session group therapy format delivered over five weeks.  The intervention 
included psycho-education, CBT techniques for dealing with images, creating an alternative 
ending for a chosen nightmare via a written script and imaginal rehearsal of the new script.  





Following the intervention, the results highlighted that nightmare frequency significantly 
decreased, PTSD symptoms decreased and sleep quality improved in comparison to the 
wait list control group, who evidenced minimal changes in the above measures (Krakow et 
al., 2000).  This early study revealed promising results for the efficacy of a nightmare 
specific intervention for PTSD sufferers. 
 
Since the first study of Krakow et al. (2000) several studies have used IR as an intervention 
for nightmares.  All the reported studies share similar components; psycho-education, 
creating a re-script for a target nightmare and using imaginal rehearsal of the new script.  
However different protocols have evolved.  Some protocols emphasise the importance of 
an additional exposure and relaxation component to the rescripting of the nightmare (Davis 
& Wright, 2007; Davis et al., 2011).  Through this method Davis & Wright report that 84% of 
their trauma exposed adults with nightmares achieved a week long absence of nightmares 
at six months follow up.   In addition improved sleep quality and quantity, depression and 
PTSD symptoms were reported.  Davis et al. (2011) replicated the findings of Davis and 
Wright (2007) in addition to marking treatment related improvements in physiological 
reactivity including heart rate, skin conductance and corrugator activity (muscle 
surrounding the eyebrow).  These studies indicate that imagery re-scripting of a nightmare, 
in addition to exposure and relaxation results in changes in both psychological and 
physiological markers of nightmare severity. 
 
Other studies have suggested that rescripting is more acceptable to both patients and 
therapists than exposure and results in significantly lower dropout rates (Arntz, Tiesema & 
Kindt, 2007).  As such, Nappi, Drummond, Thorp & McQuaid (2010) utilised IR in the 
absence of an exposure element but substituted this with practicing guided imagery of a 
pleasant scene and emphasise compliance with a rehearsal schedule.  Participants chose 
their target nightmare, 85% of which related to an event occurring during military service.  
The intervention was formed of 4-5 sessions in a group or individual format, depending on 
time constraints of the participant.  Participants were guided to change the ending of the 
nightmare to a neutral or pleasant ending and to elaborate this ending in order that it was 
vivid and detailed.  Participants then practiced this rescripted nightmare twice daily for ten 
minutes.  Results indicated significant reductions in nightmare frequency and intensity, 
severity of insomnia and subjective daytime PTSD symptoms.   
 





With regards to longer term follow up of participants, Forbes et al. (2003) found significant 
improvements in nightmare frequency and intensity 12 months following cessation of their 
six session pilot of IR.  The results of Nappi et al. (2010), Krakow et al. (2000) and Forbes et 
al. (2003) form part of a larger meta-analysis of thirteen studies investigating IR for the 
treatment of post-traumatic nightmares.  This analysis revealed that IR has large effects on 
nightmare frequency, sleep quality and PTSD symptoms from initial to post-treatment 
assessment (Casement & Swanson, 2012).  Furthermore, the effects were sustained 
through six and twelve month follow up (Casement & Swanson, 2012). 
 
Thunker and Pietrowsky (2012) assessed the effectiveness of IR as a method for the 
treatment of Nightmare Disorder in those with and without post-traumatic symptoms.  
Thunker and Pietrowsky (2012) utilised an eight session manualised treatment of IR.  They 
evidenced a decrease in nightmare frequency as well as nightmare related anxiety across 
three groups; those with Nightmare Disorder only, those with nightmares in the context of 
Depression and those with nightmares in the context of PTSD.  This provides promising 
data that IR can be extended to diagnostic groups outside of PTSD alone.  A literature 
search has revealed no published studies piloting the impact of IR as a technique for 
treatment of nightmares within the context of psychosis.  IR has been used as a technique 
for treatment of intrusive daytime images for those with psychosis, as reported in 
individual case reports (Morrison, 2004; Serruya & Grant, 2009), and small case series, for 
those with persecutory delusions and intrusive visual memories, Schulze (2009), and for 
those with auditory hallucinations (Ison, 2011). 
 
The current study aims to add to the well established literature of IR for the treatment of 
post-traumatic nightmares, and to the small literature on using IR in the context of 
psychosis, by considering whether IR for nightmares might be suitably adapted for use in a 
population with psychosis. 
 
1.3.5 Exploratory hypotheses: 
Hypothesis one: Following IR there will be a reduction in a range of nightmare related 
domains; frequency, nightmare related distress, vividness of nightmares and intensity of 
nightmares. 
Hypothesis two: Following IR participants will have improved overall sleep quality, as 
measured by the PSQI 





Hypothesis three: Following IR there will be a reduction in measures of psychotic and 
affective symptomatology.  
Hypothesis four:  IR will be deemed an acceptable treatment for nightmares in patients with 











2. Methods – Study A 
The research comprises two separable studies; study A is a cross sectional study describing 
the phenomenology of nightmares in people with psychosis.   Study B is a case series 
describing the use of Imagery Rehearsal (IR) as an intervention for nightmares in those with 
psychosis (see figure 2).  The completion of the case series was reliant on study A 
demonstrating that some participants experience recurrent distressing nightmares; without 
this, no intervention was to be offered.  The methods, results and discussion for study A 
will be presented first in chapters 2, 3 and 4.  The methods, results and discussion for study 















Figure 2.  Diagram outlining the relationship between studies A and B. 
2.1 Ethical Approval 
The study was reviewed and approved by the City Road and Hampstead NHS Research 
Ethics Committee (11/LO/2045).  The Research and Development department at South 
London and Maudsley NHS Foundation Trust (SLaM) granted approval for recruitment in 
community teams, the Psychological Interventions Clinic for Outpatients with Psychosis and 
inpatient wards.  Approval was additionally granted from the SLaM Psychosis Clinical 
Academic Group (CAG).   The Research and Development Department at Oxleas NHS 
Foundation Trust granted approval to recruit via Early Intervention Teams. 
 
  






The design of study A was cross sectional.  
 
2.3 Recruitment 
Recruitment was carried out over an 11 month time period, between March 2012 and 
January 2013.  Participants were recruited via two south London NHS foundation trusts; 
South London and Maudsley NHS Foundation Trust (SLaM) and Oxleas NHS Foundation 
Trust.  Services that were approached to assist with recruitment included: Community 
Mental Health Teams (CMHT’s), an Early Intervention Team, an inpatient psychosis unit and 
a research register held by a specialist Psychological Intervention Clinic for outpatients with 
Psychosis (PICuP). 
 
Team consultant psychiatrists, team leaders or Consultant Clinical Psychologists were 
emailed with an outline of the study, attaching a Participant Information Sheet (see 
Appendix 10.2).  Consent was sought to attend a team meeting to discuss the study with 
team members.  In meetings, the researcher explained briefly the scientific rational for the 
study, the potential relevance to clinical practice, the inclusion and exclusion criteria and 
what the role of care co-ordinators and participants would be through the research.  
Participant Information sheets were handed out to care co-ordinators who identified 
suitable participants and gained their consent for their contact details to be passed to the 
researcher.  Potential participants were initially contacted via telephone by the researcher, 
offered further information about the study and invited to take part.  Those who suggested 
that they were interested were sent an appointment letter and information sheet via post 
or email.   
 
For those participants who were recruited via the PICuP research register, their consent to 
be contacted for research purposes had already been granted by virtue of them being on 
the register.  The first contact was therefore made directly to the patient.  For those 
patients who were on an inpatient ward, the team Consultant Clinical Psychologist 
approached patients face to face with an Information sheet about the study.  Patients 
subsequently met with the researcher at the ward if they were interested. 
 
  





In all cases, if participants agreed to attend a research appointment, they were met by the 
researcher at the Institute of Psychiatry, at their clinical team base or on the inpatient ward 
where they resided.  A note of attendance was written on the participants electronic 
clinical records either by the researcher (for SLaM participants), or by the care co-ordinator 
(for Oxleas NHS Foundation Trust participants).  If any clinical or risk issues relevant to the 
clients care arose during the assessment this information was passed to the participant’s 
care co-ordinator.   
 
Seven teams were approached to facilitate recruitment, four teams agreed.  Across these 




























2.4 Inclusion and Exclusion Criteria 
Inclusion criteria for taking part in the study were: 
1. Experience of delusions or hallucinations (psychosis) 
2. Proficient use of the English language for the purpose of filling in questionnaires. 
3. Aged 18 or over. 
4. Able to give informed consent. 
Participants were aware that the study was investigating “sleep patterns”, but the 
information sheet stated: “whether you sleep very well, or have had sleep difficulties we 
would like to hear from you”.  The importance of referring any person with psychosis, 
irrespective of sleep quality, was also emphasised to teams. 
Reasons for exclusion from the research: 
1. A primary diagnosis of alcohol or substance dependency. 
2. An organic syndrome such as dementia. 
3. Learning disability. 
 
2.5 Measures 
2.5.1 General Information Questionnaire 
All participants completed the General Information Questionnaire.  This asked participants 
for their age, gender, ethnicity, alcohol use over the past 7 days and non-prescribed drug 
use over the past 14 days.  In addition participants prescribed medications and dosages and 
subjective reports of side effects were noted.  In instances where participants could not 
recall their current medications, these were taken from electronic medical records.  Anti-
psychotic medications were converted into Chlorpromazine equivalents using published 
tables (Woods, 2003; Atkins, Burgess, Bottomly & Riccio, 1997; Wulff et al., 2012).  Lastly 
participants were asked to report any strategies (both helpful and less helpful) that they 
use to facilitate their sleep (Appendices: 10.4). 
 
2.5.2 The Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman & 
Kupfer, 1989)  
The PSQI is a self-report measure of sleep quality over the month prior to assessment date.  
The questionnaire comprises 19 self report items and five questions rated by a bed partner.  
In order to avoid excluding participants who do not have a partner, the five informant rated 
measures were omitted.  This decision was taken based on recruitment to a previous trial 
  





in which 218/301(72%) of people with psychosis did not identify a person with whom they 
had a caring relationship / spent longer than 10 hours per week with (Garety et al., 2008).  
The PSQI questionnaire derives a Total Sleep Quality Index formed from seven sub-scores; 
duration of sleep, sleep disturbance, sleep latency, daytime dysfunction, sleep efficiency, 
subjective sleep quality and use of sleeping medications.  See appendices: 10.5. 
 
Evaluation of the PSQI indicates the seven component scores have good internal 
consistency (cronbach’s alpha = .83) and the global index score and seven component 
scores yield acceptable test-retest reliability (Buysse et al., 1989).  A cut off score of >5 for 
the global index score has been shown to provide good diagnostic sensitivity and specificity 
for distinguishing good from poor sleepers (Buysse et al., 1989).  The psychometric 
properties reported in Buysse et al. (1989) were derived from a sample of participants with 
diagnosed sleep disorders, healthy controls without sleep complaints and those with major 
depressive disorder.  A literature review revealed that the psychometric properties have 
not yet been evaluated in those with psychosis. 
 
2.5.3 Dream Log for study A.  Adapted from dream logs used by Levin & Fireman (2002).   
Participants completed a retrospective dream log (adapted from Levin & Fireman, 2002).  
Participants were informed that they would be asked about the presence of nightmares at 
the point of making an appointment for the study.  Previous research has indicated that 
retrospective nightmare frequency logs measuring up to a month in the past do not yield 
statistically different measures to prospective nightmare logs (Robert & Zadra, 2008).  
Participants were asked to indicate how many nightmares they estimated they had 
experienced over the past two weeks (14 nights).  If the participant had experienced at 
least one nightmare they were asked to answer four further questions based on their worst 
nightmare.  Participants rated the chosen nightmare on a seven point likert scale for 
intensity, vividness and distress engendered.  Lastly they were asked whether they had 
experienced that chosen nightmare before to mark whether that nightmare was recurrent.  
See appendices 10.6. 
 
2.5.4 The Psychotic Symptom Rating Scale (PSYRATS; Haddock, McCarron,Tarrier & 
Faragher, 1999)  
The Psychotic Symptom Rating Scale (PSYRATS; Haddock et al., 1999) measured the 
severity of different dimensions of auditory hallucinations and delusions.  The scales 
  





comprise of a semi-structured interview marking severity of 17 items (11 items assess 
auditory hallucinations, six assess delusions), using a four point scale.  Evaluation of the 
PSYRATS indicates that the scale has good inter-rater reliability for both the delusion items 
(≥.88; Haddock et al. 1999) and the auditory hallucination items (≥.78; Haddock et al. 
1999).  Concurrent validity has been demonstrated; the delusions scale correlated with the 
Positive and Negative Syndromes Scale (PANSS), delusion item (Spearman’s = 0.43; Drake, 
Haddock, Tarrier, Bentall & Lewis, 2007) and the hallucination scale correlated with the 
PANSS hallucination item (Spearman’s = 0.81; Drake et al., 2007).  The PSYRATS 
hallucination and delusion scales are sensitive to change over time; change in delusions 
scale score correlated with the PANSS delusion item score change(Spearman’s = 0.80; 
Drake et al., 2007) and change in hallucinations score correlated with the PANSS 
hallucination item score change (Spearman’s = 0.88; Drake et al., 2007).  See appendices: 
10.7 and 10.9. 
 
2.5.5 Depression Anxiety Stress Scales (DASS-21; Lovibond & Lovibond, 1995a)  
The Depression, Anxiety Stress Scale 21 item measure (DASS-21; Lovibond & Lovibond, 
1995a) was completed based on participants’ experience over the past week.  The scale 
comprises of 21 items (E.g. 15: I felt I was close to panic), rated on a scale from zero (did 
not apply to me at all) to three (applied to me very much, most of the time).  Seven items 
each load onto three factors; depression, anxiety and stress and combine to create a total 
score.  The scale is a short form version of the full 42 item version (Lovibond & Lovibond, 
1995a). 
 
Henry and Crawford (2005) have analysed the psychometric properties of the DASS-21.  
They report the internal consistencies to be good for the depression scale (cronbach’s 
alpha = 0.88) and the anxiety scale (cronbach’s alpha = 0.82) and very good for both the 
stress scale (cronbach’s alpha = 0.90) and the total score (cronbach’s alpha = .93).  The 
depression and anxiety sub-scales of the original 42 item version has been shown to have 
good construct validity, as evidenced by the strong correlation between the depression 
sub-scale and the Beck Depression Inventory, as well as between the anxiety sub-scale and 
the Beck Anxiety Inventory (Lovibond & Lovibond, 1995a).  Although the full DASS was 
designed as a screening measure in non-clinical populations, it has been validated for use 
  





with clinical populations (Brown, Chorpita, Korotitsch & Barlow, 1997).  See appendices: 
10.11. 
 
2.5.6 CORE-10 (Connell & Barkham, 2007) 
The CORE-10 (Connell & Barkham, 2007) was used as a screening measure of psychological 
distress.  The construct of psychological distress is not linked to a particular disorder, but 
individual items cover anxiety (2 items), depression (2 items), trauma (1 item), physical 
problems (1 item) functioning (3 items) and risk to self (1 item; CORE-ims, n.d.). The CORE-
10 has been shown to be sensitive to change and has good internal reliability with a 
Chronbach alpha of .82 (Connell & Barkham, 2007).  It correlates well with measures of 
anxiety, depression and general mental health (Connell & Barkham, 2007).   
 
2.5.7 Posttraumatic Diagnostic Scale (PDS; Foa, Cashman, Jaycox & Perry (1997) 
The Posttraumatic Diagnostic Scale (PDS; Foa et al., 1997) was used as a self-report 
measure of post-traumatic stress disorder.  The scale can be used to yield a preliminary 
PTSD diagnosis according to DSM-IV criteria as well as mark symptom severity.  It has been 
shown to have high internal consistency, test re-test reliability and high diagnostic validity 
when compared with the Structured Clinical Interview and good sensitivity and specificity 
(Foa et al., 1997).   
 
2.5.8 Time Budget Questionnaire (Jolley et al., 2006) 
The Time budget Questionnaire (Jolley et al. 2006) was administered as a structured clinical 
interview assessing use of time over the preceding week.  The measure was designed 
specifically for those with psychosis.  It maps activities over a seven day week, with each 
day split into 4 time reference periods (morning, middle of the day, afternoon and 
evening).  Interviewers probe for activities, degree of independence in activities, and 
number and nature of social contacts (Jolley et al. 2006).  Activities are rated according to 
the complexity of the activity and the effort required.  The measure has been shown to 
have convergent validity with regard to activity levels and social contact (Jolley et al., 2006).  
See appendices: 10.12. 
 
  





2.5.9 Digit Span sub-test - Wechsler Memory Scale third edition (WMS-III) 
This is a widely used measure of working memory in both clinical and research settings.  
The measure has been well standardised on a US representative sample of 1,250 adults 
aged between 16 and 89.  The digit span has a reliability coefficient of .86.  The digit span 
raw score is converted to a scaled score ranging between 1 and 19.  The scaled score has a 
mean of 10 and a standard deviation of 3.  Scaled scores are standardised across age range. 
 
2.6 Procedure for Study A 
All participants met with the author for approximately 1.5 hours.  Each participant 
completed three semi-structured interviews, four questionnaires and one 
neuropsychological sub-test. 
 
Participants were thanked for attending the appointment.  They were given the 
opportunity to read the information sheet again and ask any questions prior to informed 
consent being sought.  It was explained to participants that they could take a break at any 
point during the research.  Participants were told that information given throughout the 
assessment would remain confidential but that if the researcher was concerned about the 
safety of the person, or others around them they would share this information with the 
persons NHS care team.  Following this, participants completed the consent form for study 
A. 
 
Participants completed the General Information Questionnaire, the PSYRATS for 
hallucinations followed by the PSYRATS for delusions with the researcher.  Following this 
participants completed the Pittsburgh Sleep Quality Index, the Dream log for study A, the 
CORE-10 and DASS-21 independently but were given the option of completing the 
questionnaires verbally (using the researcher as a scribe).  Following this, the PDS and Time 
Budget Questionnaire were completed with the researcher.  Lastly, participants completed 
the Digit Span sub-test from the WMS-III, administered by the researcher. 
 
The order of assessment measures (as described above) was held constant across all 
participants with the trauma questionnaire (PDS) intentionally placed after the psychotic 
(PSYRATS) and mood symptom (Core-10 and DASS-21) questionnaires.  This order was 
decided to reduce the impact of mood changes induced by the trauma questionnaire (PDS).  
  





Fatigue effects were minimised by offering participants breaks and interchanging between 
verbal and written assessment measures. There was one exception in which the order was 
changed; one participant completed the independent measures prior those that are 
completed with the researcher due to room availability difficulties on a busy ward. 
 
Following completion of the measures participants were thanked for their time, a brief 
explanation of the study was offered and if they met the eligibility criteria for study B, their 
interest in taking part was discussed and noted.  Participants were told that the researcher 
would contact them at a later date should they be invited to take part. 
 
2.7 Power Calculation 
This study is an exploratory study; no other study has investigated nightmares within the 
context of psychosis.  The following power analysis is therefore based on the assumption 
that the associations between nightmare distress and daytime symptomatology is at least 
as strong as in the general population.  Levin and Fireman (2002) observed correlations of 
between .43 and .55 between nightmare distress and daytime symptomatology.  The study 
will have 80% power to detect a correlation of .43 if a sample of at least 37 participants is 
recruited.  This will therefore be the minimum number of participants to be recruited. 
 
2.8 Analyses 
PASW statistics version 18 was used to perform all inferential statistics.  The only exception 
to this is that 95% confidence interval for proportions was calculated using Graphpad.com 













3. Results – Study A 
This chapter will report on the results from study A.  The sample with be described with 
regards to demographic variables and clinical characteristics.  Following this, the 
phenomenology of nightmares in the context of psychosis will be reported on.  Specifically, 
the frequency of nightmares in psychosis will be reported and compared to data from a 
general population sample. The link between nightmares and a range of daytime 
symptomatology will be reported and lastly, whether nightmare frequency or nightmare 
distress best accounts for links with daytime symptomatology. 
 
3.1 Sample demographics 
The mean age of participants was 41.9 years (range 18-68). The sample comprised of 62.5% 
males and 37.5% females. The ethnicity of the majority of the sample was White British 
(42.5%), the second largest category was Black African (20.0%; table 1).   
 
Table 1.  Ethnicity of the Sample (n=40) by Categories used in Office of Population 


















Category Frequency % 
White British 17 42.5 
Black African 8 20.0 
White (other) 4 10.0 
White Irish 2 5.0 
Black Caribbean 2 5.0 
Black British 1 2.5 
Asian Indian 1 2.5 
Mixed Afro-Caribbean 1 2.5 
Mixed White British and Afro-Caribbean 1 2.5 
Mixed White and Black Caribbean 1 2.5 
Mixed Indian/Algerian 1 2.5 
Mixed (other) 1 2.5 
  





3.2 Clinical Characteristics 
3.2.1 Diagnoses 
All but one of the participants had active symptoms of psychosis, as measured by the 
PSYRATS.  The one participant who reported no active symptoms had a current diagnosis of 
Paranoid Schizophrenia and reported a history of paranoid beliefs, but 0% conviction in 
these over the week prior to assessment date.  
 
Of the sample of 40 participants, 22 (55%) had a primary diagnosis of Schizophrenia, four 
(10%) Schizoaffective Disorder, three (7.5%) Unspecified Non-organic Psychosis, three 
(7.5%) Bipolar Disorder, two (5%) Post-Traumatic Stress Disorder and two (5%) Severe 
Depressive Episode with Psychotic Symptoms.  The remaining participants had been 
diagnosed with Adjustment Disorder (n=1, 2.5%), Mental and Behavioural Disorder due to 
use of Cannabinoids (n=1, 2.5%),and Behcets Disease with Other Persistent Affective 
Disorders (n=1, 2.5%).   
 
3.2.2 Symptoms of Psychosis 
Twenty seven of the 40 participants reported hearing voices in the week prior to 
assessment.  Length of time hearing voices ranged from 10 months to 29 years.  There 
were no missing values within the data.  Analysis of the mean PSYRATS for hallucination 
scores of the 27 participants who reported hearing voices suggested that they heard voices 
at least once per day.  When heard, the mean score suggested voices lasted for several 
minutes, the voices were about the same volume as the participants’ own voice and a 
minority of the voice content was negative, saying things that related to the self-concept 
(E.g. “you’re lazy”).  A minority of the voices were distressing, to a moderate degree.  For 
these 27 participants, the mean score for disruption to life suggested that voices caused 
minimal disruption to life, such that the participant group were able to complete activities, 
but that the voices interfered with their ability to concentrate.  Mean PSYRATS for 
























2.07 1.57 Voices occur at least once a day 
Duration of voices 1.78 1.42 Voices last for several minutes 
Location of voices 1.74 1.40 
Voices outside the head, but close to ears or head. 
Voices inside the head may also be present 
Loudness of voices 2.37 1.15 About the same loudness as own voice 
Beliefs regarding 
origins of voices 
2.30 1.30 
Holds a less than 50% conviction that voices originate 





Minority of voice content is unpleasant or negative (less 
than 50%) 
Degree of negative 
content of voices 
2.52 1.74 
Personal verbal abuse relating to self-concept e.g. 
“you’re lazy, ugly, mad, perverted” 
Amount of distress 2.22 1.63 Minority of voices distressing (< 50%) 
Intensity of 
distress 
2.04 1.56 Voices are distressing to a moderate degree 
Disruption to life, 
caused by voices 
1.44 1.12 
Voices cause minimal amount of disruption to life, e.g. 
interferes with concentration although able to maintain 
daytime activity and/or social or family relationships 





Subject believes they can have some control over the 
voices but only occasionally. The majority of the time 







Thirty five (87.5%) of the 40 participants reported experiencing delusions.  Length of time 
of holding a delusional belief ranged from three months to 41 years.  There was one 
missing value for one question, across all 40 participants.  This missing value (question two) 
was calculated from the mean of the scores from the other five items for that participant 
(person-mean computation).  Analysis of the mean PSYRATS for delusions scores of the 35 
participants who experienced delusional beliefs suggested that they thought about their 
beliefs at least once per day.  When these thoughts came to mind, they lasted for several 
minutes.  The mean level of conviction in the belief was strong but not absolute; between 
  





50-99%.  The beliefs caused distress on a minority of occasions (<50%) and when 
distressing, they were moderately distressing.  Mean PSYRATS for delusions data, with 
standard deviations is reported in table 3. 
 












1.71 1.10 Thinks about beliefs at least once per day 
Duration of Pre-
occupation 




2.71 1.20 Conviction in belief is very strong, between 50-99% 
Amount of 
Distress 
2.31 1.64 Beliefs cause distress on less than 50% of occasions 
Intensity of 
Distress 
2.14 1.40 Beliefs cause moderate distress 
Disruption to 
Life Caused by 
Beliefs 
1.54 1.01 
Beliefs cause moderate amount of disruption to life 
causing some disturbance to daytime activity and/or family 
or social activities. The patient is not in hospital although 
may live in supported accommodation or receive 
additional help with daily living skills. 
PSYRATS 
Delusions Total      
(0-24) 12.55 5.81  
 
3.2.3 Affect - Depression, Anxiety and Stress 
There were four missing items across all questions and all participants.  They were missing 
from four separate participants.  Two of the four items loaded on to the depression scale, 
one on the anxiety scale and one on the stress scale.  For each instance, the missing value 
was calculated from the mean of the other six items making up that scale (person-mean 
imputation). 
 
Using norms provided from the DASS manual (Lovibond & Lovibond, 1995b) the mean 
depression score for the forty participants fell within the ‘moderate’ range (mean = 19.23, 
  





s.d. = 11.19, range = 0-42).  The mean anxiety score for the sample fell within the ‘severe’ 
range (mean, 16.03, s.d. = 9.65, range =2-38) and the mean stress score fell within the 
‘moderate’ range (mean = 19.68, s.d. = 8.70, range = 2-38).   
 
There was a spread of scores across clinical status, with participants presenting with non-
clinical levels of depression, anxiety and stress, through each category to extremely severe 
levels of depression anxiety and stress (see table 4).   
 
Table 4.  Frequency of participants falling within varying degrees of clinical severity 
across the Depression, Anxiety and Stress scales of the DASS-21 (Lovibond & Lovibond, 
1995). 
  Clinical Status 
   
Non-
clinical 










  Depression 7 (17.5%) 7 (17.5%) 9 (22.5%) 4 (10%) 13 (32.5%) 
Anxiety 9 (22.5%) 0 (0.0%) 10 (25%) 7 (17.5%) 14 (35%) 
Stress 12 (30%) 10 (25.0%) 6 (15%) 9 (22.5%) 3 (7.5%) 
 
3.2.4 Global Distress 
The mean score for global distress as measured by the CORE-10 was 1.73 (s.d. = 0.69) which 
falls into the clinical range irrespective of gender (clinical cut off scores are different for 
male and female participants; Connell & Barkham, 2007).  This mean score would be 
classified as ‘moderate’ distress (Connell & Barkham, 2007).  The global distress of 

















Table 5.  Frequency of participants as a function of the level of severity of global distress 
(N=40) (Connell & Barkham, 2007) 
Level of Severity of 
Global Distress 
Frequency 
Healthy 1 (2.5%) 
Low Level Distress 2 (5.0%) 
Mild 12 (30.0%) 
Moderate 13 (32.5%) 
Moderate to severe 7 (17.5%) 
Severe 5 (12.5%) 
 
3.2.5 Post-Traumatic Stress Disorder (PTSD) 
All participants answered the section of the PDS relating to experience of traumatic events.  
Thirty six (90%) of the 40 participants reported experiencing at least one traumatic event 
throughout their life.  The mean number of traumatic events experienced by all 40 
participants was 3.20 (s.d. 2.09).  Twelve (30%) of 40 participants reported Child Sexual 
Abuse (CSA), whilst 28 (70%) reported no history of CSA.  The PDS questionnaire separates 
participants into those meeting a preliminary diagnostic criteria for PTSD, those who do not 
meet preliminary diagnostic criteria and lastly, those who would require further 
information (beyond that of the questionnaire) in order to clarify whether that participant 
meets diagnostic criteria.  Thirty nine participants completed questions sufficient to code 
into these categories.  Seventeen (44%) out of 39 participants met criteria for a diagnosis of 
PTSD, 20 (51%) participants did not meet diagnostic criteria for PTSD and two (5%) 
participants required further information beyond the PDS questionnaire in order to clarify 
whether they met diagnostic criteria.  Eleven of the 17 participants who met criteria for a 
diagnosis of PTSD (65%) had weekly nightmares.  This was not significantly higher than the 
10/20 (50%) participants who reported weekly nightmares but did not meet diagnostic 
criteria for PTSD (X
2 
(1, n=37) = .81, p = n.s.). 
 
Given the wide range of events that were reported by a person with psychosis as traumatic 
and their relation to illness characteristics, further analysis of traumatic events were 
undertaken.  The index event which the participant chose to complete the PDS for (i.e. the 
one that bothered them the most) was coded on the basis of its proximal link to the person 
  





and their psychosis (Picken & Tarrier, 2011)
1
.  Four categories were used; whether the 
event was (1) ‘independent’ from the participants own action (e.g. natural disaster or child 
sexual abuse), (2) ‘possibly independent’ from their own action (e.g. a physical assault), (3) 
‘dependent on illness behaviour’ (for example being hospitalised against their will) and (4) 
‘dependent on a symptom’ (e.g. a traumatic hallucination or delusion).  Twenty two (64%) 
out of 36 index events were independent of the person and their psychotic symptoms.  Ten 
(28%) events were possibly independent, two (6%) were dependent on illness behaviour, 
one (3%) was dependent on a symptom and one (3%) participant did not provide enough 
information to code the event.  
 
3.2.6 Substance Use 
Nine of the forty participants had taken non-prescribed drugs or medications in the week 
prior to assessment date.  Of these nine, two reported taking cannabis.  The remaining 
seven took over the counter medications; five participants reported taking paracetamol for 
pain relief, one participant took ‘Kalms’ tablets (a herbal remedy designed to promote 
sleep) and one participant took a multi-vitamin. 
 
The distribution of alcohol use in the week prior to assessment date was positively skewed.  
24 of the 39 (61%) participants who reported their alcohol use consumed zero units of 
alcohol, resulting in a median alcohol use of zero units.  Alcohol use ranged from zero units 
to 80 units.  The recommended daily intake of alcohol is 2-3 units for females and 3-4 units 
for males (Department of Health, 2012).  Using these figures as a guide and multiplying 
them by a seven day week suggested that three male participants (12%) and one female 
participant (7%) were consuming above the recommended intake of alcohol.   
 
3.2.7 Insomnia 
A score of greater than five on the PSQI indicates clinically relevant sleep disturbance 
(Backhaus, Junghanns, Broocks, Riemann & Hohagen, 2002).  Of the total sample of forty 
participants, 34 (85%) had a score greater than five, 6 (15%) participants had a score less 
than or equal to five.   
                                                           
1
 Within the context of psychosis, studies have widened the context of traumatic index event to 
include involuntary hospitalisation, distressing symptoms and treatments (Picken & Tarrier, 2011). 
  





More detailed analysis of the PSQI data indicates that the mean hours of sleep per night of 
the forty participants was seven hours (s.d. 2.59) suggesting that participants were 
receiving adequate hours of sleep in total.  However their sleep efficiency was 71.92% (s.d. 
22.48), suggesting that on average less than three quarters of the amount of time spent in 
bed was spent actually asleep. 
 
3.2.8 Medication 
Thirty nine out of 40 (97.50%) participants reported taking at least one medication for 
either physical or mental health problems.  Thirty five out of 40 (87.5%) reported taking an 
anti-psychotic medication, 17/40 (42.50%) were prescribed an anti-depressant, 7/40 
(17.50%) were prescribed a mood stabiliser and 5/40 (12.50%) reported being prescribed 
medication for insomnia.   
 
When asked to list side effects experienced from all medications, 15/40 (37.50%) 
participants mentioned sleep (ie. sleep onset/offset/drowsiness during the 
day/parasomnias).   One participant listed “dream more rapidly” as a side effect of 
Simvastatin medication (for high cholesterol).  Four participants were prescribed 
Simvastatin; these four experienced between 3 and 40 nightmares over the course of 14 
nights.  
 
Chlorpromazine equivalents of anti-psychotic medications were not significantly correlated 
with nightmare frequency (rs(40) = -.16, p = .34) nor nightmare related distress (rs(40) = -
.07, p = .71).  A medium negative correlation was found between chlorpromazine 
equivalents and sleep quality (rs(40) = -.40, p < .05) and a medium positive correlation was 
found between sleep efficiency (percentage of hours in bed spent asleep; rs(40) = -.4, p < 
.01).   
 
Chlorpromazine equivalents of antipsychotic medications were not significantly correlated 
with PSYRATS for delusions score (rs(40) = -.04, p = .82), global distress (rs(40) = .03, p =.86), 
depression (rs(40) = -.07, p =.68), anxiety (rs(40) = .17, p =.29), stress(rs(40) = .06, p =.70), 
PTSD symptom severity (rs(20) = -.04, p =.88), time budget (daytime activities: rs(39) = -.03, 
p =.86) or working memory (rs(39) = .30, p =.06).  There was however a medium positive 
  





correlation between dose of anti-psychotic medication and PSYRATS for hallucinations 
(rs(40) = .33, p < .05). 
 
Further analyses involving measures of sleep quality, sleep efficiency and auditory 
hallucinations shall therefore control for anti-psychotic medication dose. 
 
3.3 Distribution of key variables; nightmare frequency and nightmare 
distress 
In order to establish whether a correlation co-efficient is significant using a parametric 
(Pearson’s) correlation, data are required to be normally distributed on both variables.  The 
assumption of normality was assessed for the two key variables (nightmare frequency and 
nightmare distress) via both visual plots and descriptive statistics of skewness and kurtosis.  
A histogram and Q-Q plot both indicated that the nightmare frequency variable was 
positively skewed (see figure 3).  This was substantiated by a skewness of 4.09 (SE = .37) 
resulting in a z-score for skewness of 11.05.  This indicates significantly positive skew 
(p<.001).  The kurtosis score of 18.62 (SE = .73), results in a z-score for kurtosis of 25.51, 
which is significant (p<.001).   
Figure 4.  Skewed distribution of nightmare frequency data as evidenced by A) histogram 
and B) Q-Q Plot. 
 
A histogram indicated a degree of negative skew for nightmare distress, whilst the Q-Q plot 
was more ambiguous to interpret (see figure 4).  A skewness value of -.794 (SE = .441) 
  





resulted in a non-significant z-score for skewness of -1.80 (p>.05).  The kurtosis was -.171 
(SE = .858) resulting in a non-significant z-score for kurtosis of -0.20 (p>.05).  Given the 
negative skew indicated by the histogram, non-parametric (Spearman’s) correlations will be 
reported.  This also serves to maintain consistency with the non-parametric correlation 
coefficients that are reported for nightmare frequency.   
 
 
Figure 5.  Skewed distribution of nightmare distress data as evidenced by A) histogram 
and B) Q-Q Plot. 
 
3.4 Power and risk of a Type II error 
The study had 80% power to detect significant correlations of at least .43, utilising data 
from the entire sample of participants recruited.  This was planned to be a minimum of 37.  
Therefore, any correlation smaller than .43, or variables completed by a sub-sample of 
participants (E.g. nightmare distress) are at risk of a Type II error.   
 
3.5 Phenomenology of Nightmares  
Twenty eight of the sample of 40 (70%) reported at least one nightmare over the two week 
reference period.  Of the 28 people who reported a nightmare, 16 reported that their most 
distressing nightmare over the two week period was a recurrent nightmare.  The median 
  





score for nightmare related distress (from the scale from 1-7) was 6, median vividness of 
the nightmare was 6 and median intensity of the nightmare was also 6. 
 
3.5.1 Hypothesis 1: Nightmares are more prevalent in the context of psychosis than in the 
general population. 
This hypothesis was supported.  Large community based epidemiological studies from 
outside of the UK indicate that 0.9-6.8% of the general population report weekly 
nightmares, a frequency thought to reflect moderately severe pathology (Nielson & Levin, 
2007).  Within the current sample of 40 participants with psychosis, 55.0% experienced at 
least weekly nightmares (ie. two or more nightmares over a two week period).  The 95% 
confidence interval is 38.5% to 70.7%.  The 0.9-6.8% prevalence of nightmares in the 
general population does not fall within the 95% confidence interval (38.5-70.7%), indicating 
that there is a significantly higher proportion of people with psychosis who experience 
weekly nightmares than found in the general population (figure 5). 
 
Figure 6.  Percentage of people experiencing weekly nightmares as a function of sample; 
psychosis (current study) versus results of a literature review of non-UK based large 
epidemiological studies (Nielson & Levin, 2007; Li et al., 2010; Janson et al., 2005).  Error 
bars for psychosis group indicate 95% confidence interval, error bars for general 
population indicate the range of values reported across all studies reviewed (0.9-6.8%). 
 
The one study reporting the prevalence of nightmares from a UK sample found that 42% 
experienced at least one nightmare over a two week time period (Blagrove et al., 2004).  
Based on the reported 42% fortnightly prevalence and the sample size of 147, the 95% 
confidence interval is 34.0% to 50.6%.  The current sample of 40 people with psychosis 



















































95% confidence interval, calculated using Graphpad.com is 53.5% - 83.4%.  The confidence 
interval for the current sample (53.5-83.4%) does not overlap with the confidence interval 
calculated from the general UK sample of Blagrove et al. (2004) (34.0-50.6%).  As such, the 
proportion of people with psychosis who experience fortnightly nightmares is significantly 
higher than that found in the general UK population (figure 6). 
 
 
Figure 7.  Percentage of people experiencing fortnightly nightmares as a function of 
sample; psychosis (current study) versus the general UK population (Blagrove et al., 
2004).  Error bars indicate 95% confidence intervals. 
 
3.5.2 Hypothesis 2: Nightmare frequency will be correlated with the measures of sleep.  A 
positive correlation is expected between overall sleep quality (measured by the PSQI) 
and nightmare frequency (higher scores on the PSQI indicate worse sleep quality).  A 
negative correlation is expected between nightmare frequency and sleep efficiency. 
 
This hypothesis was supported (see figure 7).  A non-parametric Spearman’s rho was 
calculated for the two correlations.   Hochberg’s correction for multiple comparisons will be 
reported in addition to the original significance level. 
 
A large positive correlation was found between nightmare frequency and overall sleep 
quality, as measured by the PSQI (rs(40) = .50, p < .01).  When adjusted for multiple 
comparisons (Hochberg’s correction) this remained significant (p <.01).  When anti-
psychotic medication was controlled for, a medium positive correlation remained (rs(37) = 
.48, p < .01).  Nightmare frequency was negatively correlated with sleep efficiency (hours 
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.01) which remained significant after correcting for multiple comparisons (p < .01).  When 
anti-psychotic medication was controlled for, a large negative correlation remained, (rs(37) 
= -.51, p < .01). 
 
Figure 8.  Scatter plots illustrating nightmare frequency as a function of A) Sleep Quality 
Index and B) Sleep efficiency (percentage of hours in bed spent asleep).  Trend line 
indicates the quadratic R
2
(A = .35, B = .42, C = .61). 
 
Given that nightmares interrupt continuous sleep, exploratory analysis investigated the 
relationship between nightmare frequency and total hours of sleep per night.  A medium 
negative correlation was found between nightmare frequency and sleep quantity (overall 
hours of sleep per night; rs(40) = -.44, p < .01).  This remained significant when adjusted for 
multiple comparisons (p < .01).  When anti-psychotic medication was controlled for, a 
medium negative correlation remained, (rs(37) = -.42, p < .01). 
 
3.5.3 Hypothesis 3: Nightmare frequency will be positively correlated with severity of 
daytime psychiatric symptoms.  These include severity of delusions, auditory 
hallucinations, PTSD symptoms, depression, anxiety, stress and global distress. 
 
This hypothesis was partially supported (figure 8).  Two way Spearman’s rho indicated a 
large positive correlation between nightmare frequency and the depression scale of the 
DASS-21 (rs(40) = .53, p =.000).  This finding remained significant when adjusting for 
multiple corrections (p=.000).  A medium positive correlation was found between 
nightmare frequency and global distress, as measured by the CORE-10 (rs(40) = .35, p < .05).  
However, this lost significance when adjusting for multiple comparisons (p=.19).  All other 
A B 
  





measures of daytime symptomatology yielded small positive correlations with nightmare 
frequency and were therefore in the expected direction; however each failed to reach 
statistical significance.  This included severity of hallucinations (voices) as measured by the 
PSYRATS (rs(40) = .15, p =.35), severity of hallucinations whilst controlling for anti-psychotic 
medication (rs(37) = .2, p =.19), severity of delusions as measured by the PSYRATS (rs(40) = 
.15, p =.37), anxiety scale from the DASS-21 (rs(40) = .27, p =.09), stress scale from the 
DASS-21(rs(40) = .24, p =.13) and PTSD symptom severity as measured by the PDS (rs(40) = 
.26, p =.26).  Scatter plots for all non-significant results can be found in appendix 13.   
Figure 9.  Scatter plots indicating nightmare frequency as a function of A) DASS-21 
measured depression and B) CORE-10 measure of global distress.   Trend line indicates 
the quadratic R
2 
(A =.26, B= .18). 
 
3.5.4 Hypothesis 4: Nightmare related distress better accounts for disturbance in daytime 
psychological functioning and daytime activity levels than nightmare frequency. 
 
This hypothesis was supported (see figure 9).  As reported above, one large significant 
correlation was found between nightmare frequency and a measure of daytime 
psychological functioning; depression (rs(40) = .53, p =.00) (see figure 8).  This remained 
significant after Hochberg’s correction for multiple comparisons (p = .00).   
 
Nightmare distress however was significantly correlated with four measures of daytime 
psychological functioning.  A large significant correlation was found between nightmare 
distress and delusional severity, as measured by the PSYRATS (rs(28) = .59, p <.01), this 
remained significant after controlling for multiple comparisons (p<.05).  A large significant 
A B 
  





correlation was found between nightmare distress and stress (rs(28) = .53, p <.01), this 
remained significant after controlling for multiple comparisons, (p<.05).  A large significant 
correlation was found between nightmare distress and anxiety (rs(28) = .53, p <.01) and this 
too remained significant after controlling for multiple comparisons (P<.05).  Similarly to 
nightmare frequency, a large significant correlation was found between nightmare distress 
and depression (rs(28) = .61, p <.01), this again remained significant when controlling for 
multiple comparisons (see table 6).   
 
Figure 10.  Scatter plots indicating nightmare distress as a function of A) PSYRATS 
measured delusional severity B) DASS-21 measured stress C) DASS-21 measured anxiety 
and D) DASS-21 measured depression.   Trend line indicates the quadratic R
2 
(A =.31, B= 










There was a medium positive association between nightmare distress and global distress 
(rs(28) = .47, p <.05), however this fell below significance when controlling for multiple 
comparisons (p=.06) and should therefore be treated with caution.  The measure of 
daytime activities (Time Budget Questionnaire) was negatively correlated to a medium 
degree with nightmare distress, however this fell just short of significance (rs(28) = -.33, p 
=.09) prior to adjustment for multiple comparisons. 
 
There were two negative findings; there was little to no significant association between 
nightmare distress and severity of PTSD symptomatology (rs(28) = -.04, p =.88) prior to 
adjustment for multiple comparisons.  Lastly, there was a medium but non-significant 
positive correlation between hallucinations and nightmare distress (rs(28) = .33, p =.08) 
prior to adjustment for multiple comparisons.  When controlling for anti-psychotic 
medication this medium positive correlation fell just short of significance (rs(25) = .37, p 
=.06). 
 
Table 6.  Spearman’s rho correlation correlations of nightmare frequency and nightmare 

























Global Distress 0.35 0.47 
Hallucinations 0.15 0.33 
Delusions 0.15 0.59* 
Stress 0.24 0.53* 
Anxiety 0.27 0.53* 
Depression 0.53*** 0.61* 














Daytime activities -0.16 -0.33 
*P<.05 after Hochberg’s correction for multiple comparisons 
***P<.001 after Hochberg’s correction for multiple comparisons 
 
  





3.5.5 Hypothesis 5: Nightmare frequency and nightmare distress exert independent 
effects on measures of sleep and daytime psychiatric symptomatology.  
This hypothesis is supported (table 7).    A medium negative correlation continues to exist 
between nightmare frequency and sleep efficiency (rs(24) = -.45, p<.05) and nightmare 
frequency and total sleep quality (rs(24) = .53, p<.01) after controlling for variance in both 
nightmare distress and anti-psychotic medication dose.  Lastly, a medium positive 
correlation continues to exist between nightmare frequency and depression (rs(25) = .42, 
p<.05) when controlling for nightmare distress.   
 
Similarly, the significant associations found between nightmare distress and measures of 
sleep quality and daytime symptomatology continue to exist, when controlling for variance 
in nightmare frequency.  A medium negative correlation continues to exist between 
nightmare distress and sleep efficiency (rs(24) = -.39, p<.05) and medium positive 
correlation with total sleep quality (rs(24) = .45, p<.05) when controlling for nightmare 
frequency and anti-psychotic medication dose.   A large positive correlation continues to 
exist between nightmare distress and severity of delusions (rs(25) = .59, p<.001).  The 
variance in delusional severity accounted for by variance in nightmare related distress is 
34.81% (R
2 
* 100).  A medium positive correlation exists between nightmare distress and 
both daytime stress (rs(25) = .49, p<.05) and anxiety rs(25) = .48, p<.05).  A large positive 
correlation continues to be found between nightmare distress and depression (rs(25) = .50, 
p<.05). 
 
The number of nightmares reported by people with psychosis and the distress associated 
with them are both independently associated with both overall sleep quality and measures 
of depression, after controlling for shared variance.  The proportion of variance in sleep 
quality explained by nightmare frequency (R
2 
* 100) is 28.09%, whilst the proportion of 
variance explained by nightmare distress is 20.25%.  Nightmare frequency accounted for 
17.64% of the variance in depression scores, whilst nightmare distress accounted for 












Table 7.  Partial correlations of nightmare frequency and nightmare distress to sleep 
measures and daytime psychiatric symptomatology, controlling for shared variance.  
Correlations including sleep efficiency, total sleep quality additionally control for variance 
in anti-psychotic medication.  Numbers in brackets indicate the correlation coefficient 























 Sleep efficiency -0.45*  (-.52) 20 -0.39* (.48) 15 


























PSYRATS Delusions 0.01  0.59***  (.59) 35 
DASS-21 Stress 0.21  0.49*  (.53) 24 
DASS-21 Anxiety 0.21  0.48*  (.53) 24 
DASS-21 Depression 0.42*  (.53) 18 0.50*  (.61) 25 
*P<.05  
** P < .01 
***P<.001  
 
3.5.6 Hypothesis 6: Overall sleep quality will be negatively correlated with working 
memory.  Furthermore it is expected that nightmare frequency will be negatively 
correlated with working memory. 
 
This hypothesis was not supported.  Overall sleep quality was not significantly correlated 
with working memory (rs(39) = -.19, p =.26).  Controlling for anti-psychotic medication 
made no difference to this result (rs(36) = -.06, p =.70).  Nightmare frequency was not 
significantly correlated with working memory (rs(39) = .02, p =.90).   
 
Given that earlier results indicated that nightmare distress was more associated with 
daytime symptomatology than nightmare frequency, exploratory analysis was undertaken 
to assess the link between nightmare distress and working memory.  This revealed a large 
negative correlation between nightmare distress and working memory (rs(27) = -.50, p < 
.01) which remained significant when controlling for variance in delusional severity (rs(24) = 
-.42, p < .05) and depression (rs(24) = -.43, p < .05), but not anxiety (rs(24) = -.36, p = .07). 
 





4. Discussion study A: Cross sectional study 
Nightmares are characterised by awakening from rapid eye movement sleep with 
recollection of disturbing mental activity (Nielson & Levin, 2007).  Frequent nightmares 
have been shown to impact on sleep architecture (Simor, Bodizs, Horvath and Ferri, 2013), 
suicidal thoughts and behaviours (Pigeon et al. 2012).  In addition, nightmare distress was 
related to paranoia and affective symptomatology in a healthy student sample (Levin & 
Frieman, 2002).  This is the first systematic investigation of nightmares within a sample 
experiencing symptoms of psychosis.  The key result is that nightmares are a common 
problem for those with psychosis and found more often in this sample than the general 
population.  Furthermore, the frequency of nightmares is associated with poorer sleep 
quality and the distress associated with them relates to both sleep quality and a range of 
daytime functioning: delusional severity, depression, anxiety and stress.  
 
This chapter will present a summary of the findings from the cross-sectional study.  
Following this the current results will be placed within the context of existing literature and 
the clinical implications of the research will be outlined.  Lastly, the strengths and 
limitations of the study will be considered. 
 
4.1 Summary of the results 
The key finding of study A is that over half (55%) of the participant group, selected on the 
basis of symptoms of psychosis, reported experiencing weekly distressing nightmares.  
Weekly nightmares are thought to reflect moderately severe pathology (Nielson & Levin, 
2007).  As predicted, weekly nightmares were significantly more frequent in the psychosis 
sample (55%) than figures reported in large non-UK based epidemiological studies (0.9-
6.8%; Nielson & Levin, 2007; Li et al., 2010; Janson et al., 2005) and fortnightly nightmares 
were significantly more common in the sample (70%) than reported in a UK based study 
(42%; Blagrove et al., 2004).  The higher frequency of nightmares in the psychosis sample 
was not associated with anti-psychotic medication dose. 
 
As predicted, a higher frequency of nightmares was associated with both poorer sleep 
quality and poorer sleep efficiency (percentage of hours spent in bed spent asleep), after 
controlling for medication dose.  There was one select link between nightmare frequency 
and daytime psychiatric symptoms; a large positive association was found between 
  





nightmare frequency and depressed mood in patients.  Nightmare frequency was not 
associated with measures of the severity of delusions, hallucinations, PTSD symptoms, 
depression, anxiety or stress and thus offered only partial support for hypothesis three.   
Instead, it was the distress associated with nightmares that better accounted for a range of 
daytime psychiatric problems.  Large significant associations were found between 
nightmare related distress and measures of delusional severity, stress, anxiety and 
depression.  There was a non-significant  positive correlation between auditory 
hallucinations and nightmare related distress, which requires further investigation. 
 
As predicted, nightmare frequency and nightmare distress exerted independent effects on 
measures of sleep and daytime psychiatric symptomatology.  Nightmare related distress 
and nightmare frequency were both independently associated with overall sleep quality 
and sleep efficiency.  Similarly, the distress related to nightmares and the frequency with 
which they occur were independently positively associated with depression.  After 
controlling for nightmare frequency, a large correlation was found between nightmare 
distress and delusional severity and a medium correlation was found between nightmare 
distress and both stress and anxiety. 
 
Lastly, contrary to expectations there were no significant associations between working 
memory and either overall sleep quality or frequency of nightmares.  Instead there was a 
large significant negative correlation between nightmare distress and working memory 
which remained significant after controlling for variance in delusional severity and 
depression but not anxiety. 
 
4.2 Comparison of results to existing research 
4.2.1 The frequency of nightmares 
Nightmare Disorder was found in 18.3% of those with Primary Insomnia (Ohayon et al., 
1997) and 49% of those with BPD (Semiz et al., 2008).  These reported figures fall slightly 
lower than the current sample with psychosis (55%).  Although the measurement of 
nightmares was different in the current study, weekly distressing nightmares is generally 
accepted to reflect moderately severe pathology (Nielson & Levin, 2007; Levin & Fireman, 
2002) and can therefore be considered an estimate of Nightmare Disorder.   
 
  





With regards to PTSD, in which nightmares are a well established symptom of the disorder, 
52% of participants in that study reported nightmares ‘sometimes or more often’ in the 
National Vietnam Veterans Study (Neylan et al., 1998).  This is comparable to the 55% of 
the current sample with psychosis who complained of weekly nightmares.  In a further 
study (Leskin et al., 2002), 71% of participants with PTSD ‘complained of nightmares’, 
though no frequency was specified.   In the current sample 70% of participants complained 
of at least one nightmare over the previous fortnight, which is similar to the figure reported 
by Leskin et al., (2002).  Despite differences in measurement method, the above results 
indicate that nightmares occur with similar frequency in this sample with psychosis when 
compared to samples with PTSD.  The importance of this finding is highlighted by the fact 
that nightmares are one of the most commonly reported symptoms of PTSD (Nappi et al., 
2010) and form part of diagnostic criteria (DSM-IV; APA, 2000), yet this is the first study to 
show that nightmares are also a common problem for those with psychosis. 
 
4.2.2 The relationship between nightmares and sleep problems 
In the current sample, nightmares were related to poorer overall sleep quality and poorer 
sleep efficiency.  Although this is the first time nightmares have been associated with sleep 
difficulties in those with psychosis, it is not a novel finding in other populations.  In a 
community based cohort from Hong Kong, Li et al. (2010) reported medium positive 
correlations between nightmare frequency and indices of poor sleep including: difficulties 
initiating sleep, difficulties maintaining sleep, early morning awakenings and restless sleep.  
In a separate study of those diagnosed with Primary Insomnia, co-morbid Nightmare 
Disorder was associated with increased night time awakenings and abnormally long sleep 
onset (Ohayon et al., 1997).  Although the current result fits neatly with the literature 
implicating a link between nightmares and sleep quality, it is unclear what the direction of 
this effect is.  Although it seems intuitive to think that nightmares might cause increased 
awakenings, it is equally as plausible that there is heightened dream recall frequency in 
those with poorer sleep (Li et al., 2010).  This remains an area for further investigation. 
 
The finding that those with psychosis have poorer sleep quality and sleep efficiency is not 
novel.  Afonso et al., (2013) report that those with schizophrenia have poorer sleep 
efficiency, increased sleep latency and increased night time awakenings.   Eighty five 
percent of the current sample had clinically relevant sleep disturbance and reduced sleep 
  





efficiency.  The current sample spent an average of 71% of their time in bed actually asleep.  
Despite using the same measure of sleep efficiency, this figure is lower than the 93% sleep 
efficiency reported in Afonso et al. (2013), though is closer to the 82% reported by Wulff et 
al. (2012).   
 
A further difference when compared to Afonso et al.’s (2013) results is that there was no 
increase in total hours of sleep in the current sample.  The current sample reported a mean 
of seven hours of sleep per night.  This finding is in contrast to that of Afonso et al., (2013) 
in which those with schizophrenia were found to sleep for over nine hours.  However, in 
the study by Wulff et al. (2012) their schizophrenia group slept for an average of eight 
hours.  It is clear there is variability in sleep length and efficiency.  Given that the current 
study found higher anti-psychotic medication dose to be associated with better sleep 
quality and sleep efficiency, this might be one cause.  Furthermore, the frequency and 
distress of nightmares correlated with sleep quality and efficiency and might be an 
additional cause of large individual differences. 
 
4.2.3 Nightmare distress and the link with daytime symptoms 
The finding that nightmare distress better accounts for links with measures of daytime 
delusional severity, depression, anxiety and stress than nightmare prevalence has not been 
reported elsewhere in a sample with psychosis.  The current results do however replicate 
those of Levin and Fireman (2002) who recruited a non-clinical sample.  Levin and Fireman 
(2002) report that nightmare distress better accounted for the link with daytime 
symptomatology than nightmare frequency and that nightmare distress in particular was 
associated with depression, anxiety, psychoticism and paranoia.   
 
A somewhat unexpected result is the lack of association between either nightmare 
frequency or distress and PTSD symptomatology.  Given that nightmares and insomnia are 
regarded as a hallmark of PTSD (van Liempt et al., 2013), it was expected that PTSD severity 
would be related to nightmares.  This was not the case.  There are both theoretical and 
methodological interpretations of this result.  Firstly, it is possible that nightmares are a 
common problem in those with psychosis in general, irrespective of PTSD diagnosis.    This 
would result in elevated nightmares in those both with and without PTSD, thus making the 
additional diagnosis irrelevant.  Freeman et al., (2013) reported that following an assault, 
  





paranoia and post-traumatic reactions were correlated, and both disorders shared many of 
the same predictive cognitive factors.  It is therefore possible that both disorders share 
such a trans-diagnostic problem as nightmares; this would be an area for further study.  
There were limitations to the method of measuring PTSD that might also have contributed 
to the non-significant result.  This will be discussed within the limitations section. 
 
4.2.4 The association between nightmare distress and working memory 
It was surprising that overall sleep quality and nightmare frequency were not associated 
with working memory.  This is contrary to the finding that rest activity cycle was the best 
predictor of frontal executive functioning (alongside age; Bromundt et al., 2011) and other 
findings relating sleep and cognitive performance (Keshavan et al., 2011; Wamsley et al., 
2011).  Instead, the current study revealed a large negative correlation between nightmare 
distress and working memory.  This suggests that it is the affective quality of night time 
imagery (rather than sleep quality or frequency of sleep disturbance) that links with 
working memory.  One plausible account for this link is Eysenck, Derakshan,  Santos and 
Calvo’s (2007) Attentional Control Theory that links anxiety and cognitive performance.  
This theory asserts that worry is the component of state anxiety that is responsible for 
poorer task performance, due to its propensity to consume limited attentional resources of 
working memory.  This results in less working memory capacity, which in turn impedes 
performance.  It is possible that nightmare distress and its association with anxiety 
symptoms reduces working memory capacity.  This post-hoc hypothesis is supported by the 
finding that controlling for variance in anxiety resulted in a loss of the previously large 
negative correlation between nightmare distress and working memory.  This explanation 
warrants further empirical testing. 
 
4.3 Clinical implications 
The results indicate that nightmares are a clinically relevant problem for just over half of 
this sample with symptoms of psychosis.  Given their prevalence within this population, 
nightmares and sleep quality should form part of routine assessment of service users with 
psychosis.  Assessment can be brief; asking service users how many nightmares they 
experience per week and how distressing they find the experience.  Furthermore, given 
that nightmare related distress is associated with measures of delusional severity, 
depression, anxiety, stress and working memory nightmares should be considered as a 
  





phenomenon that has consequences over and above the night time sleep experience.   
Nightmares are not short, discreet experiences but instead impact on the full 24 hour day.     
 
The lack of association between nightmares and PTSD symptom severity suggests that 
clinicians should not assume nightmares to be related to past trauma.  Instead nightmares 
may be highly distressing to the individual and be associated with worse daytime 
symptoms, but not as a result of a traumatic memory.  In clinical practice, nightmares 
should be considered as a separate problem that can be co-morbid with a range of other 
diagnoses (Krakow, 2006).  Indeed nightmares have been shown to be co-morbid with BPD 
(Semiz et al., 2008), Primary Insomnia (Ohayon et al., 1997) as well as PTSD (Leskin et al., 
2002) and now psychosis. 
 
4.4 Strengths and limitations 
4.4.1 Sample 
The male to female ratio of the sample was 1.59 : 1, consistent with the reported higher 
incidence of schizophrenia in males (McGrath, 2006).  The age range spanned across 
adulthood from 18 to 68 and comprised a range of ethnicity that was broadly 
representative of a South London borough (Office for National Statistics, 2011). 
 
Whilst attempts were made to obtain a representative sample of participants with 
psychosis from those engaged in services, there was no systematic sampling procedure 
used.  The sample may therefore be biased in two ways, first towards those experiencing 
less functional impairment as a result of their psychosis and who would therefore be more 
inclined to take part.  Second, recruitment may have been biased towards those who were 
experiencing difficulties with sleep.   Potential participants were made aware that the study 
was investigating sleep processes through advertising material, where it was stressed that 
the study was aiming to recruit any person with psychosis, irrespective of whether they 
slept well, or had sleep difficulties.  However, participants may have selected themselves 
on the basis that the research was relevant to their current difficulties.  Further to this, 70% 
of the sample was recruited from one location, a specialist outpatient clinic providing CBT 
for psychosis.  The majority had therefore received, or were waiting to receive 
psychological therapy.  This figure is significantly higher than a recent report that stated 
  





only one in ten people with psychosis received CBT (Schizophrenia Commission, 2012).  The 
current findings should therefore be replicated in a larger representative sample. 
 
With regards to symptom severity, the mean scores for depression anxiety and stress in the 
current sample were comparable to those reported elsewhere (Ison, 2011; Schulze, 2009; 
Huppert et al., 2002).  With regard to symptoms of psychosis, measured by the PSYRATS 
questionnaire, delusional severity was broadly similar to other samples with psychosis 
(Schulze, 2009; Steel et al., 2007).  The mean auditory hallucinations total score (mean = 
23.41, standard deviation = 12.19) was within the standard deviation of a larger sample of 
144 people recruited on the basis of symptoms of psychosis (mean = 27.6, standard 
deviation = 6.7; Steel et al., 2007).  Individual sub-scale scores were compared to a recent 
study of 32 participants recruited based on their experience of auditory hallucinations 
(Hartigan, McCarthy-Jones & Hayward, 2013).  This revealed that none of the sub-scales 
scores were significantly different to sub-scale scores from the current study (as indicated 
by overlap in reported standard deviations).  Although there was no statistically significant 
differences, the majority of sub-scales in the Hartigan et al., (2013) study had a 
descriptively higher mean when compared to the current sample.  The exception to this 
was the disruption to life, caused by voices, which was descriptively lower than the current 
sample. The above comparisons indicate that the severity of auditory hallucinations in the 
current sample are broadly in line with other samples of people with psychosis (Steel et al., 
2007; Hartigan et al., 2013).  The descriptively lower scores on some scales might be 
explained firstly by the fact that participants were not recruited on the basis of their voices 
and secondly that the participants may be better able to manage their voices, owing to the 
majority being recruited from a clinic providing CBTp.  
 
With regards to trauma, the majority (90%) of the sample experienced at least one 
traumatic event, 30% had experienced CSA and just under half (43%) met criteria for PTSD.  
The rate of CSA is marginally lower than that reported in other samples (34-53%; Morrison 
et al., 2003), however the high rate of trauma is consistent with other research in which 
100% of their sample had experienced at least one trauma (Shaw et al., 2002).   
 
  






There was no control group utilised in the current design.  Instead, the frequency of 
nightmares was compared to the general population from figures reported within other 
published research studies.  Given that the study was not a direct replication of those that 
it compared nightmare prevalence figures with; it is possible that the figures are not 
directly comparable.   
 
A further limitation with the design of the study is that it was underpowered for some of 
the correlations undertaken, particularly with regards to nightmare related distress.  Given 
that 45% of the sample did not experience any nightmares over the reference period, they 
were not asked about nightmare related distress.  This reduced the sample size for this 
analysis.  It is recommended that further investigations either include the presence of 
nightmares as an inclusion criteria in order that nightmare related distress can be 
measured for all participants, or a larger sample should be recruited.   
 
Although the study controlled for anti-psychotic medication dose, it is possible that other 
medications impact on sleep.  A recent systematic review has revealed that tricyclic anti-
depressants and Phenalyzine can induce more positive dream emotions and that in some 
cases, withdrawal of such medication caused nightmares (Tribl, Wetter & Schredl, 2013).  A 
future study might consider controlling for anti-depressant medication and asking about 
recent cessation of medications. 
 
4.4.3 Measures 
The psychometric properties of the log used to assess nightmares have not been formally 
established.  Although the use of nightmare logs has been used extensively in other 
research protocols (Levin & Fireman, 2002; Robert & Zadra, 2008; Blagrove et al., 2004; 
Long et al., 2011) there was no validated measure to assess nightmares retrospectively. 
This is despite evidence that retrospective nightmare logs measuring up to one month in 
the past, yield similar frequency estimates to prospective measures (Robert & Zadra, 2008).  









The lack of association between PTSD symptoms and nightmares was surprising.  It is 
possible that this is a reflection of the measurement method for PTSD symptoms and the 
complexity of measuring the disorder in those with multiple traumas and co-morbid 
symptoms of psychosis.  The PDS questionnaire asks participants to note all of their trauma 
experiences and then pick the trauma that bothers them the most in order to answer 
questions about PTSD symptoms.  The mean number of traumatic events experienced was 
3.2, (SD 2.9), however questions were answered in relation to just one of these traumas.  It 
is possible that other factors impacted on their choice of trauma, e.g. which trauma they 
felt comfortable sharing with the researcher.  Lastly, when asked about the impact of PTSD 
symptoms on daily living, some participants noted that their psychosis symptoms were the 
key reason for impairment.  It might therefore have been challenging to consider whether 
PTSD related difficulties might have impacted on activities of daily living, given the context 
of more salient symptoms. 
 
4.5 Conclusion 
Weekly nightmares occurred in over half of this sample with psychosis.  This finding is 
comparable to studies investigating the frequency of nightmares as a symptom of PTSD.  
Nightmare frequency and distress were independently associated with sleep quality and 
sleep efficiency.  Nightmare distress was associated with severity of delusions, depression, 
anxiety, stress and working memory but had no association with PTSD symptom severity.  
Further research (powered to detect smaller associations) is required to establish whether 
auditory hallucinations are correlated with nightmare distress.  This is the first study to 
show that nightmares are a frequent and clinically relevant problem for a diverse sample 
recruited on the basis of their experience of psychosis. 
 





5. Methods – Study B 
5.1 Ethical Approval 
Similarly to study A, the study was reviewed and approved by the City Road and 
Hampstead NHS Research Ethics Committee (11/LO/2045).  The Research and 
Development department at South London and Maudsley NHS Foundation Trust (SLaM) 
granted approval for recruitment in community teams, the Psychological Interventions 
Clinic for Outpatients with Psychosis and inpatient wards.  Approval was additionally 
granted from the SLaM Psychosis Clinical Academic Group (CAG).   The Research and 
Development Department at Oxleas NHS Foundation Trust granted approval to recruit via 
Early Intervention Teams. 
 
5.2 Design 
A non-consecutive case series design was utilised.  All participants undertook a baseline 
assessment before completing the intervention (Imagery Rehearsal Training). After the 




Participants for the case series (study B) were recruited from the 40 participants who 
completed study A.  Recruitment for study B commenced in July 2012, four months after 
recruitment for study A.  Of the 40 participants who took part in study A, 22 experienced 
nightmares with a frequency that was at least weekly.  Twenty of the 22 (90.9%) expressed 
an interest in being contacted about study B.  Three of the total were excluded due to the 
nightmares not being moderately distressing (n=1), having difficulty reliably attending the 
appointment for study A (n=1) and not being able to remember the content of nightmares 
(n=1).  Seventeen participants were therefore interested and eligible to take part in study 
B.  Participants were chosen on the basis of frequency of nightmares as well as date of 
assessment of study A; those first assessed were invited first.  Seven of these participants 
were invited to attend study B; six of these seven continued to experience distressing 
nightmares and all six agreed to attend a research appointment for study B (figure 10). 
  






Figure 11.  Recruitment flow chart; route to participation in study B from initial pool of 40 
study A participants. 
  
5.4 Inclusion Criteria 
Inclusion criteria for taking part in the case series were: 
1. To have completed all questionnaire measures from study A 
2. To experience nightmares of at least weekly frequency (≥2 nightmares over past 
two weeks reported on Dream Log for study A) 
3. Nightmares to be rated at least moderately distressing (≥4 on the distress scale of 
Dream Log for study A) 
4. Able to give informed consent to treatment. 
5. Recollection of the content of the nightmare. 
 
  






Participants had already completed all questionnaires for study A.  These are described in 
detail in chapter two, (section 2.4)  Recruitment for study B was planned to occur alongside 
study A, in order that data from study A could act as a baseline.  However in many cases 
this was not possible due to local R & D approval processes for study B being delayed.  For 
this reason, the following measures were repeated in session one of study B: PSYRATS, 
CORE-10, Pittsburgh Sleep Quality Index.  The DASS-21 was additionally completed where 
time permitted. 
 
5.5.1 Dream Log for Study B.  Adapted from dream logs used by Levin & Fireman 
(2002).   
Participants were sent a prospective dream log in order to record their nightmares, the 
week prior to session 1.  Each morning participants were asked to record if they had 
experienced a nightmare.  If they had, they were asked how many nightmares they recalled 
over the night and were asked to answer four further questions based on their worst 
nightmare.  Participants rated the chosen nightmare on a seven point likert scale for 
intensity, vividness and distress engendered.  Lastly they were asked whether they had 
experienced that chosen nightmare before.   
 
5.5.2  The Voice Power Differential Scale (VPD; Birchwood, Meaden, Trower, Gilbert & 
Plaistow, 2000) 
Where participants had indicated that they hear voices, they were asked to fill in the Voice 
Power Differential Scale (VPDS; Birchwood et al., 2000).  The VPD assesses the power 
differential between the voice and the voice hearer through seven dimensions:  power, 
strength, confidence, respect, ability to inflict harm, superiority and knowledge (Birchwood 
et al., 2000).  Each dimension is measured on a five point likert scale, for example for the 
dimension of power,  “1 = I have much more power than my voice”, “3 = We have about 
the same amount of power as each other” and “5 =  My voice is much more powerful than 
me”.  Scores on the seven dimensions of power are summed together.  The scale has been 
shown to have good internal reliability (cronbach’s alpha = 0.85) and good one week test-
re-test reliability (r = 0.82; Birchwood et al., 2000). 
  






5.5.3  Persecutor Power Differential (PPD; Adapted from the VPD; Birchwood, Meaden, 
Trower, Gilbert & Plaistow, 2000) 
 
The Persecutor Power Differential Scale has been adapted from the VPD.  It assesses the 
same seven power dimensions of the VPD (power, strength, confidence, respect, ability to 
inflict harm, superiority and knowledge), though wording of the items is changed so that 
voice is replaced with a persecutor.   The psychometric properties of the scale have not 
been described.  
 
5.5.4 Subjective Units of Distress (SUDs) 
Each week participants were asked to describe their level of distress over the past week on 
a ten point scale (1 = not distressed, 10 = very distressed).  They were similarly asked to 
rate their fear of their nightmares on a ten point scale (1 = not fearful, 10 = very fearful).  





following qualitative feedback on changes from participant one.  
 
5.6  Procedure for Study B 
Upon being invited to take part in study B participants were sent an information sheet.  
Participants were advised that in the first assessment session they would be asked detailed 
questions about their nightmares and for this reason it would be helpful for them to make 
a note of nightmares the week preceding the assessment.  They were sent the Dream log 
for study B to assist with this process.   
 
The method of Imagery Rehearsal was adapted from that used by Nappi, Drummond, 
Thorp & McQuaid, (2010).  Participants required between four and six sessions in order to 
complete the protocol.  The increased session number was judged on the basis of clinical 
need.   
 
5.6.1 Phase one 
Participants were offered a further opportunity to read the information sheet and informed 
consent was taken.  It was explained to participants that information shared through the 
research would remain confidential, unless the researcher became concerned regarding 
  





the safety of the participant or those around him/her.  Where necessary, clinical teams 
were contacted regarding risk issues and in all cases this was discussed and agreed with 
participants during the research session. 
 
Given that there was an unplanned delay between participants completing study’s A and B, 
some core measures from study A were repeated.  Participants therefore completed the 
CORE-10, the PSYRATS for delusions and hallucinations, the Pittsburgh Sleep Quality Index 
and the Dream Log for Study B.  Four of six participants had completed the dream log 
prospectively through the preceding week. 
 
Participants were provided with psychoeducation to normalise their experience of 
nightmares.  Topics included the prevalence of nightmares in the general population, 
normalising strong emotional reactions to vivid negative content and discussion about 
possible causes of nightmares (related to life experiences or idiopathic).  In some cases, the 
basic architecture of sleep cycles was discussed in order to normalise night time 
awakenings.  The method of Imagery Rehearsal was introduced with regards to first, 
creating an alternative script for the ending of the nightmare, second, elaborating the 
script to include detailed sensory information through imagery and lastly, the need to 
practice the re-script.  
 
Participants were asked to provide a very brief description of each of their current 
distressing nightmares.  Participants were asked to pick one nightmare with which to target 
with the intervention, ideally their most distressing nightmare or the worst they felt they 
could tolerate.  The target nightmare was described by the participant and summarised by 
the researcher on a scene by scene basis.  Participants rated the scenes according to 
distress and the place to insert the re-script agreed; just before the point of maximum 
affect.  The participant and researcher together considered alternative neutral or positive 
endings to the nightmare.  Once the ending was agreed in principle the participant engaged 
in guided imagery.  Detailed techniques for evoking imagery are described in Hackmann, 
Bennett-Levy and Holmes (2011). 
 
Participants were encouraged to close their eyes (if they were comfortable with this), find a 
comfortable position and take a few deep breaths.  Participants were prompted to imagine 
  





the beginning of the dream and describe the scene in the first person, present tense.  They 
described the event of the nightmare, including sensory detail, thoughts and feelings.  They 
were prompted to move on to the next event in the re-script if this did not occur naturally 
through their description.   The level of guidance and prompting throughout the imagery 
work was tailored to the needs of each individual.  The researcher noted changes in 
posture and facial expressions in addition to verbal reports of feelings as a means of 
monitoring affective changes.  At the end of the imagery participants were asked to sit with 
the positive emotion and then ‘return’ to the room. 
 
Participants were asked to feedback their experience of the process, and particularly to 
changes in affect throughout the course of the script.  Adjustments were made to the script 
where necessary, for example if the person did not feel any anxiety through the imagery, 
did not feel their anxiety alleviate upon imagining the re-scripted ending or that the re-
scripted ending appeared too unbelievable. 
 
5.6.2 Letter and CD 
A transcript of the re-scripted nightmare, written in the first person, was sent to the 
participant in the post.  In addition, a voice recording of the transcript, described in the 
second person tense was recorded onto CD.  Participants were encouraged to practice 
reading or listening to the re-script at least once per day, preferably prior to going to bed. 
 
5.6.3 Phase two 
In the session that followed (usually one week later), nightmares over the previous week 
were re-assessed in terms of frequency, changes in the nightmare content and the 
emotional reaction to the nightmare.  Participants were asked to rate how distressed they 
had felt over the past week and how fearful they currently felt of their nightmares (SUDs 
scale). The researcher enquired about the frequency of practice and facilitated problem 
solving the barriers to practice.  Adaptations to the re-script were made where necessary 
and the new rescript rehearsed through the imagery technique described above.   In these 
cases, a new rescript letter and CD followed in the post. 
 
  





5.6.4 Phase three 
A reassessment of nightmares took place with regard to frequency, content, changes in 
nightmare content and emotional reaction to the nightmare.   Participants were asked to 
rate how distressed they had felt over the past week and how fearful they currently felt of 
the target nightmare (SUDs scale).  Participants completed the follow up questionnaires.  
These included the Pittsburgh Sleep Quality Index, the PSYRATS for hallucinations and 
delusions, the VPD (for those participants hearing voices), the PPD (for those participants 
who experienced persecutory delusions), the DASS-21, the CORE-10, the PDS and Time 
Budget questionnaire.  The order of completion of these questionnaires remained 
consistent across participants and was broadly consistent with study A.  The only 
exceptions to consistency with study A was the addition of the VPD the PPD, as well as and 
the dream logs being completed outside of session. 
 
Participants were given a dream log to complete over the following week, with a stamped 
addressed envelope to send back to the researcher.  They were advised that they would 
receive a follow up telephone call approximately two weeks later.  Participants rated their 
satisfaction with sessions on a ten point scale (1=not satisfied at all, 10=very satisfied) and 
were asked for feedback on what they would change with regard to the sessions. 
 
5.6.5 Follow up telephone call 
Participants were asked to rate how distressed they had felt over the past week and how 
fearful they currently felt about the target nightmare (SUDs scale).  Participants’ 
nightmares were reassessed with regard to frequency, content, changes in nightmare 
content and emotional reaction to the nightmare.  Participants were thanked for their 
participation and reminded that a copy of the study’s key results would follow through the 
post, if they had expressed an interest on their consent form.  
 
5.6.6 Adaptations of IR for a psychosis population 
The protocol was adapted from that of Nappi et al., (2010) with the following key 
adaptations: 
1. The (optional) provision of a CD with an audio recording of the rescript.  The 
rationale for this was to enable those who hear voices an alternative and more 
accessible means of script rehearsal.   
  





2. The session number and length was flexible, as per recommendations in a CBTp 
manual (Fowler et al., 1995).  The rationale for this was in order to provide an 
individualised approach to therapy, given that the content of nightmares and 
possible impact of psychotic symptoms was unknown at commencement of 
therapy.  
3. All participants received IR in individual (as opposed to group) therapy format. 
4. Increased time was spent planning the alternative ending of the nightmare script.  
Participants required substantial therapist input in order to facilitate this process 
(particularly when nightmares were based on real experiences). 
 
5.6 Analysis 
Each participant is described in detail to illustrate their path through the intervention.  
Qualitative feedback regarding changes in their nightmares and satisfaction with the 
intervention will be described.  Following this quantitative measures of nightmares, 
psychotic and affective symptomatology shall be reported on.  Analysis of quantitative 
measures shall include both descriptive changes and analysis using the Reliable Change 
Index (RCI; Jacobsen & Truax, 1991).   
 
Reliable change refers to the extent to which change from pre-intervention to post-
intervention falls beyond what would be expected on the basis of measurement variability.  
For this reason, the equation uses test-re-test reliability of the measure itself, as well as a 
measure of the variance of the sample (standard deviation).   The reliable change criterion 
is 1.96 times the standard error of the difference (Evans, Margison & Barkham, 1998).  If 
the participant falls beyond the reliable change criteria specified, it can be concluded with 
95% certainty that they have evidenced a statistically reliable change in score, rather than 
that change occurring due to chance.  The equation is as follows: 
 
  	 √ √	   
 
SEdiff refers to the standard error of the difference, SD refers to the standard deviation of 
baseline observations and r refers to reliability. In the current investigation test-retest 
reliability was used.  Test-retest reliability data was obtained from: Buysse et al., (1988), 
Drake et al., (2007), Birchwood et al., (2000), Foa et al., 1997, Jolley et al., (2005) in order 
to calculate the reliable change criterion as specified in table 8.  The standard deviation was 
  





taken from the baseline measure of the five participants.  Whilst this is a small sample from 
which to derive the standard deviation, there are no other published studies reporting 
standard deviations for these measures in those with both psychosis and sleep disturbance.   
Whilst this criterion indicates statistical significance, it should be noted that it does not by 




Table 8.  Test-retest reliability, baseline standard deviation and reliable change index 







PSQI .85 5.34 6 
PSYRATS Delusions .70 1.87 3 
PSYRATS Hallucinations .70 2.86 4 
Voice Power 
Differential Scale 
.82 4.32 5 
PDS .83 6.08 7 
Time Budget 
Questionnaire 










6. Results – Study B 
This chapter will report on the results from the case series of Imagery Rehearsal; study B.  
Each of the six participants will be individually introduced and their current experience of 
nightmares described.  Following this their intervention will be reported on alongside 
qualitative descriptions of outcome.  Lastly, quantitative markers of change will be 
reported.  The names and some details have been changed in order to retain anonymity.  
 
6.1  Participant 1; “Chrissie” (4 sessions,3 of which were intervention 
sessions) 
6.1.1 Presentation at Baseline 
Chrissie was a black British female in her forties.  She lived independently, received support 
from a formal carer and had a supportive son and grandchildren.  Chrissie had a diagnosis 
of paranoid schizophrenia and had been experiencing symptoms for ten years.  She 
reported hearing a voice who spoke to her almost continuously and visual hallucinations 
that she described as shadows.  She had beliefs that people were talking about her and 
looking at her strangely.  She held 75% conviction in this belief at baseline and found it 
markedly distressing.  Chrissie also met criteria for a diagnosis of PTSD, in relation to 
experience of childhood sexual abuse.   
 
6.1.2 Assessment of Nightmares 
Chrissie had experienced seven nightmares in the week prior to study B.  She described 
three key recurrent nightmares that had death as their main theme.  Her first nightmare 
involved a one legged dancer pirouetting, with blood spilling out of the place where the leg 
was missing, her second nightmare was of an animal circling around a church steeple.  
Chrissie had experienced the animal nightmare since she was a child.  Her last nightmare 
was the one chosen for the intervention and involved people in her life who had passed 
away scratching at a coffin.   
 
Chrissie considered that her target nightmare was triggered by daytime thoughts.  She had 
tried distraction strategies before going to sleep, however her sleep was still interrupted by 
her chosen nightmare 2-3 times per week.   Chrissie achieved an average of 3-4 hours sleep 
per night (despite taking sleep medication nightly).  Chrissie’s target nightmare is 
summarised in figure 11.  It was related to two difficult memories.    
  











Figure 12.  Diagrammatic representation of the scenes in Chrissie’s 
nightmare.  Bold box indicates the point of maximum affect, as 




In order to create a script which related enough to the original nightmare and which had a 
sufficiently positive ending, the script went through a design process of three phases 
(Figure 12).  At each stage Chrissie elicited the detail of the script via imagery in session and 
listened to a CD of the script each night in between sessions.   
 
Figure 13.  Diagrammatic representation of the re-script in three stages of development 
alongside rationale for further amendments. 
 
 
1. With Brad 
on holiday.   
 
2. At a Madonna 
concert.  There’s an 
argument with 
someone who’s 
betrayed me.  
3. Still at concert: 
Brad disappears 
and I continue to 
argue. 
4. Phone call 
being told 




I am feeling 
and coping 
6. See an image of a 









6.1.4 End of session feedback: 
Chrissie reported feeling less fearful of her dreams.  When they did occur, she reported 
waking up and reading her script as a coping strategy; “I read the script and get good 
thoughts”.  She hadn’t seen the image of the disintegrating face in the coffin over the past 
week of using the script.   Chrissie reported that although Brad still occurs in her dream 
content, she wakes up smiling.  Chrissie reported feeling 10/10 satisfied with sessions and 
considered that they could be improved by adding relaxing sounds in the background of the 
CD recording and by adding a coffee machine for participants. 
 
6.1.5 Two week follow up telephone call: 
 
Chrissie reported that she had not seen the disintegrating face in the coffin since the last 
session.   Brad still featured in her dreams but she reported feeling better able to cope.  As 
such, Chrissie reported feeling more in control.  She reported that she still listened to the 
CD before going to bed and still read the script as a coping strategy in the event of a 
nightmare. 
 
6.2 Participant 2; “Nick” (4 sessions,3 of which were intervention 
sessions) 
6.2.1 Presentation at Baseline 
Nick was a young male student.   He met criteria for PTSD in relation to childhood sexual 
abuse.  He had a diagnosis of unspecified non-organic psychosis and experienced hearing 
voices for over five years; one of whom commanded him to hurt himself and other people.  
Nick also had beliefs in telepathy and psycho-kinesis which he had held for approximately 
one year.  He held 100% conviction in these beliefs and they caused him moderate levels of 
distress.  At the time of commencement of the case series, Nick had experienced some 
changes in his accommodation and started a new episode of study.  He was receiving CBT 
for psychosis alongside the intervention. 
 
6.2.2 Assessment of Nightmares 
Nick had experienced eight nightmares in the week prior to study B.  He described three 
key recurrent nightmares; the first he described as ‘green liquid’, the second involved 
  





people being violent to him and the third nightmare was related to traumatic life events.  
Although the second and third nightmares were the most frequent, he felt that the first 
nightmare (green liquid) was the most distressing and therefore chose this one for the 








Figure 14.  Diagrammatic representation of the scenes in Nick’s nightmare.  The fractions 
indicate level of distress; 0=no distress, 10=couldn’t feel more distressed.  Bold box 
indicates the point of maximum affect, as described by Nick. 
 
6.2.3 IR 
The pre-planning stage (prior to imagery) was particularly important in order to decide on a 
helpful ending for the script in which Nick did not experience the feeling of being infected 
(as he did in the original nightmare).  Below is a list of options explored: 
 
• Hold the liquid back with the power of mind          Therapist trying to avoid                            
methods related to psychotic beliefs 
• Burning off the liquid           Therapist trying to avoid acts of aggression to self / 
others 
• Create a barrier 
• Find an escape route 
• Clean or dissolve the liquid 
• Visualise the liquid as if it is treacle or molasses  
• Black liquid hardens and shatters               Chosen for re-script 
 
The script went through a design process of two phases (figure 14).  At each stage Nick 
elicited the detail of the script via imagery in session and read the script in between 
sessions.  Within sessions Nick reported that his voices had worsened.  He reported his 
voice telling him to harm the therapist and that as a result it was difficult to engage in 
1. Normal 





room.   
 
6/10 
3. A man 
spits green 
liquid into 
my face.   
8/10 
4. A woman (the voice 
Nick hears) is crying 
green liquid tears.  
They start to fill the 
room  
7/10 
3. Green liquid 
comes out of 
my face  
10/10 
 Could not comprehend them 
working; ‘didn’t feel right’ 
  





imagery.  This was a difficulty he had reported with previous therapists.   Nick’s care team 
were contacted to facilitate risk assessment and help management this risk.  At the end of 
the sessions Nick reported that he was feeling angry following his nightmares.  Nick was 
therefore offered two follow up sessions to work specifically with the angry feeling he was 
left with.  Nick agreed to further sessions, however, due to difficulties with study 
commitments as well as fluctuation in his mental health he was unable to attend. 
 
 
Figure 15.  Diagrammatic representation of the re-script in two stages of development 




6.2.4 End of session feedback: 
 
Nick reported that the nightmare content had changed slightly in his target nightmare; his 
nightmare now integrated him hugging the woman (his voice) and him ending in his 
bedroom watching the television, as per his re-script.  Nick reported that the nightmare 
  





was now more disjointed and not a “linear” story.  The worst part of his dream in which the 
green liquid gets to him was still occurring; he rated this part 7/10 distressing.  At the first 
session Nick rated this 10/10 distressing.   
 
Nick reported that his emotional response to his nightmare was that he felt angry after the 
nightmare.  This contrasts to his previous reaction in which he felt frightened.  Although 
this was still a negative emotion, Nick considered that he would prefer to feel angry than 
frightened.  Nick reported that one of his other key nightmares had also taken on a more 
angry tone.   
 
Nick suggested that he was no less fearful of his nightmares.  He felt 7/10 satisfied with the 
sessions.  Nick did not consider that there was anything within the researcher’s control that 
could have improved his satisfaction with sessions, but acknowledged that his voice had 
made it challenging to engage in the imagery. 
 
6.2.5 Two week follow up telephone call: 
 
Nick reported that he was still left feeling angry after his nightmares.  He reported that the 
worst part of his nightmare in which the green liquid comes out of his own body, no longer 
happened on every occasion.  With regard to nightmare frequency, Nick suggested that he 
was “not having as many bad ones”, but his three recurrent nightmares were still 
happening and he was having “little random ones”.   
 
6.3 Participant 3; “Elaine” (5 sessions, 4 of which were intervention 
sessions) 
6.3.1 Presentation at Baseline 
Elaine was a white British lady in her fifties.  She lived independently and had previously 
been engaging in voluntary work, though had stopped due to a recent deterioration in her 
mental health.  She reported feeling depressed and hopeless at the outset of therapy, 
accompanied by suicidal ideation.  She had no suicidal plans but rather thoughts such as 
“maybe it wouldn’t be so bad”.  She rated her level of distress in the first session as 9/10 
(1=not distressed, 10=very distressed).  Elaine met criteria for PTSD in relation to an event 
  





At this point Elaine feels a presence around her, 
feels the house shaking and hears her voice 
telling her to wake up.  She feels jolted back into 
reality (though actually sleeping) 5/10 
in which she found her brother who had committed suicide.  Elaine had experienced voices 
as well as visual, olfactory and tactile hallucinations since late childhood.  She also held the 
belief that she had the power to make bad things happen, which was accompanied by 
marked distress.   
 
6.3.2 Assessment of Nightmares 
Elaine had experienced six nightmares in the week prior to study B.  She described three 
key nightmares; in the first, she walks around a large house knowing that there is 
something beneath the floorboards and has a sense of ‘foreboding’.  She had experienced 
this nightmare since her early twenties.  The second nightmare she had since a teenager 
and involved a witch waiting in a van to take her away.  The last nightmare was most 
distressing and chosen for the intervention.  This nightmare related to her brother and 
nephew committing suicide in close succession four years previously (see figure 15).  She 
















Figure 16.  Diagrammatic representation of the scenes in Elaine’s nightmare.  The 
fractions indicate level of distress; 0=no distress, 10=couldn’t feel more distressed.  Bold 
box indicates the point of maximum affect, as described by Elaine. 
 
 








says: I don’t 
want to go, I 





on, it’s not so 
bad here.  
Let’s go” 
10/10 
4. Brother says: 
“You go, Elaine’s 
going to take me 
with her”.   
10/10 
5. I’m helpless.  
I’m not saying 













Elaine had difficulty comprehending how the ending of her nightmare could be different, 
given that it was largely based on a real life experience.  Elaine was therefore offered 
additional time to plan an ending that would not invalidate her past experiences (see figure 
16).  
 
Figure 17.  Diagrammatic representation of the re-script in two stages of development 
alongside rationale for further amendments. 
 
Despite a plan of the script being drawn out prior to the imagery, the imagery exercise 
itself revealed a significant level of detail in the images of where her brother would be, 
after committing suicide.  This was not interrupted within the process of imagery but the 
therapist reflected upon the helpfulness of these given that Elaine would be reading the 
script each night and had herself been struggling with suicidal thoughts. She agreed to 
amend the script. 
 
  





6.3.4 End of session feedback 
 
Elaine’s reported fear of her nightmares had reduced to 6/10 (previously 10/10).  She was 
10/10 satisfied with the sessions and considered they could only be improved by using the 
same research room each week.  Elaine had experienced one nightmare over the week 
preceding the follow up assessment.  This nightmare was the target nightmare.  Despite 
not being able to get back to sleep after the nightmare she explained that she did not wake 
up in terror as had previously occurred.  In addition, she was no longer affected by the 
nightmare through the day, whereas previously the nightmare had “ruined my day”.  Elaine 
considered that the reason she reacted differently to the nightmare was because the 
memory of the event had been “deconstructed” through the session and “put back 
together”; she now reported there was nothing more she could have done to help her 
brother.  She described that the end of the re-script reinforced to her where her brother 
should be and where she herself wanted to be.  As such, she had not experienced any 
suicidal thoughts and had reengaged in voluntary work. 
 
6.3.6 Two week follow up telephone call 
 
Elaine reported that she was still using the script approximately twice a week and that she 
had experienced her target nightmare, but less frequently.  There had been one occasion 
when the nightmare had been “as horrendous” but on the whole the nightmare was less 
vivid, less clear and less intense; it had more colour, was less dark with regards to what she 
saw visually and how she felt.  With regards to other nightmares, Elaine had not had her 
nightmare involving the floorboards, which was unusual for her (this was a frequent 
nightmare), but had experienced her nightmare involving being taken away in a van.   
 
6.4 Participant 4; “Roland” (4 sessions, 4 of which were intervention 
sessions) 
6.4.1 Presentation at Baseline 
Roland was an African gentleman in his thirties.  He had a diagnosis of paranoid 
schizophrenia.  He did not report hearing voices, but had a belief that images were being 
inserted into his head which he held with 50-99% conviction.  Roland’s chief concern was 
frequent nightmares.  Roland disclosed no significant trauma history on the PDS, however 
  





it was known that he grew up in an East African country amidst political unrest and 
warfare.  Roland rarely offered eye contact through sessions; he spoke slowly, with a flat 
intonation to his voice and offered short answers.   
 
6.4.2 Assessment of Nightmares 
Within study A, Roland reported experiencing an estimated 40 nightmares over the past 14 
nights.  He had reported having nightmares that occur along a similar theme; they usually 
involved his mother.  The most distressing nightmare involved him going into a room where 
he sees his mother naked with a penis.  This nightmare left him feeling sad and weak. 
 
At the assessment session of study B Roland had completed the dream log prospectively 
which summed 67 nightmares over the preceding week, none of which were recurrent.  He 
was 9/10 fearful of his nightmares, 10/10 scared of falling asleep and felt 8/10 distressed 
over the week prior to assessment.  He was no longer troubled by nightmares involving his 
mother and reported difficulties recalling his nightmares.  He reported experiencing no 
sleep at all; however after enquiry as to when his nightmares occurred he considered that 
he had likely slept for around thirty minutes per night.  Roland had distressing images 
through the day and at night; it was therefore difficult for him to distinguish whether he 
was asleep.  Roland’s bedtime routine involved him watching television, having a cup of 
tea, getting into bed and thinking about rest.   
 
Roland was able to describe two recent nightmares that he had found distressing.  The 
content of the nightmares had little story, but rather appeared to be more discreet images.  
There were therefore no points of maximum affect.  One of these is illustrated in figure 17 
below. 
 





Figure 18.  Diagrammatic representations of one of Roland’s recent nightmares.   
 
I’m jumping up and down on some kind 
of pattern.   
I wake up and I feel 
intimidated because I 
can’t believe I was acting 









Roland noted his nightmares between sessions one and two and brought a more detailed 








Figure 19.  Diagrammatic representation of the scenes in Roland’s nightmare.  The 
fractions indicate level of distress; 0=no distress, 10=couldn’t feel more distressed.  Bold 
box indicates the point of maximum affect, as described by Roland. 
 
6.4.3 Nightmare themes 
 
Given there were no recurrent nightmares it was hoped that by picking one target 
nightmare that represented the theme of control (running the race), this might impact on 




Roland’s progress and feedback through the sessions is summarised in figure 19. 




There is a kid, 
warming up 
7/10 
I don’t feel 
like sprinting.  
I don’t want 
to race 
8/10 
I’m forced to 
try & do try 
9/10 
I can’t move 
7/10 
  






Figure 20.  Roland’s progress through the intervention, including feedback. 
 
6.4.5 Last session 
 
Roland reported that there had been no change in his nightmare frequency as a result of 
the four sessions he had attended.   
 
6.4.6 Two week follow up telephone call 
Roland did not consider that his nightmares had changed in neither content nor frequency; 
however, he did feel slightly better able to cope with them.   
 
  





6.5 Participant 5; “Louise” (4 sessions, 3 of which were intervention 
sessions) 
6.5.1 Presentation at Baseline 
Louise was a white British lady in her forties.  Louise had previously achieved a high level of 
education, despite having symptoms of psychosis since she was a teenager.   She 
experienced command hallucinations telling her to hurt others, though had never followed 
their commands.  She had completed previous CBTp to help manage these.  In addition 
Louise experienced visual hallucinations of shadows, olfactory hallucinations and tactile 
hallucinations.  Louise experienced distressing persecutory delusions.  Louise grew up with 
domestic violence; however she did not report any PTSD symptoms.  Louise had developed 
strategies to deal with her voices, through previous sessions of CBT for psychosis.  Louise 
had been a high achiever until becoming unwell. At the time of assessment she was 
engaged in part time employment.  She lived independently in a flat which she had enjoyed 
decorating with bespoke furniture. 
 
6.5.2 Assessment of Nightmares 
Louise had experienced one nightmare over the week prior to assessment, which she chose 
as her target nightmare.  This was a recurring nightmare which occurred around three 
times per month and related to when she started a job and had been experiencing 
symptoms of psychosis, which had not been formally diagnosed at that time.  The 
nightmare left her feeling “depressed” when she woke up (figure 20).  It was notable in the 
session that the nightmare was linked to much rumination about the life event and its 
consequences.  Louise experienced three other recurring nightmares; one that was 
described to involve the way she looked, a second which involved monsters and fire and a 
third which involved alarms to warn of a nuclear bomb.  These other nightmares were less 
























Figure 21.  Diagrammatic representation of the scenes in Louise’s nightmare.  The 
fractions indicate level of distress; 0=no distress, 10=couldn’t feel more distressed.  Bold 




Louise found it difficult to consider an alternative ending that was related to the original 
nightmare.  Discussion of the nightmare led to many ruminative questions such as “why 
didn’t I do something?” and “if only they had given me a separate office, I would have been 
alright”.  The helpfulness of these thoughts was considered prior to the imagery work in 
order to facilitate creation of the script.  The script was created in two phases following 




Turn up for work on 
1
st
 day.  I walk in and 
see people. 
  8/10 
Sit down at new desk.  
There is another new 
girl a few desks away.  
  6/10 
I do nothing.  I’m so 
overwhelmed.  No-
one comes up to 
speak to me. 
 9/10 
I feel myself crying 
  8/10 
  






Figure 22.  Louise’s progress through the intervention, including feedback. 
 
6.5.4 End of session feedback 
 
Louise had experienced no nightmares for three weeks.  This was unusual for her; she 
reported previously experiencing nightmares at least once per fortnight.  Louise reported 
8/10 fear of her nightmares, pre-IR this was 5/10.  Louise attributed the increase to the fact 
that she was thinking about them more and was unsure how the intervention might impact 
on them.  Louise reported that the event that was related to the nightmare had been 
“locked in for years”, the session helped her to feel more accepting about the event 
through the day.  Louise was 9/10 satisfied with the sessions and could suggest no 










6.5.5 Two week follow up telephone call 
 
Louise reported experiencing one nightmare since completing the intervention two weeks 
previously.  The content of which had changed; Louise saw herself going to work and doing 
a lot of work.  She reported waking up feeling good rather than feeling anxious.  She 
reported that she felt 7.5/10 fearful of her nightmares.    
 
6.6 Participant 6; “Nicola” (4 sessions, 3 of which were intervention 
sessions) 
6.6.1 Presentation at Baseline 
Nicola was a white British female in her forties.  Her symptoms of psychosis started 
approximately twenty years prior to assessment.  Nicola held the belief that people in the 
street had bad thoughts about her and reported hearing two voices that she found 
extremely distressing.  Her voices made accusations against her, e.g. “you’re a child 
abuser”.  Nicola had previously completed CBTp and was in private therapy.  Nicola had 
experienced significant sexual abuse as a child and also later as an adult.  Despite having 
symptoms of PTSD in relation to childhood sexual abuse, she did not meet diagnostic 
criteria on the basis that there was no significant impairment in daily functioning (as 
measured by the PDS).  Nicola lived in supported accommodation.  At the commencement 
of sessions Nicola disclosed feeling suicidal, she was therefore re-referred by her local team 
to a crisis resolution team.   
 
6.6.2 Assessment of Nightmares 
Nicola reported experiencing frequent nightmares for approximately ten years.  She 
reported three key nightmares; the first involved being put onto a psychiatric ward.  In the 
second, there was a dead person buried beneath the floorboards and she is interrogated by 
police.  The last nightmare involves Nicola being accused of being a paedophile.  This was 
chosen as her target nightmare on the basis that it was one of her most frequent and most 
distressing (figure 22).  Nicola attributed the cause of the nightmare to one of her previous 
partners asking her why she was not a child abuser herself, given that she had been abused 
as a child.  Nicola took medication to aid her sleep, reported sleeping for approximately 
eight hours per night but considered her sleep quality as ‘fairly bad’. 
 
  





One of my 





I’m trying to 















Figure 23.  Diagrammatic representation of the scenes in Nicola’s target nightmare.  
Fractions indicate level of distress; 0=no distress, 10=couldn’t feel more distressed.  Bold 




The script was created in two phases, following feedback from Nicola (figure 23).   
 
I’m with people 
I don’t know. 
 8/10 





People that I 
recognise tell 
me to kill 
myself 10/10 
I tell them I’m 
not 
 10/10 
I try to run away 
 10/10 
  






Figure 24.  Nicola’s progress through the intervention, including feedback. 
 
6.6.4 End of session feedback 
Nicola reported one target nightmare between the third and fourth session, which had a 
marked change in content.  Although Nicola was accused of being a child abuser, she was 
not told to kill herself.  Instead she was with another person who was treated in the same 
way, they supported each other and followed an escape plan.  Nicola reported waking up 
with the thought “I can cope with that”.  Nicola reported feeling 10/10 satisfied with the 
intervention.   
 
6.6.5 Two week follow up telephone call 
Nicola reported that she had not had any of the target nightmares since the end of the 
intervention, a fortnight previously.  She reported that she felt 3/10 fearful of her 
nightmares, whereas she had previously felt 7/10 fearful.  She reported that she does still 
have nightmares but that they are about “silly stuff” (E.g. her sister taking a baby on a 
motorbike).  Her distress over the week prior to the phone call was rated 3/10, this was 
  





previously 9/10.  Nicola reported that her voices had changed; they still accused her of 
things (E.g. you’re a child abuser”) however she reported that the frequency of these 
comments had lessened, it did not feel so intense when they made comments and she was 
able to “laugh it off”. 
 
6.7 Outcomes 
Roland’s data is excluded from the outcome analysis on the basis that he dropped out of 
therapy and did not complete all the necessary follow up measures.  Study A was intended 
to act as a baseline for the IR, however, given that there was a four month delay in the start 
of recruiting for study B, many (but not all) measures were repeated.  The period between 
study A and pre-IR therefore indicates natural fluctuation in outcomes as well as the effect 
of being on a waiting list.  For standardised measures in which there was test-retest 
reliability data available, the reliable change index (Jacobsen & Truax, 1991) was calculated.  
 
One of five participants decreased their frequency of nightmares between the beginning of 
IR and the end of IR.  All participants evidenced a decrease in the vividness of their 
nightmares from prior to IR to the end of IR (see figure xx) and four out of five participants 
decreased in the distress related to their nightmares and the intensity of their nightmares 
from the period prior to IR to the end of IR.  One participant (Louise) exhibited no change in 
the distress or intensity of her nightmares (see figure 24). 
  






Figure 25.  The phenomenology of nightmares as a function of time point in the 
intervention.  (A) frequency of nightmares, (B) nightmare related distress, (C) nightmare 
intensity and (D) vividness of nightmare.   
 
The PSQI indicates improved sleep quality through a decrease in total score.  The PSQI 
indicated that overall sleep quality improved in four out of five participants (see figure 25).  
Nick (participant 3) was the only participant to have not improved his overall sleep quality.   
None of the participants reached below a PSQI score of five, which is an optimal cut-off to 
distinguish those with sleep difficulties.   Despite four (80%) of participants reporting 
improved sleep quality, none of these participants (0%) achieved a 6 point change in score 










Figure 26.  Pittsburgh Sleep Quality Index Score as a function of time point during the 
intervention 
 
Global distress, as measured by the CORE-10 clinical score decreased from the pre-IR 
(baseline) to the time point immediately following IR in four out of five cases (see figure 
26).  Chrissie (participant 2) evidenced an increase in global distress despite a marked 
decrease in nightmare related distress.  Her distress was discussed within session when she 
disclosed that a friend had passed away that week. 
 
Barkham et al., (2012) report a reliable change index of 6 for the CORE-10 total score 
(clinical score*10), recommending a 90% false positive rate rather than the traditional 95%.  





































































Figure 27.  Global distress as a function of time point of intervention. 
 
DASS-21 data were captured in study A and the end of Study B for all participants.  For 
three participants it was additionally captured at the commencement of study B (figure 27).  
This additional measure was sought due to changes in participant’s presentation between 
study A and study B.  Four out of five participants decreased their depression scores 
between study A and the end of the intervention.  Of the three participants who completed 
a baseline assessment for study B, two decreased in depression (Elaine, participant 3 and 
Nicola, participant 6) and one participant stayed constant (Louise, participant 5).   
 
With regard to anxiety, two out of five participants decreased their anxiety score between 
study A and the end of the intervention, two participants remained constant and one 
participant had higher levels of anxiety.  Of those who also completed a baseline 
assessment, 3/3 decreased their anxiety (Elaine, participant 3, Louise, participant 5 & 
Nicola, participant 6).   
 
With regards to stress, three of five participants decreased their stress, whilst two 
increased in stress.  Of the three participants with a baseline assessment, one participant 
evidenced no change (Louise, participant 5), one decreased in anxiety (Nicola, participant 
6) and one participant increased (Elaine, participant 3).  There is no published test-retest 
reliability score from which to calculate the Reliable Change Index.   
 
  






Figure 28.  DASS-21 measures as a function of time point across the intervention.  (A) 
indicates DASS-21 Depression scores, (B) indicates DASS-21 Anxiety scores and (C) 
indicates DASS-21 Stress scores.  Missing bars marked with *** indicate missing data. 
 
Four out of five participants evidenced a decrease in PSYRATS for delusions scores between 
the pre-IR assessment and end of IR (figure 28), whilst one increased (Nicola, participant 6).  
Two participants (40%; Chrissie, participant 1 and Elaine, participant 3) showed statistically 
reliable improvement in delusional severity (with 95% confidence) as evidenced by the 
reliable change index.  
 
The PSYRATS for hallucinations scores indicated a decrease in score from the pre-IR score 
to the end of IR score in four out of five cases (figure 28).  Two of five participants (40%; 
Chrissie, participant 1 and Elaine, participant 3) evidenced a statistically reliable 
improvement in PSYRATS for hallucination score, as evidenced by the reliable change index 
(95% confidence).  Nick (participant 2) was the only participant to have evidenced an 
increase in the severity of his voices.  This was also a statistically reliable change as 
calculated by the reliable change index.   
 
  





Figure 29.  PSYRATS scores as a function of time period in the intervention.  Part (A) 
indicated PSYRATS for delusions scores, part B indicates PSYRATS for hallucinations 
scores. 
 
The perceived power of voices was marked pre-IR (baseline of study B) and immediately 
following IR (figure 29).  Three out of the five participants evidenced an improved power 
relationship.  Nicola (participant 6) evidenced a deterioration and Nick (participant 2) 
exhibited no change with regards to power relationship with voice(s).  Two of the five 
participants (20%) had statistically reliable change, Chrissie (participant 1) indicated an 
improvement in the perceived power of her voice and Nicola (participant 6) reported a 
deterioration in the perceived power of her voices (with 95% confidence), as calculated by 
the reliable change index.   
 
Figure 30.  Voice Power Differential Score as a function of time point across the 











































Two participants completed the Persecutor Power Differential Scale pre-IR (baseline of 
study B) and at the end of IR (figure 30).  Both participants evidenced a slight decrease 
from pre to post-intervention.  There is no reported test-retest reliability data and as such 
the reliable change index cannot be calculated. 
 
Figure 31.  Persecutor Power Differential Scale as a function of time point across therapy; 
baseline (pre-IR) and immediately following IR. 
 
The following two measures were administered during study A and at the end of study B 
(there was no pre-IR measure).  Given the gap between study A and B the results should be 
interpreted with caution. 
 
Three participants met criteria for PTSD (Chrissie, participant 1; Nick, Participant 2 and 
Elaine; Participant 3), as assessed during study A (figure 31).  Their PTSD symptom severity 
was repeated at the end of study B.  Whilst two of these participants’ PTSD symptom 
severity score grew slightly worse (Chrissie, participant 1 and Nick, participant 2) by the end 
of IR, one participant’s (Elaine, participant 3) score decreased by a marginal amount.  She 
still met criteria for PTSD at the end of IR.  Chrissie’s (participant 1) deterioration in PTSD 
symptom severity met criteria for a statistically significant reliable change index.  It should 
be noted that no pre-IR PTSD measure was collected and there was on average a four 



















































































Figure 32.  PTSD symptom severity across study A and the end of IR in three participants 
who met criteria for PTSD during study A. 
 
The Time Budget questionnaire was administered during study A and at the end of the 
intervention.  Three out of five participants evidenced improved activity levels at the end of 
IR, when compared with their activity levels during study A (see figure 32).  None of these 
increases in activity levels met criteria for statistically reliable change according to the 
reliable change index.  Louise (participant 5) was the only participant to show a slight 






































































7. Discussion study B: Case series 
The aim of study B was to assess whether IR might be suitably used as an intervention for 
nightmares for those with psychosis.  Specifically, the study aimed to assess the impact of 
IR on nightmares (frequency, distress, vividness and intensity), sleep quality, psychotic and 
affective symptomatology.  Furthermore the acceptability of the intervention was assessed 
via ratings of satisfaction and end of session feedback. 
 
This chapter will present a summary of the results and compare those results with existing 
literature.  The clinical implications of the findings will be considered and the strengths and 
limitations of the study. 
 
7.1 Summary of the results 
This exploratory case series was the first to investigate the use of IR as an intervention for 
nightmares in the context of psychosis.  The main finding is that IR is an acceptable 
treatment option for people with psychosis who present with recurrent and distressing 
nightmares.  It was possible to implement the intervention in a research setting, with a 
group of participants who presented with auditory hallucinations and / or delusions outside 
of an established therapeutic relationship.  Five out of six participants completed the full 
intervention and assessment measures. 
 
Exploratory hypothesis one stated that: Following IR there will be a reduction in a range of 
nightmare related domains; frequency, nightmare related distress, vividness of nightmares 
and intensity of nightmares.  This hypothesis was partially supported.  There was no 
consistent pattern of change in the frequency of the nightmares experienced.  However, 
this null result may be a result of a lack of sensitivity of the measure (which shall be 
discussed later).  Four out of five participants reported a reduction in nightmare related 
distress following the intervention, one participant reported no change.  Four out of five 
participants reported reduced intensity of their nightmares, one participant reported no 
change and all participants reported a reduction in the vividness of their nightmares.  This 
quantitative result is substantiated by Nick’s (participant 2) post-intervention feedback that 
his target nightmare had become more disjointed and was less of a “linear” story.   
 
  





In the qualitative feedback all five participants reported some content change in their 
nightmare, this ranged from small changes such as Elaine (participant 3) reporting seeing 
more ‘colour’ in both what she saw and how she felt in the dream, to larger changes, for 
example Nicola (participant 5) reported a dream in which she went to work and was able to 
work (when she had previously been distressed by being unable to complete her work).  In 
line with the reductions in quantitative measures of distress, all participants reported 
changes in their reaction to the nightmare upon awakening.  Elaine (participant 3) reported 
that she woke feeling less “terror” and that it no longer “ruined” her day, whilst Nicola 
reported waking to the thought “I can cope with that”.  Not all the changes were positive; 
Nick’s response had changed from feeling very distressed upon awakening to waking 
feeling angry.  Unfortunately he was unable to complete further sessions to consider 
further changes to the rescript.  
 
Exploratory hypothesis two stated that:  following IR participants will have improved sleep 
quality.  PSQI scores decreased in four out of five participants, in line with an improvement 
in overall sleep quality.  However, none of these participants met criteria for the reliable 
change index, suggesting that it is possible that these results occurred due to chance.  This 
hypothesis requires replication in a larger sample powered to detect changes in a sample 
with much variability in sleep quality. 
 
Exploratory hypothesis three stated that: following IR there will be a reduction in measures 
of psychotic and affective symptomatology.  Four out of five participants decreased in the 
severity of their delusions.  Two of these participants evidenced a statistically significant 
reliable change index score.  Two out of two participants noted an improved power 
differential between themselves and their persecutor.  Four out of five participants 
decreased in measures of the severity of auditory hallucinations; two of these participants’ 
change met criteria for the reliable change index.  The last participant evidenced a 
statistically significant deterioration in the severity of their auditory hallucinations.  There 
was no clear pattern of change in the voice power differential.  Two participants found it 
challenging to engage in the intervention due to symptoms of psychosis.  The impact of 
these symptoms will be discussed later. 
 
  





Four out of five participants decreased in their depression scores from pre-therapy 
measures to post-therapy measures.  Three of five participants decreased their anxiety and 
their stress scores from pre-therapy to post-therapy.  It was not possible to calculate 
whether these reported changes were statistically significant reliable changes.  Four out of 
five participants reduced their global distress score.  One of these participants achieved a 
statistically significant reliable change.  There was no clear pattern of change with regard to 
PTSD symptom severity from pre to post therapy.  In addition to markers of symptomatic 
change, participants completed questionnaires to indicate their level of daytime activity.  
There was no clear pattern of improvement or deterioration. 
 
Exploratory hypothesis four stated that: IR will be deemed an acceptable treatment for 
nightmares in patients with psychosis, as indicated by end of session feedback and 
satisfaction ratings for the intervention.  This hypothesis is supported; the mean rating for 
the level of satisfaction participants felt with the intervention was 9.2/10.  When asked to 
suggest improvements to the intervention participants recommended using the same 
research room for each appointment, adding availability of a coffee machine in the waiting 
area and adding relaxing sounds to the recording of the re-script.  The lowest satisfaction 
rating (7/10) was from Nick (participant 2) who acknowledged the challenges of his voice 
during the intervention but did not consider there was anything that the researcher could 
have done to improve this.   
 
7.2 Implementing IR in the context of psychosis 
Chapter one (review of the literature) outlined several factors that might impact on the 
delivery of CBT based interventions for those with psychosis.  Managing risk issues was one 
such factor that was particularly relevant to the delivery of the intervention.  Of the six 
participants who entered the intervention, care teams were contacted for four participants 
in order to assess and manage risk that arose during the course of the intervention, but 
unrelated to  the intervention.  Two participants disclosed voices commanding them to 
hurt others (including the therapist) and two participants disclosed significant risk of 
suicide.  This finding is consistent with reports of elevated risks of violence (Mullen, 2006) 
in those with psychosis and increased risk of suicide in those with psychosis  (Palmer et al., 
2005) and those with nightmares (Pigeon et al., 2012).  This is an important consideration 
  





when implementing a protocol originally developed in non psychosis diagnostic groups 
where risk might be lower. 
 
It is worth considering the role of auditory hallucinations in both the nightmares 
themselves as well as the ability to engage in imagery.  Nick (participant 2) saw a depiction 
of his voice in his original nightmare, and within his re-script he provided his voice with the 
comfort that he himself could have benefitted from (by choosing to hug her).  In addition, 
his ability to engage in the imagery element of the intervention was challenged by his voice 
telling him to harm the therapist.  He described that the volume of his voice increased in 
order to compete with the therapists’ own voice.  Elaine (participant 3) reported that her 
voice took on a protective role in the original nightmare, waking her up from her nightmare 
at the point of maximum affect.  Given that arousal and stress have been associated with 
an increase in auditory hallucinations during the day (Slade, 1972) it seems reasonable to 
consider that distressing nightmares might also include the presence of auditory 
hallucinations.   
 
Symptoms of delusions also impacted on therapeutic progress.  Much of the distress that 
Roland (participant 4) experienced in relation to his nightmares was due to meta-cognitive 
beliefs.   Whilst lack of control was a distressing theme in Roland’s nightmares, his distress 
additionally arose from his belief that spirits were inserting his nightmares into his head.  
This resulted in him being ambivalent about the intervention; he believed reading the script 
meant engaging with the spirits.  This highlights the importance of a thorough assessment 
of the appropriateness of IR for nightmare content versus CBTp for delusions, prior to 
undertaking the work.  For another participant their ongoing delusional belief was apparent 
in devising the rescript.  Nick (participant 2) considered using his belief in psycho-kinesis as 
a means to create an alternative ending to his nightmare.  It was challenging to suggest 
viable alternatives that were as acceptable to him, but which did not reinforce his belief.  
For this participant, it was important to spend more time planning the script prior to 
undertaking the imagery work.  This is in line with Fowler et al.’s, (1995) treatment manual 
that suggests an approach that is both flexible and considers the role of symptoms of 
psychosis within the session.  
 
  





7.3 Comparison to previous research 
The current study adds to the small body of literature suggesting that imagery techniques 
may be a helpful therapeutic tool for those with psychosis (Schulze, 2009; Serruya & Grant 
2009; Ison, 2011; Morrison, 2004).  It is difficult to draw clear conclusions regarding the 
effectiveness of the intervention given the small sample and the lack of control group.  
However, results indicate change on a range of nightmare related measures including 
nightmare distress, intensity and vividness.  Furthermore, two participants evidenced 
improvements on measures of auditory hallucinations and delusions.  Whilst these require 
replication in a larger sample, the results are encouraging.  Adverse effects were not 
apparent as a direct result of the use of IR although the psychosis symptoms of some 
participants needed to be considered carefully and some adaptations made, to ensure an 
individual and flexible approach, as in interventions with psychosis in general (Fowler et al 
1995). 
 
The IR protocol was originally developed for those with PTSD related nightmares.  It is 
therefore helpful to consider potential similarities and differences in outcomes as well as 
the adaptations that might be required for those with psychosis.  A recent meta-analysis 
indicated that IR was effective in reducing PTSD related nightmare frequency and daytime 
PTSD symptoms whilst also improving sleep quality in those with PTSD related nightmares 
(Casement & Swanson, 2012).  The current investigation did not find a clear change in 
nightmare frequency.  Furthermore, despite improvements in sleep quality for the majority 
of participants (4/5), it was not possible to conclude that these were not a reflection of 
variability in measurement error and normal fluctuations.  Instead, there were positive 
improvements in nightmare related distress as well as nightmare intensity and vividness as 
well as severity of delusions and hallucinations.  The following section will consider the 
importance of nightmare distress as a more appropriate outcome measure. 
 
A primary outcome for IR within PTSD literature is nightmare frequency.  This is despite the 
evidence suggesting that nightmare distress is a better indicator of daytime 
psychopathology (Nielson & Levin, 2007; Semiz et al., 2008; Levin & Fireman, 2002).  This 
finding from the nightmare literature has parallels with findings from those with positive 
symptoms of psychosis.  A review by Kuipers et al., (2006) reports that hallucinations and 
delusions occur within the general population in addition to clinical samples and that 
  





distress distinguishes between those that require clinical services and those that do not.   It 
is therefore suggested that a reduction in nightmare related distress, as was found within 
the current study, is an important outcome and one to be taken forward to future studies. 
 
It might also be considered that the current sample were a more complex sample to treat 
than the majority of studies which have used PTSD civilian samples.  All participants 
reported 3-4 key recurrent nightmares rather than a single target for intervention.  Results 
from study A indicated that in those with psychosis, higher nightmare distress was related 
to increased severity of delusions, depression, anxiety and stress.  Furthermore, the 
majority of study B participants presented with risk to self or others which warranted 
session time for assessment and management.  These factors presented in addition to the 
fact that three out of five participants met criteria for PTSD, as measured on the PDS.  More 
intensive IR packages have recently been developed in order to increase the effect of 
interventions.  Long et al. (2011) added an exposure element and increased the number of 
sessions in order to increase the opportunity for script rehearsal.  Ulmer et al. (2011) and 
Swanson et al. (2009) have taken the alternative route of adding CBT for insomnia to an IR 
protocol in order to create a comprehensive package intervention that considers pre-sleep 
factors in addition to imagery.  Given Myers et al. (2011) showed promising reductions in 
insomnia and persecutory delusions through their pilot of CBTi for psychosis, these 
additions might complement the current IR intervention.   
 
7.4 Clinical implications 
The key clinical implication is that it is feasible to adapt IR for those with symptoms of 
psychosis.  The results described above are encouraging but warrant a larger study in order 
to draw strong conclusions regarding the impact that such an IR protocol might have on 
these outcomes in a psychosis population. 
 
It is recommended that that the IR protocol be imbedded within a comprehensive CBTp 
protocol.  This would help the IR protocol be more inclusive to those with symptoms that 
impact on the intervention.  For Roland (participant 4) for example, the primary source of 
his distress arose from his daytime beliefs, rather than recurrent nightmare content.  In this 
case a standard CBTp treatment manual would be more appropriate prior to considering IR.  
It would also have been helpful to have a more comprehensive assessment of Nick’s voices 
  





with regard to triggers, how they might respond during the imagery and consider the 
possibility of a graded approach to working with the nightmare.  Given the short length of 
the IR protocol, it would be feasible to imbed the intervention into current NICE (2009) 
recommended CBTp. 
 
The practical implementation of the IR protocol relied on careful time planning.  In order to 
allow participants to practice the script in between sessions the researcher typed out the 
script and recorded it onto CD immediately following the session.  This was sent in the post 
as soon as possible.  Ideally, the participants would have spent a week reading or listening 
to the script, however, with postal delays some participants reported not receiving the 
package until half way through the week.  It might be more appropriate to have sessions 
every 10 days (rather than weekly) in order to allow for potential delays, utilise emails or 
record scripts within session in order to facilitate timely rehearsal. 
 
Supportive and well organised supervision was of much benefit to the research.  In 
particular, discussion of risk issues, of the impact of hearing distressing traumatic memories 
on the researcher and discussion of adaptations for the psychosis population.  Given the 
timing difficulties mentioned above, it was important that supervision was planned on the 
same day, but after the session, in order to allow the script to be sent to the participant.   
 
7.5 Strengths and limitations 
A strength and limitation of the case series is the heterogeneity of the sample in respect of 
presence of delusions, hallucinations, PTSD symptomatology and previous experience of 
therapy.  This is a strength with regard to the versatility of the IR protocol however, future 
research might utilise a more homogenous sample in order to draw clear conclusions 
regarding correlates and mechanisms of change.  Future considerations to strengthen 
conclusions regarding IR for nightmares in the context of psychosis would include: a 
treatment as usual and active control group, blinded assessments and a larger sample.   
 
Despite participants reporting a decrease in the target nightmare at the two week follow 
up phone call this was not translated into decreases in frequency on the nightmare log.   
Nicola reported that at the two week follow up telephone call she had not experienced any 
target nightmares, Nick reported less “big” nightmares, Elaine reported a decrease in 
  





frequency and Louise reported only one nightmare since the intervention at the two week 
phone call.  One plausible explanation for the lack of calibration between quantitative and 
qualitative measures in that the nightmare logs were designed to capture all nightmares, 
including those that were not the focus of the intervention.  It is possible that whilst the 
target nightmare might have reduced in frequency, non-target nightmares may have 
increased.  Indeed, Nick reported that whilst he was “not having as many bad ones”, he 
was having “little random ones”.  A further study might consider increasing the nightmares 
log’s sensitivity to change by measuring the frequency of target and non-target nightmares 
separately.   
 
Given the link between nightmare distress and affective symptomatology reported in study 
A, the importance of gaining a sensitive measure using the DASS-21 is highlighted.  
However, due to a delay in carrying out the case series element of the research there was a 
four months gap in assessment of the DASS-21 measure in two cases.  This gap also 
impacted on measures of daytime activity levels and PTSD symptomatology.  The delay was 
the result of local R&D approval procedures; evidence of nightmares in those with 
psychosis was required from study A, prior to approval being granted for study B.   
 
7.6 Conclusions  
IR has a strong evidence base as a nightmare specific intervention for those with PTSD 
(Casement & Swanson, 2012).  This preliminary investigation suggests that IR is a protocol 
that can be suitably adapted as an intervention for people with nightmares in the context 
of hallucinations and delusions as well as co-morbid symptoms of PTSD.  Initial findings 
suggest that IR might impact on nightmare related distress, intensity and vividness of 
nightmares, affective and psychotic symptomatology.  However, there are many limitations 













8. Suggestions for future research and conclusions 
8.1 Summary 
This is the first systematic investigation of the phenomenology of nightmares in the context 
of psychosis and the first to investigate the appropriateness of a nightmare specific 
intervention (IR) in this population.  The study has revealed that nightmares are a common 
problem for those with psychosis.  Higher frequency of nightmares was related to worse 
sleep quality and nightmare related distress was related to psychotic, affective and 
cognitive symptoms (delusional severity, depression, anxiety, stress and working memory).  
This study particularly highlights the importance of measuring nightmare related distress 
over and above the frequency of such an experience.  It was nightmare related distress that 
related to daytime psychiatric measures, independently of nightmare frequency. 
 
Study B showed that rescripting of nightmares is a treatment approach that can be suitably 
adapted from a PTSD sample to those with psychosis.  Although further research with 
larger sample sizes is required, this case series indicated that IR might have a positive 
impact on measure of nightmare distress, vividness and intensity of nightmares, psychosis 
symptoms and affective measures.  IR did not show adverse effects as an intervention for 
those with psychosis.  
 
This study highlights the importance of taking a symptom focused, rather than diagnosis 
focused approach.  The problem of nightmares has been shown to be prevalent outside of 
those with PTSD, and has been related to a specific symptom of psychosis: delusional 
beliefs. 
 
8.2 Suggestions for further research 
Although the current study indicated that nightmares were related to delusional severity, 
the direction of causality is unclear.  Fear extinction and emotion regulation models of 
dreaming (Nielson & Levin, 2007; Desseilles et al., 2010; Gujar et al., 2011; Nishida et al., 
2009) would predict that nightmares result from disrupted processing of distressing 
daytime experiences.  However, an alternative model might suggest that delusional ideas 
are formed following sleep disturbance (Freeman et al., 2002), which might be caused by 
nightmares.  It is of course possible that both of the above are true and that the 
relationship is bi-directional, as has been suggested in the PTSD literature (Van Liempt, 
  





2012).  A further account might place an underlying process as key in producing both 
distressing nightmares and distressing daytime symptomatology.  The following section will 
propose several areas of research to clarify these different positions. 
 
8.2.1 Nightmares as a disruption of emotional processing 
Nielson and Levin (2007) theorise that nightmares result from an interaction between what 
they term affect load and affect distress.  They postulate that fear extinction is the primary 
role of dreaming but nightmares represent a disruption in this process.  This may be due to 
increased daytime demands on the emotional memory system (increased affect load) and 
/or an increased trait disposition to experience heightened emotional distress in response 
to emotional stimuli (affect distress).  It is possible that those with delusions have increased 
demands on their night time emotion regulation system due to distressing experiences (e.g. 
feeling scared in relation to a belief that someone is plotting to harm them).  This is 
consistent with the finding that high levels of anxiety and depression are found in those 
with persecutory delusions (Freeman et al., 2012b).  Experience sampling methodology 
might help uncover whether nightmares fluctuate in response to fluctuations in distressing 
daytime experiences and is an avenue for further research. 
 
8.2.2 Nightmares result in distressing symptoms 
In their model of the formation of persecutory delusions, Freeman et al., (2002) propose a 
key role for anxiety and insomnia.  The current study has shown that both of these are 
related to nightmares.  Freeman et al. (2002) describes that anxiety heightens the 
anticipation of danger, whilst sleep disturbance is hypothesised to increase arousal 
following a precipitant event.  These processes, in addition to worry and pre-existing 
schemas and cognitive biases result in the formation of a ‘threat belief’ (Freeman et al., 
2002).  The current study has identified that nightmares are associated with sleep 
disturbance, anxiety and most importantly delusional severity.  It is possible that 
nightmares serve as a risk factor for the development of new inceptions and the 
maintenance of paranoid thinking, as has been found for insomnia (Freeman et al., 2012a).  
It would not be a novel finding that nightmares predict psychopathology; Van Liempt 
(2012) reports that pre-deployment nightmares predicted 6-month post deployment PTSD 
symptoms in military personnel.  Longitudinal research could pinpoint whether nightmares 
  





pre-exist the development of delusional ideas, are a correlate of first episode psychosis or 
follow later in the course of the illness. 
 
8.2.3 The role of cognitions in nightmares and delusions 
Given that CBTp is a recommended treatment for psychosis in the UK (NICE, 2009) and USA 
(National Institute of Mental Health, 2013), it is helpful to consider the potential overlap 
between cognitions in nightmares and psychosis.  Spoormaker (2008) has proposed a 
cognitive model of nightmares.  He asserts that a nightmare script is a fixed expectation 
pattern and if dream elements are appraised to be similar in either content or emotional 
tone to the original nightmare, the script will likely become activated.  He therefore 
proposes a role for interpretation biases in appraising dream content.   In addition, 
Spoormaker (2008) suggests that pre-sleep cognitive avoidance drives safety behaviours 
such as thought blocking, avoiding going to bed or sleeping with the light on.  Post-sleep 
meta-cognitive appraisals such as “I must be going crazy” also serve to heighten the anxiety 
attached to the nightmare script.  Given the high prevalence of both nightmares and 
insomnia in those with psychosis, it would be helpful to consider the role of cognitions 
prior to, during and following nightmares. 
 
The following section will put forward a case for further research into a cognitive 
vulnerability that spans across both distressing nightmares and distressing symptoms of 
psychosis.  Overlap in cognitive risk factors has recently been found in paranoia and 
another diagnosis which suffers frequent nightmares: PTSD (Freeman et al., 2013).  This is 
despite the fact that PTSD and paranoia are two distinct experiences (Freeman et al., 2013).  
Results from those with psychosis (from the current study) and from a sample of healthy 
students (Levin and Fireman, 2002) both place nightmare related distress as key in 
predicting psychopathology.  Cognitions have been implicated in both nightmare related 
distress (Spoormaker, 2008) and delusional/paranoid thinking (Freeman et al., 2012b; 
Freeman & Garety, 1999).  More specifically, a self-focused cognitive style and negative 
ideas about the self have been found in paranoid thinking (Freeman et al., 2012b) and 
meta-cognitive beliefs contribute to delusional distress (Freeman & Garety, 1999).  It would 
be interesting to see if these cognitive styles are also implicated in nightmare related 
distress in those with psychosis.  Such underlying cognitive processing and distortions 
across both delusions and nightmares would have exciting clinical implications for CBTp 
  





(Chadwick, Birchwood & Trower, 1996; Fowler, Garety & Kuipers, 1995; Laroi & Aleman, 
2010). 
 
8.2.4 Cognitive deficits and their link with sleep disruption and nightmares 
The finding that a higher level of nightmare distress was associated with lower 
performance on a working memory task is novel.  Whilst there is a wealth of research 
confirming the link between slow wave sleep and cognitive symptoms of psychosis 
(Keshavan et al., 2011; Wamesley et al., 2012; Phillips et al., 2012; Manoach et al., 2010), 
this is the first study linking nightmares (a phenomenon primarily found in REM sleep; 
Bosch & van den Noort, 2008) and a cognitive deficit: working memory.  Given that 
cognitive symptoms are an important attribute of clinical presentation, the best predictor 
of functional status in psychosis (Bowie & Harvey, 2006) and predate the onset of positive 
symptoms (Kayman & Goldstein, 2012), this finding clearly warrants further investigation.     
Future research might study the developmental course of nightmares, cognitive symptoms 
and positive symptoms, or observe the impact of nightmare interventions (such as IR) on 
working memory.  Lastly, the link between nightmares and other cognitive deficits found in 
schizophrenia might be investigated (E.g. speed of processing, attention, verbal and visual 
learning and memory, reasoning and problem solving; Neuchterlein et al., 2004).   
 
8.2.5 Nightmares and auditory hallucinations  
The current study revealed a non-significant medium positive correlation (.33) between 
nightmare related distress and the severity of auditory hallucinations.  This finding fell just 
short of significance (p=.08).   The current study was powered to detect correlations of at 
least .43, with a sample of 37.  The correlation between nightmare distress and auditory 
hallucinations is therefore underpowered both due to the size of the sample (28) and size 
of the correlation found (.33).  Further research, with a sample powered to detect this 
result is clearly required. 
8.2.6 IR as an intervention for nightmares in the context of psychosis 
The next stage for research of IR in the context of psychosis would be a larger pilot study in 
preparation for a larger randomised controlled trial.  Given the large significant association 
between nightmare distress and delusional severity from study A, it would be 
recommended that such a trial create a homogenous sample, including only those with 
delusions.  Study A and B combined suggested that those with frequent distressing 
  





nightmares present a complex sample to treat due to the severity of delusions, depression, 
anxiety, stress, insomnia, risk of harm to self and others in addition to the reported 3-4 
different recurrent nightmares.  Lengthening the IR intervention, increasing imagery 
rehearsal time by having larger gaps between sessions and / or combining with a CBT for 
insomnia protocol are adaptations that might increase the effect of the intervention.  
Further improvements might include thorough pre-post intervention measures of affect 
and improving the sensitivity of the measure to nightmare frequency by measuring 
frequency of each individual nightmare.  The primary outcome expected from such a trial 
would include improved nightmare related distress, with secondary outcomes including 
improved delusional severity, depression and anxiety, sleep and a reduction of risk.   
 
8.3 Conclusions 
The current investigation has highlighted that nightmares are a prevalent problem for 
those with psychosis.  Nightmares correlate with sleep quality as well as daytime psychotic, 
affective and cognitive symptoms.  IR was trialled as an intervention for nightmares within 
this context of psychosis.  Successes, challenges and future adaptations were considered.  
This study has opened up several lines of research that require investigation.  These include 
understanding when nightmares appear within the development of psychosis, better 
understanding the direction of causality and underlying processes linking nightmares with 
daytime symptoms.  Lastly, there is scope for a larger trial of IR as a treatment of 
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10. Appendices        
 10. 1. Appendix 1: Poster for clinical waiting areas 
Bryony Sheaves 
      Department of Psychology 
        Third Floor ASB PO78 
      Institute of Psychiatry 
London SE5 8AF 
Tel. 07977629247 
Email: bryony.sheaves@kcl.ac.uk 




We are running a research study 
investigating sleep patterns in people who 
have experienced unusual, worrying or 
distressing experiences or beliefs  
 
Whether you sleep very well, or have had 
sleep difficulties we would like to hear 
from you. 
 
Taking part involves meeting with a researcher for around an hour and a half 
to complete questionnaires about your sleep, your mental health and how 
you spend your time 
 
You can find out more details by speaking to your care 
co-ordinator or by contacting: 
Bryony Sheaves 
Tel No: 07977629247 
Bryony.sheaves@kcl.ac.uk 
 
This study has received ethical approval by: City Rd & Hampstead Research 








10. 2. Appendix 2: Participant Information Sheet – Study A 
 
    Bryony Sheaves 
      Department of Psychology 
        Third Floor ASB PO78 
      Institute of Psychiatry 




PARTICIPANT INFORMATION SHEET- PART A  
Version 2 – 13 January 2012 
 
Project Title: An Investigation of Nightmares, Sleep Disturbance and Psychosis with a 
case series of Imagery Rehearsal Training (IRT) 
Please take time to read the following information carefully.  Talk to others about the study 
if you wish. 
You are being invited to take part in a research study.  Before you decide whether to take 
part it is important that you understand why the research is being done and what it would 
involve for you.  Ask us if there is anything that is not clear or if you would like more 
information.  Take your time to decide whether or not you wish to take part. 
What is the purpose of the study?  
 
The study aims to understand more about the sleep experiences of people who have 
experience of psychosis.  In particular we are interested to find out more about nightmares, 
how common they are, how distressing they are and how they affect daily living.  
Nightmares are thoughts or images that occur when one is asleep.  Because they are 
upsetting they cause the person to wake from sleep.  We are aiming to speak to around 40 
people with experience of psychosis about their sleep experiences.  We want to find out if 
they experience nightmares, if so, how frequently and how they might be affected by them 
both at night and during the day.  We are interested to find out about everybody’s sleep 
experiences so it does not matter if you sleep very well or have difficulties; you are still able 
to take part. 
Why have I been asked to take part? 
We are inviting people into the study through your mental health team.  We are inviting 
any adult who has experienced unusual or distressing beliefs or experiences.   
Do I have to take part? 
No.  It is up to you to decide whether or not to take part.   







Participation involves one meeting with the researcher, Bryony Sheaves, to complete a 
face-to-face interview and some questionnaires.  You may take comfort breaks at any point 
during the meeting.   
 
Interview/Questionnaires: You will be asked a variety of questions, mostly by 
questionnaire.  If you prefer not to write you can ask the researcher to fill in the 
questionnaires on your behalf.  You will be asked some information about yourself (e.g. 
your age, gender, alcohol use) and some questions about your past and current medical 
history. The researcher will ask about your sleep, including your experience of dreams and 
nightmares over the two weeks prior to the interview.  They will ask how frequently you 
have nightmares, if at all, how distressing, vivid and intense they are.  We would also like to 
learn what strategies you use to help with your sleep.  The researcher will also ask you to 
fill in some questionnaires related to your experiences of psychosis, your mood, if you have 
had past traumatic experiences, how you spend your days and a questionnaire to measure 
day to day distress. 
 
If you choose to take part in the study we will have access to your medical records at South 
London and Maudsley NHS Foundation Trust. 
 
Will I be reimbursed for any expenses? 
Yes, we will offer you £10 to cover your expenses 
Will my information be confidential? 
All of your answers to the questionnaires will be kept anonymously and will be identifiable 
only by a number, not by your name.   
 
All information supplied to the researchers will be treated as strictly confidential and 
stored anonymously (using a code) so you cannot be identified from the data.  Your name 
will be kept separately, with the number, on a database and on paper so that we can 
identify your questionnaires in the future if we need to (for example, if you decide you no 
longer want to be part of the study). We will only identify your questionnaires for a reason 
like this. Paper copies of questionnaires will be kept securely by the researchers in a locked 
filing cabinet in a locked office. Your details will be kept for up to 12 years, and then will be 
confidentially destroyed. We will keep a completely anonymised copy of the database 
indefinitely, from which you will not be able to be identified at all.  
We will inform your clinical team that you are taking part in the study.  The information you 
give will usually be available only to the research team. However, the researcher will share 
with your clinical team any important information that is relevant to the care you receive. 
In addition, should you give any information, such as criminal disclosures, or information 
relating to your own or others safety, which requires action, including passing on 
information to others, the research team will take appropriate actions.  
What are the possible risks of taking part? 








However, some people may find it upsetting to talk about their experiences. If you find any 
of the questions asked upsetting and would like to talk about this, please let your 
researcher know who will offer you regular breaks or stop the session, if needed. During 
the study, you will have the opportunity to talk about your upset if you want to and/or to 
engage in some relaxation exercises which can be helpful in reducing distress. 
What are the possible benefits of taking part? 
There are no direct benefits for you from taking part in the research. However, we hope 
that the information collected will help us to understand better the sleep experiences in 
people who experience psychotic symptoms.  This may help the development of better 
psychological treatments to reduce distress in the future. 
What should I do if I have any problems? 
If you are concerned about any aspect of this study, please speak to the researcher to 
clarify any queries.   
If you remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from your local hospital or team base. 
Although we do not expect the study to have any risks, in the event that you are harmed 
due to the research and this is due to someone’s negligence then you may have grounds 
for a legal action for compensation against King’s College London but you may have to pay 
for your legal costs. The normal NHS complaints mechanisms will still be available to you (if 
appropriate). 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your safety, rights, wellbeing and dignity. This study has been 
reviewed by the City Road and Hampstead Research Ethics Committee (11/LO/2045)  
What will happen to the results of the study? 
A summary of the results will be submitted to a scientific journal for publication and 
written up as a doctoral thesis by Bryony Sheaves. No-one will be able to identify you in the 
description of the study. If you are interested in a written summary of the findings of the 
study, please tick the box on the consent form. 
Who is carrying out the study? 
 
The study is being carried out by Bryony Sheaves in part fulfilment of a doctorate 
qualification.  The research includes Professor Elizabeth Kuipers, Dr Nadine Keen, and Dr 









Contact for further information 
If you have any questions about the study or are unsure whether you qualify to take part, 
you are welcome to discuss your participation, in confidence, with Bryony Sheaves: 































10. 3. Appendix 3: Participant Information sheet – Study B 
 
Bryony Sheaves  
Department of Psychology 
PO78 
Institute of Psychiatry 




PARTICIPANT INFORMATION SHEET- PART B 
Version 2 – 13 January 2012 
 
Project title: An Investigation of Nightmares, Sleep Disturbance and Psychosis 
with a case series of Imagery Rehearsal Training (IRT) 
 
Please take time to read the following information carefully.  Talk to others about the study 
if you wish. 
You are being invited to take part in a research study.  Before you decide whether to take 
part it is important that you understand why the research is being done and what it would 
involve for you. 
Ask us if there is anything that is not clear or if you would like more information.  Take your 
time to decide whether or not you wish to take part. 
What is the purpose of the study?  
 
This part of the study will investigate how a process called ‘Imagery Rehearsal Training’ 
might be used to change the content of the nightmares.  We hope to find out if changing 
the content of the nightmares to a more pleasant ending will change the amount of 
distress that people experience due to their nightmare and whether it affects the 
frequency of the nightmare and effect daytime functioning.  We are looking for around 5 
people who have already completed section A of the study to complete section B.  These 
should be people who can remember their nightmare. 
Why have I been asked to take part? 
You have been asked to take part because you completed part A of the study and have 
current experiences of distressing nightmares.  
Do I have to take part? 
No.  It is up to you to decide whether or not to take part.   







Participation will involve meeting with the researcher, Bryony Sheaves, for three to four 
meetings, over the course of approximately 5 weeks. The first and last session will take 
around an hour and a half to complete, the meetings in between should take a little less.  
You are welcome to take comfort breaks and can discuss this with the researcher at the 
start of the appointments.   
 
Prior to meeting 1: The researcher will post you some dream logs to note down any 
dreams/nightmares that you may have experienced one week prior to the first meeting.  
These should take 5 minutes to complete each morning for a week. 
Meeting 1: The researcher will ask you to complete some additional questionnaires.  They 
will provide some information about sleep and nightmares and explain the idea behind the 
Imagery Rehearsal Training Treatment.  You will also practice some guided imagery of a 
pleasant place/situation.  You will be provided with a CD of this imagery to take home and 
listen to. 
Meeting 2: This session will focus on the nightmare you chose in session one.  With the 
researcher you will create an alternative, less distressing ending to your nightmare and 
practice imagining this ending in a lot of detail using the guided imagery technique learnt in 
session one. 
Letter/CD: The researcher will write a summary of the nightmare including the more 
pleasant and alternative ending and send it to you in the post.  Alternatively, if it is more 
convenient for you, you can be provided with a recording of your ‘re-scripted’ nightmare 
on CD.  You will be asked to listen to/read the re-scripted nightmare each day.   
Meeting 3 or 4: You will be invited to return for the final session.  We will review your 
progress together and adapt the nightmare re-script if necessary.  If you feel you would 
benefit from a fourth session this can be arranged at this time with the researcher.  In the 
final meeting, you will be asked to complete the same questionnaires as the ones you have 
just completed in the first part of the study.   
 
Will I be reimbursed for any expenses? 
Yes, we will offer you £10 at session one and an additional £10 at the last session, to cover 
your expenses 
Will my information be confidential? 
All of your answers to the questionnaires will be kept anonymously and will be identifiable 
only by a number, not by your name.   
 
All information supplied to the researchers will be treated as strictly confidential and 
stored anonymously (using a code) so you cannot be identified from the data.  Your name 
will be kept separately, with the number, on a database and on paper so that we can 
identify your questionnaires in the future if we need to (for example, if you decide you no 
longer want to be part of the study). We will only identify your questionnaires for a reason 
like this. Paper copies of questionnaires will be kept securely by the researchers in a locked 
filing cabinet in a locked office. Your details will be kept for up to 12 years, and then will be 
confidentially destroyed. We will keep a completely anonymised copy of the database 








You may be asked if you would be happy for sessions to be recorded on a Dictaphone.  You 
will be asked if you are happy for sessions to be recorded on the consent form for the 
study.  If you would prefer not to be recorded, you can still take part in the study.  If you do 
agree, the recordings will be stored on an encrypted, password protected memory stick, 
which will be stored securely in a locked cabinet in a locked office. 
We will inform your clinical team that you are taking part in the study.  The information you 
give will usually be available only to the research team. However, the researcher will share 
with your clinical team any important information that is relevant to the care you receive. 
In addition, should you give any information, such as criminal disclosures, or information 
relating to your own or others safety, which requires action, including passing on 
information to others, the research team will take appropriate actions.  
What are the possible risks of taking part? 
It is not expected that participation in the study has any risks.  
 
However, some people may find it upsetting to talk about their nightmares. If you do find 
that you become upset and would like to talk about this, please let your researcher know 
who will offer you regular breaks or stop the session, if needed. During the study, you will 
have the opportunity to talk about your upset if you want to and/or to engage in some 
relaxation exercises which can be helpful in reducing distress.  If you feel you require 
further support after a session your researcher can contact your care team. 
What are the possible benefits of taking part? 
Other research has found that imagery rehearsal training reduces the frequency of 
nightmares and reduces how distressing they are.  However, this research was carried out 
with people who suffer with post-traumatic stress disorder rather than psychosis.  We want 
to find out if it benefits people with nightmares and psychosis.  In making your decision to 
take part, you therefore need to remember that it is possible that imagery rehearsal 
training will have no effect on your nightmares. 
 
We hope that the information collected will help us to understand better the experiences 
of people who have nightmares in the context of psychosis. This may help the development 
of better psychological treatments to reduce distress in the future. 
What should I do if I have any problems? 
If you are concerned about any aspect of this study, please speak to the researcher to 
clarify any queries.   
If you remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from your local hospital or team base. 
Although we do not expect the study to have any risks, in the event that you are harmed 







for a legal action for compensation against King’s College London but you may have to pay 
for your legal costs. The normal NHS complaints mechanisms will still be available to you (if 
appropriate). 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your safety, rights, wellbeing and dignity. This study has been 
reviewed by the City Road and Hampstead Research Ethics Committee (11/LO/2045)  
What will happen to the results of the study? 
A summary of the results will be submitted to a scientific journal for publication and 
written up as a doctoral thesis by Bryony Sheaves. No-one will be able to identify you in the 
description of the study. If you are interested in a written summary of the findings of the 
study, please tick the box on the consent form. 
Who is carrying out the study? 
The study is being carried out by Bryony Sheaves in part fulfilment of a doctorate 
qualification.  The research includes Professor Elizabeth Kuipers, Dr Nadine Keen, and Dr 
Juliana Onwumere from the Department of Psychology at the Institute of Psychiatry, King’s 
College London. 
 
Contact for further information 
If you have any questions about the study or are unsure whether you qualify to take part, 
you are welcome to discuss your participation, in confidence, with Bryony Sheaves: 


















10. 4 Appendix 4: General Information Questionnaire – Study A 
Bryony Sheaves 
Department of Psychology 
3rd Floor 
Addiction Science Building 






GENERAL INFORMATION QUESTIONNAIRE 
Title of Project: An Investigation of Nightmares, Sleep Disturbance and 
Psychosis with a case series of Imagery Rehearsal Training (IRT) 
 
Name of Researcher: Bryony Sheaves 
Date: _________________ 
Participant number: _________________ 
 
TO BE COMPLETED BY THE PARTICIPANT 
Gender:  M      F   
Age:  __________________________________________________ 
Ethnicity:_________________________________________________ 
 
In the past week (i.e. the past 7 days) how much alcohol have you 
consumed?_________________________________________________ 
 
Researcher to calculate units of alcohol___________________________ 
 
In the past two weeks (i.e. the last 14 days) have you taken any non-
prescribed drugs? 








IF YES, what did you take? 
___________________________________________ 
 
How much did you take?______________________________________ 
When did you take it?_________________________________________ 
 
What prescribed medications are you currently taking? 
Medication Name Dose Purpose of the 
medication 
Side effects you 
experience as a 






   
 
 
Please tell us any strategies that you use to help you sleep. 
These might be things you do (E.g. keeping the radio on in the background), things 
you eat or drink, prescribed or non-prescribed medications, things you think about 
















10. 5. Appendix 5: Pittsburgh Sleep Quality Index 
Pittsburgh Sleep Quality Index (Buysee et al., 1989) 
 
Answers should indicate sleep habits for the majority of days over the past month. 
1. What time have you usually gone to bed at night? Bed time______ 
2. During the past month, how long in minutes has it usually taken you to fall 
asleep?  ___ minutes 
3. What time have you usually gotten up in the morning? Getting up 
time______ 
4. During the past month, how many hours of actual sleep did you get at 
night? ______hours 
 
5. During the past month, how often have you had trouble sleeping because 
you: 
 
A) Cannot get to sleep within 30 minutes? 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
B) Wake up in the middle of the night or early in the morning? 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
C) Have to get up to use the bathroom? 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
D) Cannot breath comfortably 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
E) Cough or snore loudly 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
F) Feel too cold 
• Not during the past month 
• Less than one per week 







• Three or more times per week 
G) Feel too hot 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
H) Had bad dreams 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
I) Have pain 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
J) Other reasons: Please describe___________ 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
6. Over the past month, how would you rate your sleep quality overall? 
Very good ____ 
Fairly good____ 
Fairly bad ____ 
Very bad ____ 
7. During the past month how often have you taken medicine to help you 
sleep? (Prescribed of over the counter?) 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
8. During the past month how often have you had trouble staying awake while 
driving, eating meals, or engaging in social activity? 
• Not during the past month 
• Less than one per week 
• Once or twice per week 
• Three or more times per week 
9. During the past month, how much of a problem has it been for you to keep 
up enough enthusiasm to get things done? 
• No problem at all 
• Only a very slight problem 
• Somewhat of a problem 








Over the past two weeks, how many nightmares have you 
experienced? 
        
  _____ 
 
If you have experienced at least one nightmare over the past two 
weeks please pick the worst nightmare to answer the questions below. 
 
How intense was the nightmare? 
 
Not intense at all    Very Intense 
1 2 3 4 5 6 7 
 
How vivid was the nightmare? 
 
Not vivid at all     Very vivid 
1 2 3 4 5 6 7 
 
How distressing did you find the nightmare? 
 
Not distressing at all    Very distressing 
1 2 3 4 5 6 7 
 
10. 6. Appendix 6: Dream Log – study A 
Bryony Sheaves 
Department of Psychology 
3rd Floor 
Addiction Science Building 
Institute of Psychiatry 
London 
SE5 8AF 
Tel. 07977629247  
Email. Bryony.sheaves@kcl.ac.uk  
 
Dream Log 
























**[For study B, the dream log was completed each morning, asking how 
many nightmares the participant had experience the previous night, 













10. 7. Appendix 7: PSYRATS for Hallucinations 
Psychotic Symptom Rating Scales (Haddock et al, 1999) 
 
PSYRATS - Auditory hallucinations 
(rating period over the last week) 
Length of time experiencing voices: How long ago did you start hearing 
voices?   __years __ months 
 
1 Frequency How often do you experience voices? E.g. every day, all day 
long, etc 
0  Voices not present or present less than once a week 
1  Voices occur for at least once a week 
2  Voices occur at least once a day 
3  Voices occur at least once an hour 
4  Voices occur continuously or almost continuously i.e. stop for only a few 
seconds or minutes 
 
2 Duration When you hear your voices, how long do they last? A few 
seconds, minutes, hours, all day long? 
0  Voices not present 
1  Voices last for a few seconds, fleeting voices 
2  Voices last for several minutes 
3 Voices last for at least one hour 
4  Voices last for hours at a time 
 
3 Location When you hear voices, where do t hey sound like they're coming 
from? - Inside your head and/or outside your head?- If voices sound like they 
are outside your head, whereabouts do they sound like they are coming from? 
0  No voices present 
1  Voices sound like they are inside head only 
2  Voices outside the head, but close to ears or head. Voices inside the head 
may also be present. 
3  Voices sound like they are inside or close to ears and outside head away 
from ears. 
4  Voices sound like they are from outside the head only. 
 
4 Loudness How loud are your voices? Are they louder than your voice, about 
the same loudness, quieter or just a whisper? 
0  Voices not present 
1  Quieter than own voice, whispers. 
2  About same loudness as own voice 
3  Louder than own voice 
4  Extremely loud, shouting 
 
5 Controllability Do you think you have any control over when your voices 
happen?  Can you dismiss or bring on your voices? 
0  Subject believes they can have control over the voices and can always bring 







1  Subject believes they can have some control over the voices on the majority 
of occasions 
2  Subject believes they can have some control over their voices approximately 
half of the time 
3  Subject believes they can have some control over their voices but only 
occasionally. The majority of the time the subject experiences voices which 
are uncontrollable 
4  Subject has no control over when the voices occur and cannot dismiss or 
bring them on at all. 
 
6 Beliefs re-origin of voices. What do you think has caused your voices? Are 
the voices caused by factors related to yourself or solely due to other people 
or factors? If patient expresses an external origin: How much do you believe 
that your voices are caused by ___ ________ (add patient's contribution) on a 
scale from 0 – 100 with 100 being that you are totally convinced, have no 
doubts and 0 being that it is completely untrue? 
0  Voices not present 
1  Believes voices to be solely internally generated and related to self 
2  Holds <50% conviction that voices originate from external causes 
3  Holds >=50% conviction that voices originate from external causes 
4  Believes voices are solely due to external causes (100% conviction) 
 
7 Amount of negative content 
Can you give me some examples of what the voices say? Do your voices say 
unpleasant things or negative things? How much of the time do the voices say 
these types of unpleasant or negative items? 
0  No unpleasant content 
1  Occasional unpleasant content (<10%) 
2  Minority of voice content is unpleasant or negative (<50%) 
3  Majority of voice content is unpleasant or negative (>=50%) 
4  All of voice content is unpleasant or negative 
 
8 Degree of negative content (Rate using criteria on scale, asking patient for 
more detail if necessary) 
0  Not unpleasant or negative 
1  Some degree of negative content, but not personal comments relating to self 
or family e.g. swear words or comments not directed to self, e.g. `the 
milkman's ugly' 
2  Personal verbal abuse, comments on behaviour e.g. `shouldn't do that or 
say that' 
3  Personal verbal abuse relating to self-concept e.g. `you're lazy, ugly, mad, 
perverted' 
4  Personal threats to self e.g. threats to harm self or family, extreme 
instructions or commands 
to harm self or others 
 
9 Amount of distress Are your voices distressing? How much of the time? 
0  Voices not distressing at all 
1  Voices occasionally distressing, majority not distressing (<10%) 







3  Majority of voices distressing, minority not distressing (>=50%) 
4  Voices always distressing 
 
10 Intensity of distress When voices are distressing, how distressing are 
they? Do they cause you minimal, moderate, severe distress? Are they the 
most distressing they have ever been? 
0  Voices not distressing at all 
1  Voices slightly distressing 
2  Voices are distressing to a moderate degree 
3  Voices are very distressing, although subject could feel worse 
4  Voices are extremely distressing, feel the worst he/she could possibly feel 
 
11 Disruption to life How much disruption do the voices cause your life? Do 
the voices stop you from working or other daytime activity? Do they interfere 
with your relationships with friends and/or family? Do they interfere with your 
ability to look after yourself, e.g. bathing, changing clothes, etc? 
0  No disruption to life, able to maintain social and family relationships (if 
present) 
1  Voices causes minimal amount of disruption to life e.g. interferes with 
concentration although able to maintain daytime activity and social and family 
relationships and be able to maintain independent living without support 
2  Voices cause moderate amount of disruption to life causing some 
disturbance to daytime activity and/or family or social activities. The patient is 
not in hospital although may live in supported accommodation or receive 
additional help with daily living skills 
3  Voices cause severe disruption to life so that hospitalisation is usually 
necessary. The patient is able to maintain some daily activities, self-care and 
relationships while in hospital. The patient may also be in supported 
accommodation but experiencing severe disruption of life in terms of activities, 
daily living skills and}or relationships 
4  Voices cause complete disruption of daily life requiring hospitalization. The 
patient is unable to maintain any daily activities and social relationships. Selfcare 






















10. 8. Appendix 8: Voice Power Differential Scale 
Voice Power Differential Scale 
(Birchwood, Meaden, Trower, Gilbert & Plaistow, 2000) 
 
Client’s Name:........................................................................... Date Assessed........................ 












I am much more 
powerful than my 
voice 
 
I am more 
powerful than my 
voice 
 
We have about the 
same amount of 
power as each 
other 
 
My voice is more 
powerful than me 
 














I am much 
stronger than my 
voice 
 
I am stronger than 
my voice 
 
We are as strong 
as each other 
 
My voice is 
stronger than me 
 
My voice is much 












I am much more 
confident than my 
voice 
 
I am more 
confident than my 
voice 
 
We are as 
confident  as each 
other 
 
My voice is more 
confident than me 
 














I respect my voice 
much more than 
they respect me 
 
I respect my voice 
more than they 
respect me 
 
We respect each 
other about the 
same 
 
My voice respects 
me more than I 
respect them 
 
My voice respects 
me much more 













I am much more 
able to harm my 
voice than they are 
able to harm me 
 
I am more able to 
harm my voice 
than they are able 
to harm me 
 
We are equally 
able to harm each 
other   
 
My voice is more 
able to harm me 
than I am able to 
harm them 
 
My voice is much 
more able to harm 
me than I am able 















































I am greatly  
superior to my 
voice 
 
I am superior to 
my voice 
 
We are equal to 
each other 
 
My voice is 
superior to me 
 
My voice is greatly 


















I am much more 
knowledgeable 
than my voice 
 
I am more 
knowledgeable 
than my voice 
 
We have about the 
same amount of 
knowledge as each 
other 
 
























































10. 9. Appendix 9: PSYRATS - Delusions 
 
Psychotic Symptom Rating Scales (Haddock et al, 1999) 
PSYRATS – Delusions 
 
(ratings over past week) 
1 Preoccupation In the last week, how much time did you spend thinking of 
your beliefs? All the time/daily/weekly etc.? 
0  No delusions, or delusions which the subject thinks about less than once a 
week 
1 Subject thinks about beliefs at least once a week 
2  Subject thinks about beliefs at least once a day 
3  Subject thinks about beliefs at least once an hour 
4  Subject thinks about delusions continuously or almost continuously 
 
2 Duration of preoccupation with delusions When beliefs come into your 
mind, how long do they persist? Few seconds/minutes/hours? 
0  No delusions 
1  Thoughts about beliefs last for a few seconds, fleeting thoughts 
2  Thoughts about delusions last for several minutes 
3  Thoughts about delusions last for at least 1 hour 
4  Thoughts about delusions usually last for hours at a time 
 
3 Conviction (at the time of interview) At the present time how concerned 
are you that your beliefs are true? Can you estimate this on a scale from 0 - 
100, where 100 means that you are totally convinced by your beliefs and 0 
being that you are not convinced at all? 
0  No conviction at all 
1  Very little conviction in reality of beliefs,<10% 
2  Some doubts relating to conviction in beliefs, between 10-49% 
3  Conviction in belief is very strong, between 50-99% 
4  Conviction is 100% 
 
4 Distress Do your beliefs cause you distress? How much of the time do they 
cause you distress? 
0  Beliefs never cause distress 
1  Beliefs cause distress on the minority of occasions 
2  Beliefs cause distress on <50% of occasions 
3  Beliefs cause distress on the majority of occasions when they occur between 
50-99% of time 
4  Beliefs always cause distress when they occur 
 
5 Intensity of distress When your beliefs distress you, how severe does this 
feel? 
0  No distress 
1  Beliefs cause slight distress 
2  Beliefs cause moderate distress 







4  Beliefs cause extreme distress, could not be worse 
 
Disruption to life How much disruption do your beliefs cause you? - Do they 
prevent you working or carrying out a daytime activity? - Do they interfere with 
your relationships with family or friends? - Do they interfere with your ability to 
look after yourself, e.g. washing, changing clothes, etc.? 
0  No disruption to life, able to maintain independent living with no problems in 
daily living skills. 
Able to maintain social and family relationships (if present) 
1  Beliefs cause minimal amount of disruption to life, e.g. interferes with 
concentration although able to maintain daytime activity and social and family 
relationships and be able to maintain independent living without support 
2  Beliefs cause moderate amount of disruption to life causing some 
disturbance to daytime activity and/or family or social activities. The patient is 
not in hospital although may live in supported accommodation or receive 
additional help with daily living skills 
3 .  The patient is able to maintain some daily activities, self-care and 
relationships while in hospital. The patient 
maybe also be in supported accommodation but experiencing severe 
disruption of life in terms of activities, daily living skills and}or relationships 
4  Beliefs cause complete disruption of daily life requiring hospitalization. The 
patient is unable to maintain any daily activities and social relationships. Selfcare 





















10. 10. Appendix 10: Persecutor Power Differential 
Persecutor Power Differential Scale 
(Adapted from the Voice Power Differential Scale VPD 
Birchwood, Meaden, Trower, Gilbert & Plaistow, 2000) 
 
Client’s Name:........................................................................... Date Assessed........................ 












I am much more 
powerful than my 
Persecutor 
 
I am more powerful 
than my Persecutor 
 
We have about the 
same amount of 
power as each other 
 
My Persecutor is 
more powerful than 
me 
 
My Persecutor is 













I am much stronger 
than my Persecutor 
 
I am stronger than 
my Persecutor 
 
We are as strong as 
each other 
 
My Persecutor is 
stronger than me 
 
My Persecutor is 













I am much more 
confident than my 
Persecutor 
 
I am more confident 
than my Persecutor 
 
We are as confident  
as each other 
 
My Persecutor is 
more confident than 
me 
 
My Persecutor is 
much more 












I respect my 
Persecutor much 
more than they 
respect me 
 
I respect my 
Persecutor more 
than they respect me 
 
We respect each 




respects me more 
than I respect them 
 
My Persecutor 
respects me much 













I am much more able 
to harm my 
Persecutor than they 
are able to harm me 
 
I am more able to 
harm my Persecutor 
than they are able to 
harm me 
 
We are equally able 
to harm each other   
 
My Persecutor is 
more able to harm 
me than I am able to 
harm them 
 
My Persecutor is 
much more able to 
harm me than I am 












I am greatly  superior 
to my Persecutor 
 
I am superior to my 
Persecutor 
 
We are equal to each 
other 
 
My Persecutor is 
superior to me 
 
My Persecutor is 





















We have about the 
same amount of 
knowledge as each 
other 
 
















10. 11. Appendix 11: DASS-21 (Lovibond & Lovibond, 1995a) 
DAS S 21 ID Number: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement applied to 
you over the past week.  There are no right or wrong answers.  Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found it hard to wind down 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 








10. 12. Appendix 12: Time Budget Questionnaire (Jolley al., 2006) 
 
 





The following guidelines should be read before administration. 
 
1.  The measure should be completed for a typical week (e.g. not one when the respondent 
was unusually unwell, or in hospital) unless an atypical week is particularly required. 
 
2. Start the week with whatever ‘yesterday’ was – this should be easier for participants to 
remember. Prompt if memory is poor. Ask about any known activities, or activities emerging 
as a pattern (e.g. ‘when did you get up’; ‘did you have breakfast?’; ‘what did you do then?’; 
‘you go to the day centre, don’t you – did you do that in the afternoon?’). If the week is very 
repetitive, it is OK to say – was that morning the same? Anything different?  Normalise lack 
of activity for some time periods, empathise with difficulties particularly if client is upset by 
lack of activity. Normalise difficulty remembering. Try to help the respondent as much as 
possible. See Appendix 1 for prompt questions. 
 
3. Stick to usual times of day when determining which box to complete. For example, if the 
person does not get up until lunchtime, score the morning as sleeping (0) and fill in the rest 
of the day from lunchtime onwards. If the person goes to bed late with lots of evening 
activities, these should still go in the ‘evening’ box, and can only achieve a maximum score 
of 4. 
 
4. All activities should be noted, without judgement. Even where activities are deemed 
inappropriate by the interviewer, these should still be added and scored. It is quite usual for 
people to have 0 and 1 scores for time periods in their week, even when functioning quite 
highly. E.g. common behaviours such as having a lie in will receive a 0, and watching TV a 1. 
 
5. Complete the additional questions. Note new and resumed activities (Q1) in the relevant 
columns. 
 
6. Each time period is given a score (Appendix 2). Scoring is based degree of planning, 
complexity and effort required. 
 
exertion (eg, sense of heart rate increase, heart missing a beat) 
20 I felt scared without any good reason 0      1      2      3 







Time Budget Measure 
 
 
Name:………………………………….                                 Date:…………………. 
 
We are interested in finding out a bit more about how you spend your time. This would 
include activities outside the home, such as work, study, any groups or centres that you 
attend, how you spend your leisure time, as well as home-based things for example, 
watching TV, reading, cooking and housework. 
 
I would also like to know about social activities- seeing or going out with friends, talking 
on the phone, chatting to neighbours or other people and so on. 
 
Thinking about the past week, perhaps we could divide up each day and think about what you 
can remember doing? Has the past week been an average week for you? 
 
M   Morning N R Middle of Day N R  Afternoon N R Evening N R 
            
            
            
            
            
        
T    Morning N R Middle of Day N R   Afternoon N R Evening N R 
            
            
            
            
            
        
W   Morning N R Middle of Day N R   Afternoon N R Evening N R 
            
            
            
            
            
        
T   Morning N R Middle of Day N R  Afternoon N R Evening N R 
            
            
            
            
            
        
F   Morning N R Middle of Day N R  Afternoon N R Evening N R 
            
            
            
            













1. Are any of the activities that you have just told me about things that you have 
recently taken up, or things that you had previously stopped doing but have recently 
restarted? By recently, I mean within the past six months? (go through each day of the 
week) 
 
2. Are there any things that you are not doing at the moment, but have plans to do, or 
would like to do in the future? 
 
3. Do you live with, or see a lot of, a family member or someone with whom you have a 




4. How satisfied are you with what you have been doing in the past week on a scale of 
1-5, with 1 = not satisfied, and 5 = very satisfied? 
 
1                            2                             3                             4                             5 
 
 







S  Morning N R Middle of Day N R  Afternoon N R Evening N R 
            
            
            
            
            
        
S  Morning N R Middle of Day N R Afternoon N R Evening N R 
            
            
            
           
           







10.13. Appendix 13: Scatter plots indicating non-significant 
correlations 
The following scatter plots indicate the non-significant correlations from hypothesis 3 
(3.4.3).    
Figure 10.13.1.  Scatter plots indicating nightmare frequency as a function of A) PSYRATS 
measured hallucinations and B) PSYRATS measured delusions.   Trend line indicates the 
quadratic R
2 















Figure 10.13.2.  Scatter plots indicating nightmare frequency as a function of A) DASS-21 
measured anxiety and B) DASS-21 measured stress.   Trend line indicates the quadratic R
2 





















Figure 10.13.3.  Scatter plot indicating nightmare frequency as a function of PTSD 




















Figure 10.13.4.  Scatter plot indicating nightmare distress as a function of CORE-10 





















Figure 10.13.5.  Scatter plot indicating nightmare frequency as a function of daily 














Figure 10.13.6.  Scatter plot indicating nightmare distress as a function of daily activities, 










Figure 10.13.7.  Scatter plot indicating nightmare distress as a function of A) PTSD 



































Session 1 focused upon psychoeducation about sleep, nightmares, imagery, and the theoretical basis of 
IRT. Initial sleep and nightmare assessments were completed and a daily nightmare log was introduced. 
Veterans were instructed to document, each morning, the nightly frequency and intensity (on a 1-to-10 
Likert-type scale where 0=extremely disturbing) of nightmares, defined as dreams that elicit negative 
affect and are experienced as distressing.  
 
In Session 2, veterans learned guided pleasant imagery, developed a personalized pleasant imagery scene, 
and established an imagery rehearsal schedule. Veterans were to practice pleasant imagery for 10 minutes 
at least two times daily and document these sessions on the nightmare log. 
 
Session 3 started with a review of veteran adherence to the pleasant imagery rehearsal schedule, which 
was documented on the nightmare log. Compliance difficulties were addressed. Behavioral strategies to 
improve compliance were suggested and a “dose response” curve (i.e., relationship between length of time 
spent rehearsing imagery and likelihood of nightmare reduction) was emphasized. Session 3 also included 
“rescripting” of nightmares. Veterans selected one nightmare they wished to change (the target 
nightmare). Therapists suggested the target nightmare should be one that occurs with frequency (i.e., 
more than 1x/week). Ultimately, however, veterans were free to rescript any nightmare of their choosing. 
Among participating veterans reported upon here, 97.1% (n=33) elected to rescript a nightmare related to 
a past traumatic event. Of these, 84.8% were related to military service. Using Krakow and Neidhardt's 
(1992) directions to change the nightmare “any way you wish,” therapists taught veterans to identify and 
elaborate on an alternative, neutral and/or pleasant ending for the target nightmare (the “rescript”). 
Specifically, therapists guided veterans in writing a highly detailed, vivid, and creative alternative ending 
that did not elicit negative affect or include distressing content from the target nightmare. The alternative 
ending was attached to the target nightmare in such a way that only non-distressing nightmare content 
from the target nightmare was present in the rescript. Veterans practiced visual imagery of the rescripted 
nightmare in session and were assigned imaginal rehearsal of the “new dream” at least twice daily for 10 
minutes. 
 
Session 4 involved review of treatment progress and compliance with imagery rehearsal, adjustment of 
rescript and/or imagery schedules, and identification of potential barriers to treatment compliance. 
Common barriers included difficulty focusing on the rescripted imagery and experience of negative 
intrusive thoughts and/or negative affect during imagery rehearsal. The former was addressed by 
identification of environmental factors that compromised ability to concentrate (e.g., cell phone, noisy 
room) and review of behavioral strategies to refocus attention back on the imagery (e.g., snapping a 
rubber band on wrist, reorienting to the written script, etc.). Intrusive thoughts were countered most often 
by encouraging the veteran to change from imaginal rehearsal to reading and focusing on the written 
version of the rescript. Once the intrusive thoughts subsided, veterans were to return to imaginal 
rehearsal. If that strategy was ineffective and/or if imagery consistently elicited negative thoughts and/or 
feelings, the therapist worked with the veteran to identify and remove distressing elements from the 
rescript. 
 
Session 5 emphasized relapse prevention. Specifically, treatment success and/or failures were 
reviewed and veterans had the opportunity to demonstrate self-efficacy for the rescripting and 
imagery skills. Only one nightmare was rescripted in the course of therapy; however, veterans were 
encouraged to apply the rescripting process on their own if they experienced other distressing 
nightmares in the future. Sessions 4 and 5 were integrated in individual treatments if veterans 
exhibited rapid acquisition of imagery skill or if veteran's schedule prohibited attendance at Session 
5. For the purposes of this study, completion of four sessions was considered a full course of treatment 
(since acquisition of the treatment intervention skill occurred at Session 3 and no new skills were 
introduced after Session 3). 
 
The treatment was initially offered in an individual format that was structured, but not formally 
manualized. However, due to high demand in the clinic, the treatment was manualized and offered in 
group format (with two co-therapists, one of whom was typically the first author). This maximized the 
number of veterans treated in a timely manner. Determination of participation in individual or 
group IRT was based solely on flexibility of veterans' schedules (i.e., ability to attend the 
established time for group sessions). Other than self-report of distressing nightmares, no other 
distinguishing characteristics were used to determine group composition. As such, groups contained 
a mix of veterans from different service eras and with (or without) various comorbid conditions 






























The method of Imagery Rehearsal Training has been adapted from that used by Nappi, Drummond, Thorp & 
McQuaid, (2010).  Therapy will be delivered in an individualised approach and incorporating a degree of 
flexibility (for example in session number and length) as recommended in Fowler et al.’s (1995) CBT for 





1 Additional questionnaires completed and dream logs passed to the researcher.  Psycho-
education about sleep, nightmares, imagery and the theoretical basis for IRT.  May 
include learning guided imagery through the development of personalised pleasant 
imagery scene.  This will be recorded in session and participants will be encouraged to 
listen to the CD prior to the second session.  Alternatively, the researcher can type a 
written script and send it to the participant. 
2 Rescripting of one target nightmare (suggest one that occurs frequently, ie. more than 
once per week).  Participants to be taught to identify or elaborate an alternative neutral 
and/or pleasant ending.  This is done by guiding participants to write a highly detailed, 
vivid and creative ending that does not elicit negative affect or include distressing 
content from the target nightmare.  This alternative ending will be explored in much 
detail through imagery, eliciting as much sensory information as possible (including 
visual, auditory, olfactory and tactile detail where appropriate).  The alternative ending 
will be attached to the original nightmare, just prior to the moment of maximum affect.  
Letter The researcher will write a summary of the re-script and post to the participant and/or 
send a CD recording of the transcript.  The CD may be a more accessible means of 
rehearsal for those who hear voices.  Participants will be encouraged to read the re-
script or listen to the CD once per day, before going to bed. 
3 Participants will be invited to return for a review of progress.  Adaptations to the re-
script will be made, as appropriate. Barriers to rehearsing the rescript at home will be 
discussed and problem solved.  
4 There will be optional additional sessions for those who feel that further adaptations to 
the re-script would be beneficial.  At the end of the final session participants will 







10.16 Strategies for enhancing imagery vividness and immediacy.  










1. Get a detailed description of the environment in which the event takes place: 
‘where are you? What colour is the room? What is in the room? How does it 
smell?  What’s the temperature? 
2. Focus in particular on bodily feelings.  When asking about other elements of the 
image (e.g. emotions, thoughts, and behaviour), it is often helpful to lead with 
imagery of physical feelings and sensations (e.g. heart rate, tingling, the pit of the 
stomach, or body temperature).  ‘What are you feeling in your body?  Where do 
you feel it? What’s that like?  How extensive is it?’  The therapist picks up any 
metaphors that the clients might use, and reflects these back: ‘so it feels as if you 
have a big black hole in the pit of your stomach’ 
3. Emphasise that images can be multi-sensory: ask about visual, auditory, 
kinaesthetic, tactile, and olfactory elements; or explore felt senses and 
atmospheres. 
4. Get rich detail, such as ‘Imagine you are a film director.  I can’t see the film.  
Explain exactly what’s happening, and what you can see to me’. 
5. Have the client adopt a ‘field perspective’ where they live the experience from the 
inside.  This should be: ‘As you are looking at the wall, what are you noticing?’ 
rather than an observer perspective, where the client is looking on at the 
experience as if an ‘outsider’: ‘As you see yourself looking at the wall, what do you 
notice?’ 
6. Ask the client to use the first-person present tense, recounting the experience as if 
it is happening to them now (‘I am running down the road, being chased...’).  if at 
first this is experienced as too threatening, the client might start from the 
observer perspective using the past tense: ‘see yourself back then, six months ago, 
running down the road, being chased...’ The therapist can then move the client to 
the first person, present tense, as they gain confidence in their ability to cope with 
high emotion. 
7. Explicitly name different parts or aspects of self which may be present in the same 
image, so that the client is clear which ‘self’ is centre stage at any given time (e.g. 
adult john, 8 year old John). 
8. Keep checking with client to make sure they are staying with the process, and that 
the image is clear (e.g. ‘Tell me what you are seeing.  What’s happening in your 
body?  Where are you now?’) 
9. Ask specific questions at certain points: ‘What are you learning from this 
experience; about yourself, about other people, about life in general?’                ” 
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Objective: To investigate whether the cost of care for patients decreased following Cognitive 
Behavioural Therapy for psychosis (CBTp), delivered by a specialist clinic.  Method: Cost of care was 
defined as use of high cost services including inpatient stays and home treatment or crisis resolution 
care.  Electronic medical records were searched to identify the number of days using high cost 
services.  Service cost data were used to convert service use into cost per patient per month (N = 
70), which was compared one year prior to, during and one year following therapy.  Results:  
Overall, cost of care per month was not significantly lower following therapy.  Sub-group analysis 
however revealed that those who utilised high cost services prior to entering therapy significantly 
decreased in care costs in the twelve months following cessation of therapy.  Conclusion: For 
























To evaluate the cost effectiveness of a specialised psychology service for outpatients with psychosis.  
Cost effectiveness will be determined by evaluating the number of inpatient admissions and 
contacts with home treatment teams before, during and after psychological intervention.  The 
primary outcome of this data analysis will be to inform Primary Care Trusts, individual referrers and 
tertiary referral funding panels about the cost effectiveness of the service.  As a secondary outcome, 
the data will inform clinic therapists of relapse rates prior to, and following therapy which can inform 
the emphasis on relapse prevention offered within this therapeutic context. 
 
1.2 The PICuP clinic 
The Psychological Intervention Clinic for out-patients with Psychosis (PICuP) is a specialist tertiary 
service, which previously ran under the umbrella of the National Psychosis Unit.  Since the advent of 
Clinical Academic Groups (CAGs) in 2010, PICuP is now part of the Psychosis Recovery Care Pathway. 
PICuP offers Cognitive Behavioural Therapy (CBT) for individuals with distressing positive symptoms 
of psychosis or individuals with emotional difficulties in the context of a history of psychosis.  CBT is 
known to be efficacious with psychosis, and is recommended by the NICE Schizophrenia Guideline 
(NICE, 2009).  
 
PICuP has received almost 600 referrals over the last 9 years, 58.5% are males, with an average age 
of 38 years (range 15-67).  52% are from BME populations.  Although PICuP receives referrals 
nationally, 92% of referrals come from the seven boroughs of the South East London Sector, with 
Southwark and Lambeth being the highest referrers.  
 
1.3 Why assess cost-effectiveness? 
Given that PICuP is a specialist tertiary NHS service, therapy costs are met by Primary Care Trusts on 
a cost per case basis.  Individual referrers are required to consider the clinical benefits of referring to 
a specialist service, as well as the cost of the proposed specialist treatment.  An audit of referrers to 
the PICUP clinic revealed that 90.6% thought that PICuP was either “useful” or “very useful” (Miles, 
H. et al. 2007) suggesting that referrers believe there to be clinical benefits to referring patients to 
the PICuP clinic.   In addition 91% of service-users reported feeling satisfied/very satisfied with the 
therapy they receive and clinical effectiveness of PICuP therapy has been demonstrated on a range 
of outcomes including voices, delusions, depression, anxiety and quality of life (PICuP Business 
  





Report 2012).  However, the clinical cost before and after this therapy has not yet been explored.  
The analysis from the current evaluation could assist Primary Care Trusts, referrers and tertiary 
referral panels to make informed decisions regarding the cost of care in referring patients to this 
specialist service for outpatients with psychosis. 
 
1.4 The economic burden of schizophrenia and related psychotic disorders 
Kirkbride et al. (2011) reviewed 147 individual studies for the Department of Health in order to 
estimate the incidence, prevalence and economic burden of schizophrenia in England.  They report 
the annual incidence of all psychotic disorders to be 32 cases per 100,000, with an annual 
prevalence rate of 4 people per 1000.  Based on these prevalence data they suggest an annual 
economic cost of £8.8 billion for those with schizophrenia and £5.0 billion for other affective 
psychoses.  For schizophrenia alone, £4.1 billion of the estimated total cost (47%) is due to lost 
employment, whilst 40% of the cost is due to service related costs.  £1.7 billion of the service cost 
(49%) is due to the cost of inpatient services.  This differs from those with affective psychosis, with a 
reported 80% of costs arising from the National Health Service (NHS).    
 
The above study highlights the large economic impact of psychosis on society, as well as pinpointing 
areas in which savings could be made.  The data suggest that the cost of NHS care generally and an 
inpatient admission in particular is a useful outcome measure for evaluating the economic benefits 
of a treatment.  In the current study, we ask whether investing in PICUP’s specialist therapy service 
might later result in a reduction in the economic burden of psychosis, as represented by reduced 
inpatient stays and home treatment team contacts.  
 
1.5 Why look at inpatient and home treatment data? 
The full NICE Guideline (NCCMH, 2010) states that ‘inpatient treatment is by far the most costly 
healthcare component in the overall treatment of schizophrenia’ (p. 32).  In 2006-07 there were 
34,407 reported inpatient admissions, totalling 2,232,724 inpatient days for schizophrenia alone.  
This represents 34% of all psychiatric bed days (NCCMH, 2010).  Given both the cost and the number 
of inpatient admissions related to schizophrenia, it is an appropriate measure of the cost 
effectiveness of therapy. 
 
Crisis Resolution and Home Treatment Teams aim to avoid admitting acutely ill people to hospital by 
providing intensive home-based support (NCCMH, 2010).  The teams provide ‘any type of crisis 
  





oriented treatment of an acute psychiatric episode by staff with a specific remit to deal with such 
situations, in and beyond office hours’ (p. 354, NCCMH, 2010).  In this way, the introduction of such 
teams served to reduce the need for inpatient admissions by providing high cost community based 
support at the point of crisis.  
 
Given that the nature of both inpatient and home treatment care is to provide high intensity 
support, they are associated with high cost.   The average cost of one day on an acute ward is £312 
(Curtis, 2011).  Given that the NICE guidelines suggest figures of 2,232,724 inpatient days across 
34,407 admissions, this works out to be an average of 65 days per admission.  It can therefore be 
estimated that an average cost per admission amounts to approximately £20,246.  Curtis (2011) 
reports that the average cost per case of treatment with a Crisis Resolution/Home Treatment team 
amounts to £30,592.  This figure is determined by a team member cost, divided by their case load.  
Given that crisis teams hold a case load of approximately two cases per year per team member, their 
cost per case is significantly higher than that of a Community Mental Health Team (CMHT).  The cost 
per case for CMHT support amounts to only £2,523 (£28,069 less than for a crisis resolution/home 
treatment team).  This lower figure is attributable to the lower intensity of support and lower 
duration of support (CMHT’s do not provide support 24 hours a day, 7 days a week).  This lower 
intensity allows for an increased caseload of 27 cases per staff member.  The above calculations 
highlight the validity of utilising inpatient and Crisis Team/Home treatment team care as a measure 
of high care costs before, during and following therapy with the PICUP clinic. 
 
1.6 Cognitive Behavioural Therapy (CBT) for psychosis: 
The PICuP clinic offers Cognitive Behavioural Therapy (CBT) for psychosis.  This form of therapy is a 
‘structured and time limited approach to the management of the problems of people with psychosis’ 
(p. 83, Fowler, Garety & Kuipers, 1995).  CBT began its development in the 1950’s when Albert Ellis 
considered the role of therapy was to help a client understand the role that his beliefs played in their 
own emotional pain.  Since this time, CBT has been shown to be efficacious for a range of disorders 
and is currently recommended for people with psychosis as an adjunct to medication (NICE, 2009).  
CBT for psychosis (CBTp) aims to make links between people’s feelings and their patterns of thinking, 
which underpins their distress (Jones et al, 2010).  A highly individualised approach that fosters 
therapeutic engagement is adopted in order to reach shared goals.    A meta-analysis has indicated 
that CBTp has a modest effect on positive symptoms of psychosis (0.37), negative symptoms (0.44), 
functioning (0.38) and mood (0.36) (Wykes et al. 2008).  The full NICE guidelines (NCCMH, 2010) 
  





report that when compared with standard care alone, CBT ‘was effective at reducing 
rehospitalisation rates up to 18 months following the end treatment’ (p.266), and that the duration 
in hospital is also reduced by an average of 8.26 days. 
 
1.7 Existing literature evaluating cost effectiveness of CBT for psychosis 
There is a paucity of methodologically rigorous studies evaluating the cost effectiveness of CBTp.  
Three studies have indicated that despite the cost of providing therapy, CBTp is associated with no 
increased health related costs and a fourth study revealed increased costs following CBT.   Kuipers et 
al. (1998) carried out a post-hoc economic evaluation of a randomised controlled trial (RCT) of CBTp.  
In comparison to those receiving standard care, those who received CBT reported improved clinical 
outcomes.  The cost analysis revealed that the average monthly cost of CBT per patient was low: 
£123.  Despite this added cost for the intervention group, the overall cost of care was no higher than 
for standard care alone.  Unfortunately, as the economic analysis was performed after the initial 
RCT, the number of participants was too low to have enough power to detect significant differences 
between groups. 
 
Startup et al. (2005) evaluated two-year clinical gains and health costs following CBTp in the acute 
stage of psychosis.  In addition to the assessment of psychotic symptoms and overall functioning, 
health economic data were obtained from hospital, community, residential and primary care, 
including medication.  Compared with treatment as usual, those who received CBTp maintained 
improvements in symptoms and social functioning two years following the index admission.  Analysis 
of costs revealed that the total health cost over the 2 year period was not significantly different for 
the CBT group, compared with the treatment as usual group.  This was true despite the added mean 
cost of £769 for provision of CBTp in the treatment condition.  This study indicates that CBTp is 
associated with clinical gains over a two year period with no evidence that provision of therapy 
increases the total cost of care.   On the basis of the studies by Kuipers et al. (1998) and Startup et al. 
(2005), in addition to the clinical benefits, the full NICE Schizophrenia Guideline (NCCMH, 2010) 
concludes that CBT is potentially a cost effective intervention for people with acute psychosis or 
medication resistant schizophrenia. 
 
Peters et al. (2010) ran a trial within a routine clinical setting (PICuP) to evaluate CBTp, delivered by 
non-expert therapists.  An economic evaluation was carried out using the Client Service Receipt 
Inventory which assessed health and social care service use as well as informal care provided by 
  





family/friends.  These data were self-reported by patients and converted to monetary value using 
unit costs for particular services and professionals.  A waiting-list control design was used such that 
participants were allocated to immediate therapy or therapy after nine months wait.  Economic 
evaluation indicated that the immediate therapy group showed no significant increase in care costs 
when compared to the waiting list control despite the additional cost of therapy.  In addition, when 
the waiting list control received therapy nine months later, their care costs did not significantly 
increase.  This finding suggests that the addition of CBTp to treatment as usual need not necessarily 
increase patient cost.  
 
The fourth study to evaluate cost effectiveness for CBTp found an increase in costs related to CBTp.  
Van der Gaag et al. (2011) carried out cost effectiveness analysis for CBTp in comparison to 
treatment as usual.  This multi-site RCT utilised a measure of ‘time functioning in the normal range’ 
(p. 59) which was defined by measures of social functioning  compared to the general population, 
minimal suffering and minimal effect of persistent psychotic symptoms on daily living.  Results 
indicated that implementing CBTp gave participants increased number of days functioning within the 
normal range; however provisions of CBTp was accompanied by higher overall costs.  The increased 
cost in the CBTp group was mostly accounted for by a small proportion of participants who were 
long stay inpatients when they entered the study; CBT was not considered to either cause or 
lengthen their inpatient stay.  This study shows firstly that despite the fact that CBT improved health 
outcomes, this was not sufficient to decrease overall health related costs.  Secondly it highlights the 
influence of hospital admissions on the cost of care in those with psychosis.   
 
Although the literature to date is clear that CBT for psychosis can result in health benefits that 
persist for longer than a year, there is a relative scarcity of research evaluating the economic impact 
of such clinical gains.  Whilst the studies of Kuipers et al. (1998), Startup et al. (2005) and Peters et 
al. (2010) suggest the addition of CBT to standard care results in no additional cost, the results of van 
der Gaag suggest that some level of monetary investment must be made in order to reap the 
benefits of the clinical gains.  There are no studies to date which indicate a decrease in health 
related costs, following provision of CBTp.  The current evaluation seeks to add to the current 












Seventy participants were selected for inclusion in the evaluation from a database of all patients 
who had received therapy in PICuP.  Patients who had not consented to research were excluded.  
Although PICuP is a National Specialist service, only those patients within South London and 
Maudsley (SLaM) NHS Foundation Trust were included since only their electronic patient records 
were available for analysis.  Patients who had received further therapy following completion of their 
initial therapy with PICuP were still included in the evaluation. 
 
2.2 Measures 
Given that the highest cost of care is inpatient stays and contacts with home treatment / crisis 
resolution services, the number of days registered with each of these services was used as an 
estimate of patient care cost prior to, during and following CBT therapy with the PICuP clinic. 
The dependent variables were: 
 
1. Number of days registered on a psychiatric inpatient ward 
2. Number of days registered with a home treatment or crisis resolution team 
 
These were combined to create an overall variable with the days spent under a high cost care team.   
The independent variable was time period, which had three levels: 
 
1. One year prior to an accepted referral  
2. During therapy and before discharge 
3. One year following discharge, or until the follow up assessment was completed 
 
The duration of these time periods varied for each patient, so the number of days registered with an 
inpatient ward or home treatment team was divided by the number of months in each time period.  
In this way a value of number of days per month was calculated for both inpatient stays and crisis 
resolution/home treatment contacts.  These figures were then multiplied by the cost of care per day 
for inpatient treatment (£312) and crisis resolution/home treatment team (£103) to give cost per 
month.  Cost data were sourced from Curtis (2011). 
 
  






Participants who had declined the opportunity to take part in research were excluded from the 
initial sample of patients to be included in the evaluation.  All remaining patients held on the PICuP 
master database were sorted by date of initial assessment in order to exclude participants who had 
not completed therapy plus a follow up period of a year.  Participants who had received their initial 
assessment at least one and a half years prior to the time of data collection were therefore included.  
This resulted in patients who had completed their initial assessment in the time period from 02 
August 2006 to 01 December 2009 being included in evaluation. 
 
The Electronic Patient Journey System (EPJS; SLaM’s electronic patient records system) was used to 
search for individual patient records.  The first data to be extracted from these records were the 
three key assessment dates: initial assessment date, second assessment date (undertaken upon 
allocation to a therapist) and end of therapy assessment date.  In approximately half the cases these 
dates were available from the PICuP master database; in cases where a date was missing, EPJS was 
used to ascertain the date.  If patients had not been discharged from PICuP at least one year prior to 
the date of the search, they were excluded from the data on the basis that they had not had a long 
enough follow up period.  In addition, if a patient had not completed a minimum of five therapy 
sessions, they were excluded from the main dataset as they were considered to have dropped out of 
therapy.  Number of days under high cost care teams was collected for those who dropped out, for 
the time period prior to therapy, in order to ascertain whether those who did not engage in therapy 
differed in their service use prior to initial assessment for PICuP therapy.  
 
Lastly, for each of the remaining patients, referral/movement data from EPJS were used to ascertain 
the number of days under the care of any psychiatric inpatient ward.  This number was then entered 
into the appropriate reference period: one year prior to therapy, during therapy or, during the 
follow up period after discharge from PICuP.  This same method was used to ascertain the number 
of days under the care of a home treatment / crisis resolution team.   
 
Once all patient data were collated, the number of days on an inpatient ward was divided by the 
total number of months for the reference period.  As an example, if a patient was in therapy  for six 
months and within that time had 12 days on an inpatient ward, the number of days per month 
would be 2 (12 days / 6 months = 2days/month).  This provided a consistent unit of measurement 
across participants, since the reference time periods varied. 
 
  





Patients who did not consent to 
research excluded (n=22) 
The unit of analysis was total cost of care per month.  This was calculated by working out the 
number of days contact with inpatient or home treatment team for each participant per month and 
multiplying this figure by the cost of each service.   
 
3. Results 
Following placing patients in order of initial assessment date, 183 patients were assessed for 
eligibility and exclusion criteria in order gain a sample size of 70 patients.  Figure one indicates the 

























Patients ordered by date of initial 
assessment (n=183).  
Patients with less than one year 
follow up since end of therapy 
excluded (n=58) 
Patients whose details were not 
registered on SLaM EPJS or whose 
notes were incomplete were 
excluded (n=11) 
Patients who died between initial 
assessment and end of the follow up 
period excluded (n=4) 
Patients who completed ≤4 sessions 
excluded (n=18) 
Final sample: Patients who 
completed therapy and completed 
one year follow up (n=70) 
Patients who utilised 
high cost services in the 
year prior to therapy 
(n=13) 
Patients who did not 
utilise high cost services 










Figure 1. Patient flow diagram indicating number of patients included in analysis and number of 
patients excluded, sorted by reason for exclusion. 
 
The total cost of care per month for the participant group as a whole decreased from £31,602.19 per 
month in the 12 month period prior to contact with PICuP to £15,159.48 during therapy.  This 
decreased further to £12,056.62 in the 12 month period following cessation of therapy (see figure 
2.).  However, there were no statistical difference in cost over time, [Friedman statistic: X
2 
(2, n=70) = 
4.48, p = n.s.].  
 
 
Figure 2. The total cost of care per month for 70 participants, as a function of time period (prior to 
therapy, during therapy and in the twelve months following therapy).  
 
The total cost of care was £0 for at least 75% of patients across all three time points (see figure 3).  
This may account for the lack of significance in the cost of care across time, despite a seemingly large 
decrease in overall cost.  It is notable that the range of care costs decreased (see figure 3) from the 
period prior to therapy (£7,793.60) to the period following therapy (£4,964.91) and that the number 






























Total Cost of Care (n=70)
  






Figure 3.  The number of patients incurring costs across the three reference periods (prior to 
therapy, during therapy and following therapy).   
 
Given that most patients incurred no costs, sub-group analysis was carried out in order to analyse 
cost data for just those participants who had utilised high cost services (inpatient and home 
treatment/crisis resolution services) prior to therapy.  The aim was to investigate whether therapy in 
PICuP decreased the use of high cost services in those who were prone to use costly care packages 
beforehand. 
 
Sub-group analysis revealed that those who had contact with inpatient and home treatment team 
services in the year prior to initial assessment at the PICuP clinic significantly reduced their use of 
these high cost services during therapy (wilcoxon signed rank: z = -1.99, n=13, p <.05).  The use of 
these services also decreased from the period prior to therapy to the 12-month follow-up period 
after cessation of therapy, (z =-2.62, n=13, p <.01).   The median cost in the twelve months prior to 
therapy was £1870, and this fell to £0 both during therapy and in the twelve months following 
therapy.  There was no significant difference between the cost of care during therapy and in the 12 
months following therapy, (z = -.365, n=13, p = n.s.). This indicates that the relapse prevention gains 
made in therapy are maintained twelve months post-therapy.   
 
  






Figure 4.  Total cost of care as a function of time period (prior to therapy, during therapy and in 
the twelve months following therapy) in those using high cost care prior to entering therapy. 
 
When looking at individual costs from these 13 patients, all incurred costs related to inpatient and 
home treatment or crisis resolution team use prior to therapy.  During therapy, this fell to 3/13 
patients requiring these high cost services.  In the year post-therapy, these three patients were still 
incurring costs related to high cost services and there was also one additional patient who had 
stopped using high cost services during therapy, but resumed use of these services within one year 
post-therapy (totalling 4/13).  This suggests that the overall number of patients requiring high cost 
services prior to therapy dropped after therapy, from 13 to 4.  Analysis of the trajectory of costs for 
individual cases shows that 10/13 of these patients show a decrease in their service costs over the 


























Total cost of care as a function of 
time for high cost care users (n=13)
  






Figure 5. Cost of care trajectories plotted individually for 13 patients who utilised high cost care 












































The cost of therapy was calculated for the 13 participants who were high cost care users prior to 
therapy (see table 1).  These costs were offset against the savings made through decreased use of 
inpatient and home treatment/crisis resolution services.  The mean number of PICuP therapy 
sessions completed was 20, which equated to a mean cost of £2692.85.  When the cost of therapy 
was offset against the savings made by decreased use of high cost care, the reduced costs were no 
longer present.  Rather, to achieve a decreased use of inpatient and home treatment/crisis 
resolution services, a mean investment of £1022.33 was required (see table 1). Only 4/13 patients 
maintained their cost saving when the cost of CBTp was offset against cost savings made by 
decreased use of other services (see table 1). 
 
Table 1.  Offsetting the costs saved from reduced inpatient and home treatment/crisis resolution 
team use against the costs incurred through provision of CBTp.  
 
 
Offsetting the Cost of Therapy for patients who were high cost service 



























  3,665.20 86.33 3,578.87 1,920.00 1,658.87** 
  1,870.67 3,950.38 -2,079.71 2,432.00 -4,511.71 
  2,051.05 0.00 2,051.05 1,152.00 899.05** 
  1,819.60 0.00 1,819.60 4,224.00 -2,404.40 
  317.51 0.00 317.51 2,432.00 -2,114.49 
  257.44 0.00 257.44 1,920.00 -1,662.56 
  5,988.28 0.00 5,988.28 3,200.00 2,788.28** 
  2,712.89 4,964.91 -2,252.02 768.00 -3,020.02 
  479.25 0.00 479.25 5,985.00 -5,505.75 
  3,784.80 0.00 3,784.80 4,446.00 -661.20 
  544.39 0.00 544.39 1,792.00 -1,247.61 
  7,793.60 883.81 6,909.79 2,688.00 4,221.79** 
  317.51 0.00 317.51 2,048.00 -1,730.49 
Mean: 2,430.94 760.42 1,670.52 2,692.85 -1,022.33 
**Patient maintained their cost saving when the cost of CBTp was offset against cost saving made 









The cost of care from inpatient and home treatment/crisis resolution services prior to therapy was 
compared with the cost of care following therapy.  The cost of care following therapy included the 
cost of inpatient and home treatment/crisis resolution costs but also included the additional cost of 
provision of CBTp from PICuP.  There was no difference in the total cost of care following therapy, 
despite the added cost of CBTp from PICuP (wilcoxon signed rank: Z = -1.36, n=13, p = .17).   
 
Service use data were collected for patients who completed an initial assessment for PICuP therapy, 
but did not complete at least five sessions of CBTp.  Eighteen patients fell into this category.  Four of 
the 18 patients utilised inpatient or home treatment / crisis resolution services in the year prior to 
their initial assessment (22.2%).  This compares with 13 of the 70 patients who completed therapy 
(18.57%).  Those utilising high cost services prior to assessment for PICuP therapy were equally 
distributed between those who did and did not engage in PICuP therapy, (X
2 
(1, n=88) = .12, p = n.s.).  
This indicates that participants who did and did not engage in therapy were similar with regards to 




The current evaluation suggests that, for the whole sample, Cognitive Behavioural Therapy (CBT) had 
no significant impact on the use of intensive care services during and after therapy compared with a 
year before therapy.  Although the overall cost of care fell during and following CBT with PICuP (due 
to fewer days using these intensive services), the difference was not statistically significant.  
However, this finding should be considered in light of the large number of patients who used no 
intensive services at any time point.   
 
When the analysis was restricted to only those clients who used these high cost services prior to 
entering therapy, their cost of care did significantly decrease following therapy within the PICuP 
clinic.  Plotting the individual cost trajectory of these 13 participants indicated that 10/13 showed a 
decrease in their service costs from one year prior to therapy to 12 months following cessation of 
therapy.  This was not an artefact of patients dropping out of therapy; those who dropped out did 
not differ on the number of high cost care days prior to entering therapy.  The decreased use of 
intensive services in the year following therapy suggests that this group are not relapsing to a point 
where they require services such as inpatient or home treatment / crisis resolution.  One likely cause 
  





for this reduced risk of relapse is receipt of therapy in the PICuP clinic.  Although this was not a 
controlled study, leaving open the possibility that factors other than therapy may have caused this 
reduction in service costs, it is nevertheless an exciting result.  
 
The decreased cost of care for this sub-sample of high cost services users was no longer significant 
when the cost of therapy was offset against the cost savings.  A mean investment of £1022.33 was 
required in order to achieve reduced use of high cost services in the period following therapy.  
Critically, this investment did not significantly raise care costs beyond what they were in the year 
prior to therapy.  This suggests a shift in direction of funding; rather than funds being invested in 
inpatient and home treatment/crisis resolution care as they were prior to therapy, they are invested 
in CBTp with PICuP for a limited time period.  Three previous studies have found a similar result; that 
despite the added cost of a CBTp intervention, the overall cost of care was no higher than standard 
care alone (Kuipers et al., 1998, Startup et al., 2005, Peters et al., 2010).  Furthermore, the lack of 
increased cost in these three studies occurred in the context of significant clinical gains that were 
maintained at 3 months (Peters et al. 2010), 18 months (Kuipers et al., 1998) and two years (Startup 
et al., 2005) post CBTp.   An extension of the current evaluation might consider lengthening the 
follow up period beyond that of one year in order to consider whether reduced costs from inpatient 
and home treatment/crisis resolution are maintained, without further investment in therapy. 
 
The full NICE guidelines (NCCMH, 2010) report results from a meta-analysis of 31 randomised 
controlled trials of CBT for psychosis versus any type of control.  This review found consistent 
evidence that, when compared with standard care, CBT was effective in reducing rates of 
rehospitalisation up to 18 months following the end of treatment.  In addition, there was robust 
evidence indicating that the duration of hospitalisation was also reduced by an average of 8.26 days.  
This reduction is consistent with the data from the PICuP clinic evaluation, which found reduced 
intensive service use (inpatient and home treatment/crisis team) following therapy for those 
participants who used these services prior to entering therapy.   
 
It is noteworthy to consider the patients who fell into the sub-group for further analysis.  These were 
all patients who had utilised inpatient and/or crisis/home treatment team support within the 12 
months prior to contact with PICuP.  In this regard they might be considered to be less recovered 
from an acute episode than the participants who did not require this same level of support, and it is 
possible that these participants were not in the stable phase of the illness.  Indeed four of the 
  





thirteen patients who formed this sub-group received inpatient/home treatment support either 
during their time in therapy, or whilst on the waiting list for therapy.   
 
One study which has explored the effect of CBTp in those who have recently experienced an episode 
of psychosis, rather than being in the stable phase of the illness, is that of Garety et al. (2008).  This 
study was an RCT of CBT for psychotic patients who had recently relapsed.  The sample was more 
comparable to the sample in the current sub-group analysis as they had experienced a second or 
subsequent episode of psychosis no more than three months before entering the trial.  Initial results 
indicated that high quality CBT had no effects on rates of remission and relapse or on days in 
hospital at 12 or 24 months.  However further detailed analysis revealed that engagement in active 
CBTp techniques (as opposed to engagement and assessment only) was associated with increased 
months in remission and decreased psychotic and affective symptoms (Dunn et al. 2011).  The 
current evaluation of patients at PICuP had a smaller sample size, did not assess level of engagement 
in therapy, nor utilise a treatment as usual comparison group and is therefore not as 
methodologically robust.  Nevertheless it is a promising result to find that patients can decrease 
their use of intensive and high cost care services following an acute episode of psychosis when 
offered CBTp through specialist NHS care.   
 
This evaluation benefited from being an independent and retrospective evaluation, set in a specialist 
CBT for psychosis care setting.  In this way, the therapy delivered and the results collected were in 
no way influenced by the fact that the evaluation was taking place.  In addition they may be 
regarded as a good reflection of standard care from this specialised CBT for psychosis clinic.  Because 
of the retrospective nature of the evaluation, patients at PICuP could be followed for a long time 
period; one year prior to therapy, during therapy, as well as one year following therapy.  The long 
duration with which the patients were followed allowed enough time for fluctuation in functioning, 
which is realistic for a relapsing condition such as psychosis.  It would be interesting to follow those 
who were high cost service users prior to entering therapy further into the future: although the cost 
of their care reduced over a 12 month period, it would be interesting to revisit this group in the 
future to evaluate whether their journey to recovery continued. 
 
There are a number of limitations to the evaluation. First, current service use costs were used.  In 
fact, given that a patient may have used inpatient services one year prior to contact with PICuP and 
then engaged in therapy for six months and had a twelve month follow up period, the cost of their 
  





inpatient stay may have been calculated based on figures that are at least one financial year out of 
date.  This of course must be balanced with resource limitations; to calculate the exact service cost 
for each participant based on the exact time period that they were utilising services would have 
been unfeasible.   
 
The second limitation of note is the method of estimating cost data for each patient.  Home 
Treatment Services for example, are usually billed on a ‘per contact’ basis rather than per day.  This 
means that in real terms, the cost per day will vary based on the amount of telephone calls and face 
to face contacts a patient receives.  For the purpose of the current evaluation it was decided that 
allowing an estimate of cost per day would allow data to be collected for more patients.  Therefore 
although the cost data might be more accurate using number of contacts, the number of patients 
whose data could have been analysed to this level would have been reduced.  An additional cost 
consideration is that of those patients who had an inpatient stay, it is possible that some were 
offered absence leave.  If this is the case, the bed day may not have been billed to that patient but 
instead considered an unused bed.  It was not possible to discern this level of information from the 
patient records, therefore absence days from inpatient stays was not included in analysis. This 
method was however consistent across all time points (before therapy, during therapy and after 
therapy) and therefore should not have biased the results in a meaningful way.  
 
The data for the full set of 70 participants were skewed across all three time periods.  This level of 
skew is normal in most health service cost data where resource consumption is low for the majority 
(Kilian et al., 2002).  However, a further evaluation might consider an alternative way of collecting 
cost data.  Given that over 75% of participants did not utilise any high cost services, it is worth 
considering whether this is the best measure for evaluating costs in this cohort.  A future study 
might consider cost data from all levels of service intensity.  It is for example possible that some 
patients in the current evaluation reduced their care needs from Community Mental Health Team 
back to Primary Care.  Although this would constitute a decrease in health care costs, this type of 
change was not captured in the current evaluation due to the focus on the most costly care settings. 
 
Further to this, a future evaluation might consider extending the concept of cost effectiveness 
beyond NHS intensive care provision.  It may for example be beneficial to consider the number of 
patients who were engaging in employment, the number of patients who were discharged from 
Community Mental Health Teams back to Primary Care, or the number of patients whose carers are 
  





engaging in employment rather than fulfilling a caring role.  Indeed although employment data were 
not available for the current patient group, given that Kirkbride et al. (2011) suggest 47% of the total 
cost of schizophrenia is attributable to lost employment, this would seem a valid measure to be used 
in future cost evaluations.   
 
5. Implications for health service practice 
The current evaluation suggests that patients who have recently relapsed, but who receive CBT, 
decrease in their use of high cost care services.  Given that at least 75% of the patients who were 
included in the current evaluation had no inpatient stays or home treatment costs, it seems that 
those who have recently had an acute phase of psychosis are in the minority of people being 
referred.  This is a helpful result to feedback to Primary Care Trusts, individual referrers and tertiary 
referral panels.  When deciding on whom to refer for CBT, they could consider those who have 
recently relapsed, but who feel able to engage in regular therapy sessions.   
 
The current evaluation found that intensive service costs (from inpatient and home treatment / crisis 
resolution days) for the participant group as a whole decreased from the period prior to therapy to 
during therapy and then further decreased in the 12 month period following cessation of therapy, 
although not to the extent to be statistically significant.  This lack of significant difference is likely 
due to the majority of patients who did not use these intensive services at any time point, causing 
the data to be skewed.  In order to further aid economic evaluation of CBT for psychosis, it is 
recommended that the PICuP clinic collect data regarding employment status and whether a patient 
has been discharged to their GP, both before and after therapy.  These variables might offer a more 
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